General Information of Disease (ID: DISI1SZ7)

Disease Name Systemic lupus erythematosus
Synonyms
excess lymphocyte low molecular weight DNA; excess LMW-DNA; lupus nephritis, susceptibility to; Lupus; disseminated lupus erythematosus; SLE - lupus erythematosus, systemic; systemic lupus erythematosus, susceptibility to; systemic lupus erythematosus; lupus erythematosus, systemic; systemic lupus erythematosus susceptibility to; systemic lupus erythematosus (disease); SLE
Disease Class 4A40: Lupus erythematosus
Definition
An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
Disease Hierarchy
DISOKJWA: Lupus
DISI1SZ7: Systemic lupus erythematosus
ICD Code
ICD-11
ICD-11: 4A40.0
ICD-9
ICD-9: 710
Expand ICD-11
'4A40.0
Expand ICD-10
'M32; 'M32.1; 'M32.8; 'M32.9
Expand ICD-9
710
Disease Identifiers
MONDO ID
MONDO_0007915
MESH ID
D008180
UMLS CUI
C0024141
OMIM ID
152700
MedGen ID
6146
HPO ID
HP:0002725
Orphanet ID
536
SNOMED CT ID
55464009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 21 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Abatacept DMSA8RU Approved NA [1]
Alemtuzumab DMZL3IV Approved Antibody [2]
Anifrolumab DM3FPAQ Approved NA [3]
Belimumab DM3OBQF Approved Antibody [4]
Belumosudil DM548TK Approved NA [5]
Betamethasone DMAHJEF Approved Small molecular drug [6]
Busulfan DMXYJ9C Approved Small molecular drug [7]
Chloroquine DMSI5CB Approved Small molecular drug [8]
Cortisone Acetate DMG8K57 Approved Small molecular drug [9]
Dexamethasone DMMWZET Approved Small molecular drug [10]
Fludarabine DMVRLT7 Approved Small molecular drug [11]
Hydrocortisone DMGEMB7 Approved Small molecular drug [12]
Hydroxychloroquine DMSIVND Approved Small molecular drug [13]
Methylprednisolone DM4BDON Approved Small molecular drug [14]
Mycophenolate mofetil DMPQAGE Approved Small molecular drug [15]
Mycophenolic acid DMRBMAU Approved NA [1]
Prednisolone DMQ8FR2 Approved Small molecular drug [16]
Prednisone DM2HG4X Approved Small molecular drug [17]
Sifalimumab DM1BS03 Approved Antibody [18]
SM-101 DMFX9O6 Approved (orphan drug) Small molecular drug [5]
Triamcinolone DM98IXF Approved Small molecular drug [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 21 Drug(s)
This Disease is Treated as An Indication in 53 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Atacicept DM8GFEV Phase 3 NA [5]
BIIB059 DMUDM2Y Phase 3 NA [20]
Blisibimod DM7V9LH Phase 3 NA [5]
BVT.2733 DM6RUKX Phase 3 Small molecular drug [5]
CPL-7075 DM62E7C Phase 3 Small molecular drug [5]
Epratuzumab DMI1ZXV Phase 3 Antibody [21]
Forigerimod DM5S4DL Phase 3 Small molecular drug [22]
Litifilimab DMBZN7J Phase 3 Monoclonal antibody [23]
Nipocalimab? DM0DYAX Phase 3 Monoclonal antibody [24]
A-623 DM2GFPX Phase 2/3 Small molecular drug [25]
Afimetoran DM3HN3U Phase 2 Small molecule [26]
ALX-0061 DMO1VHC Phase 2 Antibody [5]
AMG 557 DME6QH1 Phase 2 NA [27]
AMG 570 DMY1XJH Phase 2 Small molecular drug [28]
BMS-931699 DMDS9Q0 Phase 2 NA [5]
CC-220 DMNE7L3 Phase 2 Small molecular drug [5]
Cenerimod DMU3P1K Phase 2 NA [5]
Dapirolizumab pegol DMIYFWA Phase 2 NA [5]
Daxdilimab DM5BV5H Phase 2 Monoclonal antibody [29]
DV-0100 DMT3U1I Phase 2 NA [30]
Efavaleukin alfa DMG77O2 Phase 2 Fusion Protein [31]
Frexalimab DMMJTYP Phase 2 Antibody [32]
GSK2586184 DMA2IXQ Phase 2 NA [33]
IFN-Kinoid DMKPD0B Phase 2 NA [34]
INV103 DMM29N9 Phase 2 NA [5]
Lulizumab pegol DMGWZ93 Phase 2 NA [5]
LY3361237 DMHXMYU Phase 2 Antibody [35]
M2951 DMC5MQD Phase 2 NA [5]
MEDI-545 DMPM6EL Phase 2 NA [36]
MEDI5872 DMCW2P5 Phase 2 NA [5]
NKTR 358 DMEA7HD Phase 2 NA [37]
PF-04236921 DM826SW Phase 2 NA [38]
PF-06835375 DMNIYPS Phase 2 NA [39]
Rontalizumab DMBJN19 Phase 2 Antibody [40]
RSLV-132 DMP4519 Phase 2 NA [5]
Veltuzumab DM5BL4C Phase 2 Monoclonal antibody [41]
Vobarilizumab DM9KNJT Phase 2 Antibody [42]
Xmab 5871 DMLIPY1 Phase 2 NA [5]
Milatuzumab DM4H7UY Phase 1/2 Antibody [5]
ABBV-084 DMEF48X Phase 1 NA [5]
AGS-009 DMU21JF Phase 1 Antibody [43]
AMG 811 DMEIMBP Phase 1 NA [44]
BIIB068 DMVS87W Phase 1 NA [5]
CD19 Redirected Autologous T Cells DM49RAT Phase 1 CAR T Cell Therapy [45]
CDP-7657 DMN8I5Q Phase 1 Antibody [46]
CPG 52364 DMVDYTG Phase 1 Small molecular drug [47]
DV-1179 DMDSVRP Phase 1 NA [48]
JNJ-55920839 DMZ16WQ Phase 1 NA [5]
KPG-818 DM1O2X6 Phase 1 Small molecular drug [49]
MEDI-570 DMCJFLS Phase 1 NA [50]
MEDI0700 DM68SC5 Phase 1 NA [5]
SAR113244 DMRIH0S Phase 1 NA [51]
UltraCD40L DMHG7DZ Phase 1 NA [52]
------------------------------------------------------------------------------------
⏷ Show the Full List of 53 Drug(s)
This Disease is Treated as An Indication in 2 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
TV-4710 DM81XLA Discontinued in Phase 2 NA [53]
CD40L DM4IO1P Discontinued in Phase 1 NA [54]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
RO5461111 DMRT3FK Preclinical NA [55]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 4 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BIOLUP DMWHSDI Investigative NA [56]
GX-101 DMEYI40 Investigative NA [56]
RSLV-125 DM52HVR Investigative NA [56]
X-082-NAB DM7WS7I Investigative NA [56]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 409 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
DNASE1 TTYWGOJ No Known Unknown [57]
FCGR2B TT5RWKQ No Known Unknown [58]
ACR TTAHE2N Limited Biomarker [59]
AHCY TTE2KUJ Limited Biomarker [60]
APOH TT2OUI9 Limited Biomarker [61]
CD14 TT6I7DC Limited Biomarker [62]
CD19 TTW640A Limited Biomarker [63]
CD22 TTM6QSK Limited Biomarker [64]
CD28 TTQ13FT Limited Altered Expression [65]
CD38 TTPURFN Limited Altered Expression [66]
CD74 TTCMYP9 Limited Biomarker [67]
CFB TTA0P7K Limited Genetic Variation [68]
CSK TTX6F0Q Limited Genetic Variation [69]
CX3CL1 TT1OFBQ Limited Altered Expression [70]
CXCL10 TTQOVYA Limited Altered Expression [71]
CXCR5 TTIW59R Limited Biomarker [72]
EHMT2 TTS6RZT Limited Genetic Variation [73]
EIF2AK2 TTXEZJ4 Limited Biomarker [74]
EPHB2 TTKPV6O Limited Biomarker [75]
GALC TT5IZRB Limited Genetic Variation [76]
GRIN2A TTKJEMQ Limited Altered Expression [77]
HLA-G TTLKFB3 Limited Genetic Variation [78]
HMGB1 TTWQYB7 Limited Biomarker [79]
HPGDS TTCYE56 Limited Biomarker [80]
HSP90AA1 TT78R5H Limited Altered Expression [81]
ICA1 TTMX06B Limited Genetic Variation [76]
IFNL1 TTM624L Limited Altered Expression [82]
IFNL3 TTRF4Q2 Limited Altered Expression [83]
IKZF2 TTKT5NV Limited Genetic Variation [84]
IL18RAP TTZUJVE Limited Genetic Variation [76]
IL1RN TT6GSR3 Limited Altered Expression [85]
IL21 TT9QEJ6 Limited Genetic Variation [86]
IL22 TTLDX4N Limited Genetic Variation [86]
IL25 TTVMO5W Limited Altered Expression [87]
IL32 TTD4G7L Limited Altered Expression [88]
IL33 TT5MD4P Limited Genetic Variation [89]
IL37 TTQTX98 Limited Biomarker [90]
ITGAL TT48WR6 Limited Altered Expression [65]
KIR2DL2 TTU0P73 Limited Biomarker [91]
KIR2DS1 TTVWAGF Limited Genetic Variation [92]
KIT TTX41N9 Limited Genetic Variation [93]
LONP1 TTM1VPZ Limited Altered Expression [94]
LY9 TTZCL1U Limited Altered Expression [95]
LYN TT1RWNJ Limited Biomarker [96]
MAP4K1 TTSHWUP Limited Altered Expression [97]
MIF TT6804T Limited Biomarker [98]
MMP11 TTZW4MV Limited Altered Expression [99]
MS4A1 TTUE541 Limited Biomarker [63]
MTNR1A TT0WAIE Limited Altered Expression [100]
NOTCH2 TT82FVD Limited Genetic Variation [76]
P2RY12 TTZ1DT0 Limited Altered Expression [101]
PLA2R1 TTHKW7D Limited Biomarker [102]
PLAT TTXAGYU Limited Genetic Variation [76]
PLD2 TTRLMKF Limited Genetic Variation [68]
PRKCB TTYPXQF Limited Genetic Variation [103]
PRKCQ TT1MS7X Limited Biomarker [104]
PRKG1 TT7IZSA Limited Genetic Variation [105]
PRLR TTBPXMA Limited Biomarker [106]
REN TTB2MXP Limited Biomarker [107]
SCARB1 TTRE324 Limited Genetic Variation [108]
SELE TT1PL7M Limited Altered Expression [109]
SH2B3 TT36N7Z Limited Biomarker [110]
SLAMF6 TTSIYJ6 Limited Altered Expression [95]
SLC12A1 TTS087L Limited Genetic Variation [111]
SLC15A4 TTG2XRE Limited Genetic Variation [76]
SLC44A4 TT0NYDG Limited Genetic Variation [68]
SMYD3 TTKLJYX Limited Genetic Variation [112]
SNCA TT08OSU Limited Genetic Variation [113]
SOCS1 TT8COJM Limited Altered Expression [114]
ST8SIA4 TTDP8YM Limited Genetic Variation [112]
TBX21 TTNF9PH Limited Biomarker [115]
TERT TTQY2EJ Limited Biomarker [116]
TNFRSF13B TTL9OD4 Limited Biomarker [117]
TNFSF13 TTOI1RM Limited Biomarker [117]
TNFSF13B TTWMIDN Limited Biomarker [118]
TP53BP1 TTX4UE9 Limited Genetic Variation [119]
VCAM1 TTHCEF6 Limited Altered Expression [120]
CYP21A2 TTP4GLG Disputed Genetic Variation [68]
GRB2 TTEYRJ9 Disputed Biomarker [121]
IL31 TT1RJXK Disputed Genetic Variation [122]
SERPING1 TTVQ6R9 Disputed Biomarker [123]
TNFSF15 TTEST6I Disputed Genetic Variation [124]
CCL5 TT9DWLC moderate Altered Expression [71]
CD27 TTDO1MV moderate Biomarker [125]
CR2 TT0HUN7 moderate Genetic Variation [126]
CTSS TTUMQVO moderate Biomarker [127]
CYBB TT5T8MR moderate Biomarker [128]
E2F2 TT5FYX0 moderate Biomarker [129]
EPHX2 TT7WVHI moderate Biomarker [130]
ERAP2 TTVGS1C moderate Genetic Variation [131]
GPR35 TT254XD moderate Genetic Variation [131]
GPR84 TTG0MQD moderate Biomarker [129]
HLA-B TTGS10J moderate Genetic Variation [132]
HSD11B1 TTN7BL9 moderate Biomarker [133]
HSPE1 TTWYMFE moderate Biomarker [134]
IL21R TTZO9B0 moderate Altered Expression [135]
IL9 TT0JTFD moderate Biomarker [136]
IRAK4 TTILUKB moderate Biomarker [137]
ITGAM TTB69FJ moderate Genetic Variation [138]
KLK1 TT5T3P6 moderate Genetic Variation [139]
KLK3 TTS78AZ moderate Genetic Variation [140]
KLK4 TT4319X moderate Genetic Variation [141]
LAMC2 TTNS7H3 moderate Genetic Variation [142]
PCSK9 TTNIZ2B moderate Biomarker [143]
SCGB1A1 TTONPVW moderate Genetic Variation [144]
SDC2 TT5H2F0 moderate Biomarker [145]
SLC19A1 TT09I7D moderate Genetic Variation [146]
SLC8A1 TTCF82X moderate Genetic Variation [147]
TAOK3 TTO7L0V moderate Genetic Variation [110]
TRIM27 TTTO3QN moderate Biomarker [148]
ABCA1 TTJW1GN Strong Biomarker [149]
ABHD6 TTSINOV Strong Altered Expression [150]
ADA TTLP57V Strong Altered Expression [151]
ADAM10 TTVXEGU Strong Biomarker [152]
ADIPOQ TTXKA7D Strong Altered Expression [153]
ADRB3 TTMXGCW Strong Genetic Variation [154]
AICDA TTKRTP6 Strong Biomarker [155]
ALOX5AP TTDMBF5 Strong Genetic Variation [156]
AOC3 TT7HC21 Strong Biomarker [157]
APCS TTB7VAT Strong Biomarker [158]
APOA4 TTNC3WS Strong Altered Expression [159]
APOL1 TTDB8PW Strong Biomarker [160]
ATG7 TTLVB9Z Strong Biomarker [161]
ATXN2 TTPQJ7P Strong Genetic Variation [76]
B2M TTY7FKA Strong Biomarker [162]
BCL6 TTC9YX5 Strong Genetic Variation [163]
BECN1 TT5M7LN Strong Altered Expression [164]
BGN TT0JPVF Strong Biomarker [165]
BMPR2 TTGKF90 Strong Biomarker [166]
BST2 TT90BJT Strong Genetic Variation [167]
BTLA TTER58P Strong Altered Expression [168]
C1QB TT8A9DM Strong Genetic Variation [169]
C1S TT7LRQH Strong Biomarker [170]
C5 TTKANGO Strong Biomarker [171]
CAMP TTULOB6 Strong Altered Expression [172]
CASP6 TTKW4ML Strong Biomarker [173]
CBL TT7QT13 Strong Biomarker [174]
CBLB TTHRAIJ Strong Genetic Variation [175]
CCL17 TTMPHAE Strong Biomarker [176]
CCL3 TT8I4WB Strong Genetic Variation [177]
CCND3 TT1JXNR Strong Biomarker [178]
CCR1 TTC24WT Strong Biomarker [179]
CCR6 TTFDB30 Strong Biomarker [180]
CCR7 TT2GIDQ Strong Altered Expression [181]
CCR9 TTIPS8B Strong Biomarker [182]
CD163 TTTZ9DE Strong Biomarker [183]
CD2 TTJDUNO Strong Genetic Variation [184]
CD276 TT6CQUM Strong Biomarker [185]
CD33 TTJVYO3 Strong Altered Expression [186]
CD3E TTZAT79 Strong Biomarker [187]
CD4 TTN2JFW Strong Genetic Variation [188]
CD46 TTMS7DF Strong Genetic Variation [189]
CD52 TTQT5S9 Strong Biomarker [176]
CD58 TT5KSBY Strong Genetic Variation [190]
CD69 TTPQE9F Strong Altered Expression [191]
CD79B TTBN5I7 Strong Biomarker [192]
CD80 TT89Z17 Strong Biomarker [193]
CD83 TTT9MRQ Strong Altered Expression [194]
CD86 TT53XHB Strong Altered Expression [195]
CDA TTQ12RK Strong Altered Expression [196]
CDK5R1 TTBYM6V Strong Biomarker [197]
CDKN1A TT9GUW0 Strong Biomarker [198]
CDKN2C TTBRUGA Strong Biomarker [199]
CEBPB TTUI35N Strong Altered Expression [200]
CETP TTFQAYR Strong Biomarker [201]
CFH TTUW6OP Strong Altered Expression [202]
CGB3 TTUH273 Strong Altered Expression [203]
CLEC4C TT7YT06 Strong Biomarker [204]
CMKLR1 TT4UGZL Strong Biomarker [205]
CRBN TTDKGTC Strong Biomarker [206]
CREB1 TTH4AN3 Strong Biomarker [207]
CSF1 TT0IQER Strong Biomarker [208]
CSF3R TTC70AJ Strong Biomarker [209]
CTSC TT4H0V2 Strong Biomarker [210]
CTSE TTLXC4Q Strong Altered Expression [211]
CXCL9 TTWE5PB Strong Biomarker [212]
CXCR4 TTBID49 Strong Altered Expression [213]
CYP24A1 TT82UI1 Strong Genetic Variation [214]
CYP2B6 TTMH124 Strong Biomarker [215]
CYP3A5 TTHS0OK Strong Genetic Variation [216]
DAG1 TT4X7PG Strong Genetic Variation [131]
DDIT4 TTVEOY6 Strong Altered Expression [217]
DDX58 TTVB0O3 Strong Biomarker [218]
DGAT1 TT0GV3R Strong Biomarker [219]
DNM1 TTE3JW9 Strong Biomarker [220]
DUT TTH6MBO Strong Altered Expression [221]
EGFL7 TT7WD0H Strong Altered Expression [222]
EIF2AK3 TT79U1M Strong Altered Expression [173]
EIF2AK4 TT9U4EP Strong Biomarker [223]
EIF4EBP1 TTKGEBL Strong Altered Expression [224]
EIF4EBP2 TTNBTCW Strong Altered Expression [225]
ELANE TTPLTSQ Strong Altered Expression [226]
ELAVL1 TTPC9D0 Strong Altered Expression [227]
ELK3 TT5OJMV Strong Biomarker [228]
ENAH TTY36UA Strong Biomarker [229]
ENG TTB30LE Strong Biomarker [230]
ENTPD1 TTYM8DJ Strong Altered Expression [231]
EPHB1 TT8MDAC Strong Biomarker [228]
ERN1 TTKIAT3 Strong Altered Expression [173]
ETS2 TT9AH0M Strong Biomarker [232]
F12 TTRJSMV Strong Genetic Variation [233]
F2 TT6L509 Strong Biomarker [234]
FCAR TTGUJAO Strong Genetic Variation [235]
FCER1G TTDGEC0 Strong Biomarker [236]
FCGR1A TTZK4I3 Strong Biomarker [237]
FCGRT TTKLPHO Strong Genetic Variation [238]
FPR1 TT5Y4EM Strong Altered Expression [239]
FURIN TTH9WF6 Strong Altered Expression [240]
FYN TT2B9KF Strong Altered Expression [241]
G3BP1 TTG0R8Z Strong Biomarker [242]
GABRP TT3E0DI Strong Genetic Variation [243]
GADD45B TTMDW9L Strong Genetic Variation [244]
GAS6 TT69QD2 Strong Altered Expression [245]
GCK TTDLNGZ Strong Altered Expression [97]
GNAO1 TTAXD8Z Strong Genetic Variation [246]
GPER1 TTDSB34 Strong Biomarker [247]
GPI TT19JIZ Strong Biomarker [248]
GRIN2B TTN9D8E Strong Biomarker [249]
GRN TT0LWE3 Strong Biomarker [250]
GSTO1 TTWO3SH Strong Biomarker [251]
GZMB TTKEPHX Strong Altered Expression [252]
HLA-A TTHONFT Strong Genetic Variation [73]
HLA-DQB2 TTL7VOU Strong Genetic Variation [73]
HRH4 TTXJ178 Strong Genetic Variation [253]
HSP90AB1 TTH5YN2 Strong Biomarker [254]
HSP90B1 TTFPKXQ Strong Biomarker [255]
HTR1A TTSQIFT Strong Altered Expression [256]
ICOS TTE5VP6 Strong Altered Expression [257]
ICOSLG TTB9Z8R Strong Biomarker [125]
IFNA5 TTLHGSF Strong Genetic Variation [258]
IFNAR1 TTSYFMA Strong Biomarker [259]
IFNGR2 TT13TL0 Strong Genetic Variation [260]
IKZF3 TTCZVFZ Strong Genetic Variation [261]
IL10RB TTJTRMK Strong Genetic Variation [262]
IL12A TTRTK6Y Strong Genetic Variation [263]
IL12RB2 TT4SWR8 Strong Genetic Variation [264]
IL15 TTJFA35 Strong Biomarker [265]
IL17D TTC5LTG Strong Biomarker [259]
IL19 TT87RWS Strong Genetic Variation [76]
IL1R2 TT51DEV Strong Biomarker [266]
IL1RAP TTWS50K Strong Biomarker [267]
IL20 TTNZMY2 Strong Biomarker [268]
IL24 TT1EPXZ Strong Altered Expression [269]
IL4R TTDWHC3 Strong Genetic Variation [270]
IL7R TTAWI51 Strong Biomarker [271]
INPP5D TTTP2Z1 Strong Altered Expression [272]
IRAK1 TTXAJWN Strong Biomarker [273]
IRF1 TT4TU3L Strong Biomarker [274]
IRF8 TTHUBNK Strong Biomarker [275]
ISG15 TTVOH3T Strong Biomarker [276]
ITGAE TTH0Z37 Strong Biomarker [277]
ITPR3 TTH1769 Strong Genetic Variation [278]
JAK1 TT6DM01 Strong Biomarker [279]
JAK2 TTRMX3V Strong Altered Expression [280]
JUN TTS7IR5 Strong Genetic Variation [281]
KAT2B TTVK7SB Strong Altered Expression [282]
KCNA3 TTY3UE6 Strong Altered Expression [283]
KDM6B TTDIJUQ Strong Biomarker [284]
KIF5A TTCJPAH Strong Biomarker [285]
KIR2DL1 TT4UXPE Strong Biomarker [92]
KIR2DL3 TTEX3SI Strong Genetic Variation [92]
KIR2DS2 TTV3CFI Strong Altered Expression [286]
KIR3DL2 TTQH3N0 Strong Biomarker [287]
KLRC1 TTC4IMS Strong Biomarker [288]
KLRK1 TTLRN4A Strong Biomarker [289]
LAG3 TTNVXAW Strong Biomarker [290]
LAIR1 TTSI7A8 Strong Altered Expression [186]
LANCL1 TTZW8NS Strong Biomarker [136]
LCK TT860QF Strong Altered Expression [291]
LCN2 TTKTLAI Strong Biomarker [292]
LCT TTA0OSE Strong Biomarker [293]
LDLR TTH0DUS Strong Altered Expression [294]
LGALS1 TTO3NYT Strong Biomarker [295]
LGALS3 TTFPQV7 Strong Biomarker [296]
LILRB1 TTC0QRJ Strong Biomarker [297]
LILRB4 TTREOKA Strong Biomarker [298]
LRRK2 TTK0FEA Strong Biomarker [299]
LTK TT1JZG6 Strong Altered Expression [300]
LYZ TTAOZBW Strong Biomarker [301]
MAN2A1 TT34DCN Strong Biomarker [302]
MANF TT56RYE Strong Biomarker [303]
MAP4K3 TTI0AHJ Strong Altered Expression [304]
MARK2 TTAJ45Y Strong Biomarker [305]
MBTPS1 TTNSM2I Strong Biomarker [306]
MDK TTV8UE7 Strong Biomarker [307]
MECP2 TTTAU9R Strong Altered Expression [308]
MERTK TTO7LKR Strong Altered Expression [309]
MFGE8 TT1GLAJ Strong Genetic Variation [310]
MOG TTQAFX5 Strong Biomarker [311]
MPL TTIHYA4 Strong Biomarker [312]
MRC1 TTKV8W5 Strong Altered Expression [313]
MTR TTUTO39 Strong Genetic Variation [314]
NCF1 TTZ4JC3 Strong Genetic Variation [315]
NCR1 TTQNRJM Strong Altered Expression [316]
NEDD9 TT1UREA Strong Biomarker [317]
NEK7 TTJ5SWP Strong Biomarker [318]
NFKBIA TTSHAEB Strong Biomarker [319]
NLRP1 TTQX29T Strong Genetic Variation [320]
NOTCH4 TTXDIK2 Strong Genetic Variation [73]
NR0B2 TT25A9Q Strong Biomarker [321]
NR1H3 TTECBXN Strong Genetic Variation [322]
NR1H4 TTS4UGC Strong Biomarker [323]
OSMR TTAH0KM Strong Genetic Variation [324]
P2RX1 TTJW7B3 Strong Biomarker [325]
P2RX3 TT2THBD Strong Biomarker [325]
P2RX4 TT1NLOA Strong Biomarker [325]
P2RY1 TTA93TL Strong Biomarker [325]
P2RY2 TTOZHQC Strong Genetic Variation [326]
PAH TTGSVH2 Strong Biomarker [327]
PCSK1 TTED9LZ Strong Altered Expression [328]
PDCD1LG2 TTW14O3 Strong Biomarker [329]
PDE3B TTN34SQ Strong Genetic Variation [330]
PDE7A TT1BC3A Strong Biomarker [331]
PECAM1 TT4EZB2 Strong Biomarker [332]
PEPD TTLZXI0 Strong Altered Expression [333]
PHGDH TT8DRCK Strong Biomarker [334]
PIM2 TT69J2Z Strong Biomarker [221]
PLA2G1B TT9V5JH Strong Biomarker [335]
PNP TTMCF1Y Strong Genetic Variation [336]
POLB TTA0XPV Strong Biomarker [337]
PPARD TT2JWF6 Strong Altered Expression [338]
PPP2CA TTHTKNY Strong Genetic Variation [339]
PRDX5 TTLPJWH Strong Biomarker [340]
PRKAR2B TTW4Y2M Strong Altered Expression [341]
PRKCD TT7A1BO Strong Genetic Variation [103]
PROC TTZUXYS Strong Altered Expression [342]
PRTN3 TT5MLC4 Strong Altered Expression [343]
PSIP1 TTH9LDP Strong Biomarker [344]
PSMB6 TT8EPLT Strong Altered Expression [345]
PSMB9 TTOUSTQ Strong Genetic Variation [346]
PTGDR2 TTQDMX5 Strong Biomarker [271]
PTPN2 TTY8PUS Strong Biomarker [347]
PTPN6 TT369M5 Strong Biomarker [321]
PTPRC TTUS45N Strong Altered Expression [280]
RECK TTRZBW7 Strong Altered Expression [348]
REG3A TTL4H8N Strong Biomarker [349]
REL TT1ZCTH Strong Biomarker [350]
RIPK1 TTVJHX8 Strong Biomarker [328]
RIPK2 TTCQ2E5 Strong Genetic Variation [351]
RIPK4 TTB4S01 Strong Biomarker [352]
ROCK2 TTGWKQJ Strong Biomarker [353]
RPSA TTLUW5B Strong Biomarker [136]
RSPO1 TTI9HL4 Strong Altered Expression [354]
S100A12 TTQ4ESF Strong Biomarker [355]
S100B TTQ0V86 Strong Genetic Variation [356]
S1PR1 TT9JZCK Strong Biomarker [357]
SDC1 TTYDSVG Strong Altered Expression [358]
SELL TT2IYXF Strong Altered Expression [359]
SELP TTE5VG0 Strong Altered Expression [360]
SEMA3A TTVKD3S Strong Biomarker [361]
SERPINA1 TTA7UJC Strong Biomarker [362]
SERPINB3 TT6QLPX Strong Biomarker [363]
SERPINC1 TT4QPUL Strong Biomarker [364]
SFTPD TTGLMU7 Strong Altered Expression [365]
SLAMF7 TT7ILZ1 Strong Biomarker [366]
SLC1A5 TTF7WRM Strong Genetic Variation [367]
SLC1A7 TTK41DM Strong Genetic Variation [367]
SLC22A2 TT0XOJN Strong Biomarker [355]
SLC2A4 TTP6MT5 Strong Genetic Variation [368]
SLC52A2 TT6TKEN Strong Biomarker [305]
SLC6A2 TTAWNKZ Strong Biomarker [228]
SMAD3 TTHQZV7 Strong Biomarker [369]
SOCS3 TTI0ME6 Strong Altered Expression [370]
SP1 TTZEP6S Strong Biomarker [371]
SPDEF TT2ZUPY Strong Altered Expression [355]
SPHK2 TTCN0M9 Strong Biomarker [372]
SPN TTOZAX0 Strong Biomarker [373]
SSRP1 TTETDKQ Strong Altered Expression [374]
STK17A TTEYF03 Strong Genetic Variation [375]
SUV39H1 TTUWQTK Strong Altered Expression [376]
SYK TT2HUPM Strong Biomarker [377]
TAGLN TTDRZ9H Strong Altered Expression [378]
TAGLN2 TTP6BIJ Strong Biomarker [379]
TAP1 TT7JZI8 Strong Genetic Variation [380]
TBK1 TTMP03S Strong Biomarker [381]
TGFB3 TTWOMY8 Strong Biomarker [382]
TIGIT TTWNL74 Strong Genetic Variation [383]
TIRAP TTKU0LS Strong Genetic Variation [384]
TLR3 TTD24Y0 Strong Biomarker [385]
TMBIM6 TT7QSMG Strong Altered Expression [221]
TNFRSF11B TT2CJ75 Strong Biomarker [386]
TNFRSF14 TTWGTC1 Strong Biomarker [387]
TNFRSF17 TTZ3P4W Strong Altered Expression [388]
TNFRSF18 TTG6LA7 Strong Biomarker [389]
TNFRSF25 TTDV6BQ Strong Genetic Variation [390]
TNFRSF4 TTL31H0 Strong Biomarker [391]
TNFRSF8 TT2GM5R Strong Biomarker [392]
TNFRSF9 TTPW9LJ Strong Biomarker [125]
TNFSF12 TTBTDM1 Strong Biomarker [393]
TNFSF14 TTKVENM Strong Altered Expression [221]
TOP1 TTGTQHC Strong Biomarker [394]
TPO TT52XDZ Strong Biomarker [395]
TRAF6 TTCDR6M Strong Altered Expression [396]
TRPC6 TTRBT3W Strong Biomarker [397]
TRPM2 TTEBMN7 Strong Biomarker [398]
TSPO TTPTXIN Strong Biomarker [399]
TUSC2 TTJ8O14 Strong Biomarker [349]
TXNRD1 TTR7UJ3 Strong Biomarker [400]
USP7 TTXU3EQ Strong Altered Expression [401]
VKORC1 TTEUC8H Strong Genetic Variation [402]
VSIR TT51SK8 Strong Biomarker [403]
VTCN1 TTCK85E Strong Biomarker [404]
VWF TT3SZBT Strong Biomarker [405]
XRCC5 TTCB9KW Strong Genetic Variation [406]
ZAP70 TTUMHT8 Strong Biomarker [407]
F8 TT1290U Definitive Altered Expression [408]
PADI4 TTQHAXM Definitive Genetic Variation [409]
TNFRSF1A TTG043C Definitive Altered Expression [410]
TREM1 TTHZQP0 Definitive Biomarker [411]
------------------------------------------------------------------------------------
⏷ Show the Full List of 409 DTT(s)
This Disease Is Related to 11 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
ABCA2 DTJ4NEG Strong Genetic Variation [380]
ABCC6 DT582KR Strong Genetic Variation [412]
ABCD1 DTKM9DZ Strong Biomarker [164]
SLC25A3 DTCRIWV Strong Biomarker [347]
SLC39A8 DTLPQGT Strong Genetic Variation [413]
SLC4A1 DTB0Q3P Strong Altered Expression [393]
SLC52A1 DT7NOKR Strong Biomarker [305]
SLC5A11 DT2CAPQ Strong Genetic Variation [414]
SLC7A7 DTE4HJ8 Strong Biomarker [415]
SLC7A9 DTP7AEQ Strong Altered Expression [416]
SLCO6A1 DTIFXNS Strong Genetic Variation [417]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DTP(s)
This Disease Is Related to 17 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
CEPT1 DEL87ZT Limited Genetic Variation [76]
DDO DE8PQ7T Limited Genetic Variation [68]
MT2A DEFKGT7 Limited Altered Expression [100]
NADSYN1 DELF8BA Limited Genetic Variation [68]
PON3 DETXQZ1 Limited Genetic Variation [418]
PRODH DEVJIHS moderate Genetic Variation [419]
PTGDS DER3H9C moderate Altered Expression [420]
ACP3 DEDW5H6 Strong Biomarker [349]
ACP5 DESITDW Strong Altered Expression [421]
AKR1C4 DEAJN47 Strong Biomarker [422]
CYP1A1 DE6OQ3W Strong Genetic Variation [146]
GGCT DEKW6PB Strong Genetic Variation [113]
MT1A DE5ME8A Strong Altered Expression [100]
NMNAT2 DE2HB58 Strong Genetic Variation [76]
PGM1 DEA3VM1 Strong Biomarker [423]
TPMT DEFQ8VO Strong Genetic Variation [424]
UBASH3B DE10BJ5 Strong Altered Expression [197]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 DME(s)
This Disease Is Related to 663 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
DNASE1 OTM4KWB3 No Known Unknown [57]
FCGR2B OTCJD51H No Known Unknown [58]
ABCF1 OT6Q079J Limited Genetic Variation [73]
ADAM15 OTZ7VLTP Limited Genetic Variation [76]
AHI1 OT8K2YWY Limited Genetic Variation [76]
AHNAK2 OTD2X4BX Limited Genetic Variation [326]
ALG1 OTVXPA9E Limited Altered Expression [100]
ANKRD44 OTUI0WOO Limited Genetic Variation [105]
ANKS1A OTYZP3MP Limited Genetic Variation [68]
ANP32B OT3SQMLU Limited Biomarker [117]
ANXA3 OTDD8OI7 Limited Biomarker [425]
AP5B1 OTZGM9QA Limited Genetic Variation [84]
ATP6V1G2 OTM1DSKL Limited Genetic Variation [73]
ATXN1 OTQF0HNR Limited Genetic Variation [76]
BARX2 OT0R3QD3 Limited Genetic Variation [108]
BCR OTCN76C1 Limited Biomarker [407]
BTG3 OT9ANHVT Limited Biomarker [426]
BTN2A1 OTUYPMZJ Limited Genetic Variation [73]
C1QTNF6 OT57EPQC Limited Genetic Variation [76]
CAMK1D OTU24HAU Limited Genetic Variation [108]
CAMK4 OT47RDGV Limited Altered Expression [427]
CARMIL1 OT1A5IX5 Limited Genetic Variation [76]
CDHR5 OTTBWQMN Limited Genetic Variation [76]
CREM OTJIJ5AL Limited Altered Expression [428]
CSNK2B OT2WW7R1 Limited Genetic Variation [429]
DARS1 OT0WGC2T Limited Genetic Variation [76]
DECR1 OTCDIR6X Limited Altered Expression [315]
DNASE1L3 OTEUIMC2 Limited Altered Expression [430]
EBF1 OTZ61YYH Limited Genetic Variation [431]
EVI5 OTOPAP55 Limited Genetic Variation [76]
FAM167A OT9JF3JQ Limited Genetic Variation [432]
FAM98B OTZ1O9PL Limited Genetic Variation [73]
FLI1 OT0EV3LX Limited Altered Expression [433]
GABBR1 OTU5A52J Limited Genetic Variation [73]
GPSM3 OT2MO458 Limited Genetic Variation [73]
H2BC15 OTU39CFZ Limited Genetic Variation [73]
HIP1 OT7AKCFQ Limited Genetic Variation [326]
HLA-C OTV38BUJ Limited Biomarker [91]
HLA-DQB1 OTVVI3UI Limited Genetic Variation [434]
ICAM3 OTTZ5A5D Limited Genetic Variation [435]
IFI16 OT4SPU0U Limited Biomarker [436]
IFI44L OTXKORJP Limited Posttranslational Modification [437]
IFNK OTO2WDPX Limited Altered Expression [438]
IRGM OTKD3O5Z Limited Biomarker [299]
KDM4B OT5P1UPY Limited Genetic Variation [76]
KRT20 OT4RB40L Limited Biomarker [63]
LCP1 OTK61F2A Limited Genetic Variation [68]
LGALS9 OT7MF91K Limited Biomarker [439]
LILRA1 OTZ4NA7Q Limited Biomarker [440]
LILRA2 OT1O2K47 Limited Genetic Variation [440]
LPP OT6TU8SE Limited Genetic Variation [84]
LY6G6C OTV7F59X Limited Genetic Variation [73]
LYST OTIUB1B3 Limited Genetic Variation [68]
MIEN1 OTCQ8DAD Limited Genetic Variation [76]
MT1M OTVT8PLU Limited Altered Expression [100]
MT1X OT9AKFVS Limited Altered Expression [100]
MUC21 OTQ8GP5L Limited Genetic Variation [73]
MUCL3 OTGAD3I0 Limited Genetic Variation [73]
NCF2 OTAUW7L2 Limited Genetic Variation [264]
NIN OTVH3M4Z Limited Genetic Variation [414]
NT5C1A OTS7UF36 Limited Biomarker [441]
OR14J1 OTFIHZ4O Limited Genetic Variation [73]
PAPOLG OTIV69YA Limited Genetic Variation [76]
PBX2 OTEBYCAW Limited Genetic Variation [73]
PCNX3 OTOM3GHH Limited Biomarker [116]
PDP2 OTADNMGK Limited Altered Expression [442]
PGBD1 OTSJX9UU Limited Genetic Variation [73]
PLCL1 OTJL2C79 Limited Genetic Variation [76]
POTEF OTV3WXYE Limited Biomarker [370]
PPP1R18 OT0JVGOZ Limited Genetic Variation [73]
PSORS1C1 OT9HK436 Limited Genetic Variation [73]
PTPA OTRGFOI7 Limited Biomarker [443]
PUSL1 OTOFA3BU Limited Genetic Variation [76]
RAB4A OT7BL9WW Limited Posttranslational Modification [444]
RAD51B OTCJVRMY Limited Genetic Variation [76]
RNF5 OTDQGI37 Limited Genetic Variation [73]
RPS20 OTI8052R Limited Genetic Variation [76]
RTKN2 OTV2AXQM Limited Genetic Variation [68]
SBK1 OTCO4NEI Limited Genetic Variation [76]
SCAMP5 OT9MXA2J Limited Genetic Variation [84]
SEPTIN2 OT3G33TM Limited Genetic Variation [445]
SFTA2 OTVRIUIV Limited Genetic Variation [73]
SH2B2 OTEDHHDH Limited Genetic Variation [140]
SIGLEC6 OTO4F5C9 Limited Genetic Variation [446]
SKAP2 OTSF44KP Limited Genetic Variation [76]
SLC12A9 OTR7VRAK Limited Genetic Variation [447]
SNRNP70 OTP52YZ3 Limited Genetic Variation [448]
SPRED2 OTUX685J Limited Genetic Variation [84]
SRI OT4R3EAC Limited Biomarker [449]
STK19 OTYM6437 Limited Genetic Variation [73]
SYNGR1 OT0MBUK5 Limited Biomarker [116]
TCF7 OT1ID822 Limited Altered Expression [450]
TCP11 OTHVO79B Limited Genetic Variation [76]
TIMMDC1 OTIK4I5R Limited Genetic Variation [76]
TRAF2 OT1MEZZN Limited Altered Expression [451]
TRAPPC11 OTPZYXGA Limited Genetic Variation [93]
TRIM31 OT7VW6RP Limited Genetic Variation [73]
TSBP1 OT5GE8IO Limited Genetic Variation [73]
AFF1 OTT2C78E Disputed Genetic Variation [452]
APOM OTI3FQQC Disputed Biomarker [453]
FH OTEQWU6Q Disputed Biomarker [454]
GLT1D1 OTXW0WXJ Disputed Genetic Variation [455]
ABHD8 OT736H1Q moderate Genetic Variation [456]
ADCY7 OTAWMGP3 moderate Genetic Variation [131]
ADD2 OTRCPCD2 moderate Genetic Variation [147]
ADGRL2 OTCXD2YR moderate Genetic Variation [131]
ANKRD30A OTJXYAE5 moderate Genetic Variation [131]
ANKRD55 OT62KZII moderate Genetic Variation [131]
API5 OTYX9YCZ moderate Altered Expression [457]
ARHGAP4 OTXV053R moderate Genetic Variation [110]
ARMC3 OTF6M9MM moderate Genetic Variation [110]
ATXN2L OTP5M3R9 moderate Genetic Variation [131]
BAG6 OT4Z0S2U moderate Genetic Variation [73]
C1orf141 OTASPHL0 moderate Genetic Variation [131]
CARD9 OTJ81AWD moderate Genetic Variation [131]
CENPU OTQ4TZRS moderate Genetic Variation [110]
CRB1 OTXYUNG0 moderate Genetic Variation [131]
CREBL2 OT58JBNU moderate Genetic Variation [456]
EXOSC3 OTNCF906 moderate Biomarker [127]
FLT3LG OTU0YGC4 moderate Altered Expression [458]
FNBP1 OTSJ5KKA moderate Genetic Variation [131]
FSTL1 OT6KEZUD moderate Biomarker [459]
FUT2 OTLXM6WI moderate Genetic Variation [131]
GPANK1 OT1TN2KT moderate Genetic Variation [73]
GPR19 OTR7MUS5 moderate Genetic Variation [456]
GTF2I OTUYL1TQ moderate Genetic Variation [460]
IFIH1 OTZA2AHA moderate Genetic Variation [461]
IGBP1 OTTHH4YE moderate Altered Expression [462]
IL17B OTS86H50 moderate Biomarker [463]
IL22RA2 OTGOFDCY moderate Altered Expression [464]
ILRUN OTE8FHQD moderate Genetic Variation [456]
INS-IGF2 OTZR74BO moderate Genetic Variation [131]
LAPTM5 OT2XI2JG moderate Altered Expression [465]
LURAP1L OTSJ29M5 moderate Genetic Variation [131]
MACROH2A1 OTV2DQDD moderate Genetic Variation [466]
MPRIP OT5FV5NS moderate Biomarker [467]
NELFE OTL4E94L moderate Genetic Variation [73]
NKD1 OTY3MO97 moderate Genetic Variation [131]
OR12D3 OTQ9XNBB moderate Genetic Variation [73]
OR5V1 OTSYXOD6 moderate Genetic Variation [73]
RFC1 OT3L5PK3 moderate Genetic Variation [146]
RFX1 OTZUDMPR moderate Altered Expression [468]
RNF39 OTUQA9JT moderate Genetic Variation [73]
SCO1 OTC45UGB moderate Genetic Variation [469]
SCUBE1 OT4JY1UY moderate Genetic Variation [470]
SEC14L2 OTJST64D moderate Genetic Variation [380]
SLAMF1 OTBTT3ZQ moderate Altered Expression [471]
SPPL3 OT2HLJF6 moderate Genetic Variation [110]
SUOX OTEJQ9FC moderate Genetic Variation [131]
TCF19 OT7NKLF9 moderate Genetic Variation [73]
ABCE1 OTH19LOA Strong Altered Expression [221]
ACACA OT5CQPZY Strong Biomarker [472]
ACP1 OTJ9CKLU Strong Biomarker [473]
ACSL4 OTI71MUJ Strong Biomarker [474]
ACSL5 OT3L9XO3 Strong Biomarker [474]
ADAMDEC1 OTMT7ZMG Strong Altered Expression [475]
ADAR OTQNOHR8 Strong Biomarker [476]
ADARB1 OTGKSZEV Strong Biomarker [477]
AFF3 OTR0705Z Strong Genetic Variation [478]
AGBL3 OTVH64PO Strong Biomarker [479]
AGFG1 OTI8ZKC4 Strong Altered Expression [480]
AHNAK OT6KH1WG Strong Biomarker [481]
AIM2 OT86QUI8 Strong Genetic Variation [119]
AIMP1 OTTA5C3U Strong Biomarker [482]
AMELX OTIN26MM Strong Biomarker [483]
AMH OT5FH4BD Strong Biomarker [484]
AMPD2 OTBS30JU Strong Biomarker [485]
ANO3 OTM34U6Q Strong Genetic Variation [486]
ANXA6 OT9KIQ0Y Strong Biomarker [487]
AP5Z1 OTXIPLFH Strong Biomarker [488]
ARHGDIB OT9PD6CS Strong Biomarker [489]
ARHGEF2 OTBQTFRT Strong Biomarker [136]
ARHGEF28 OT3F32IU Strong Genetic Variation [351]
ARID3A OTZZ4SFP Strong Altered Expression [490]
ARID5B OTUQ4CQY Strong Genetic Variation [84]
ARL5A OTF7AQK9 Strong Biomarker [221]
ARL8B OTD5TJIN Strong Biomarker [491]
ARMH1 OTTJC0D6 Strong Biomarker [136]
ARSF OTC0L12N Strong Altered Expression [492]
ASAP1 OT4DLRYY Strong Biomarker [349]
ASAP2 OTGEXULW Strong Biomarker [349]
ASS1 OT4ZMG0Q Strong Altered Expression [493]
ATF6 OTAFHAVI Strong Altered Expression [173]
ATF6B OTT2ZGSR Strong Genetic Variation [494]
ATF7IP OTU6ZA7F Strong Biomarker [495]
ATG12 OTJRO09Y Strong Altered Expression [164]
ATG16L1 OTEOYC5D Strong Biomarker [496]
ATG16L2 OTJYU0W8 Strong Biomarker [496]
ATN1 OTNZFLKY Strong Genetic Variation [497]
B3GNT2 OTE69HV8 Strong Biomarker [425]
BAGE3 OTBUMTWL Strong Genetic Variation [498]
BCKDHB OT8OSVYU Strong Posttranslational Modification [499]
BDH2 OTDD7G8S Strong Biomarker [500]
BID OTOSHSHU Strong Biomarker [501]
BIN1 OTK8O0X8 Strong Biomarker [73]
BMS1 OTEGQ8ZO Strong Biomarker [472]
BTNL2 OTTTEMZA Strong Genetic Variation [73]
C1QL1 OTNQ0G3E Strong Genetic Variation [502]
C1R OTA0ZNIU Strong Biomarker [503]
C1RL OTRTQWRV Strong Biomarker [504]
C2 OTHMF4YM Strong Genetic Variation [505]
C6 OTCKR304 Strong Genetic Variation [506]
CABIN1 OT4G5CIK Strong Biomarker [507]
CALM2 OTNYA92F Strong Biomarker [508]
CAMKMT OTLJBRUW Strong Biomarker [508]
CAPG OTJ86KI6 Strong Genetic Variation [189]
CASP12 OTY2W6FG Strong Genetic Variation [509]
CAST OTBXZZGF Strong Biomarker [510]
CCDC22 OT1A1ZXH Strong Genetic Variation [511]
CCL19 OTQ2UJMH Strong Biomarker [512]
CCL28 OTY6XNQ7 Strong Biomarker [513]
CCL3L1 OTQXCYB1 Strong Genetic Variation [514]
CCL4L2 OTDBSXOU Strong Genetic Variation [177]
CCT6A OTCYWL5F Strong Biomarker [515]
CD180 OTITK5E6 Strong Biomarker [321]
CD1D OT3ROU4J Strong Biomarker [516]
CD226 OT4UG0KB Strong Biomarker [116]
CD244 OTSMR85N Strong Biomarker [366]
CD247 OT45FGUX Strong Altered Expression [517]
CD48 OT83ZNPP Strong Biomarker [95]
CD5L OTPY4WQR Strong Biomarker [518]
CD63 OT2UGZA9 Strong Biomarker [519]
CD72 OTPOJID2 Strong Biomarker [520]
CD84 OTAY5B0F Strong Genetic Variation [521]
CD8A OTDWQJXK Strong Altered Expression [522]
CD8B OTMZ1T7J Strong Biomarker [523]
CDCA5 OTZLCQ5U Strong Biomarker [197]
CDK2AP2 OTR99SJ8 Strong Altered Expression [524]
CEBPZ OT11BATG Strong Genetic Variation [525]
CELF2 OTLJJ4VT Strong Biomarker [221]
CENPV OTPQ0KT9 Strong Biomarker [526]
CFHR1 OT72R16T Strong Genetic Variation [527]
CFHR4 OTWXGQMU Strong Genetic Variation [528]
CFHR5 OT7BMOYE Strong Altered Expression [529]
CGAS OTJYIXNB Strong Biomarker [530]
CHAF1A OTXSSY4H Strong Biomarker [531]
CHAF1B OTOMK4KH Strong Biomarker [531]
CHST12 OTHRMYJG Strong Biomarker [532]
CIC OTFXCHNZ Strong Biomarker [533]
CIITA OTRJNZFO Strong Altered Expression [191]
CLDN11 OTNN6UTL Strong Biomarker [534]
CLEC16A OTLGV5SV Strong Genetic Variation [76]
CLEC4A OTNLPK2C Strong Genetic Variation [535]
CLEC7A OTRTBH27 Strong Altered Expression [536]
CLIC2 OTDBURM4 Strong Altered Expression [537]
CNN3 OTJTAXAP Strong Biomarker [538]
CNOT7 OTJBKCPI Strong Biomarker [531]
CNOT8 OT6CMCS0 Strong Biomarker [531]
CNTN6 OTXVGVOR Strong Genetic Variation [73]
CNTNAP2 OT48T2ZP Strong Biomarker [539]
COG6 OTDLQITC Strong Genetic Variation [435]
CORO1A OTVAZOHC Strong Biomarker [540]
COTL1 OT6YCNLF Strong Genetic Variation [541]
COX8A OTU0NR39 Strong Biomarker [405]
CREB3L1 OT2JHIHM Strong Biomarker [542]
CRYGD OTW29JC4 Strong Biomarker [543]
CTBP2 OTGZGT87 Strong Biomarker [544]
CTHRC1 OTV88X2G Strong Biomarker [545]
CTRL OTB6NA5O Strong Genetic Variation [368]
CXCL16 OTD49T9R Strong Altered Expression [546]
CYBA OT16N9ZO Strong Genetic Variation [547]
CYCS OTBFALJD Strong Biomarker [548]
DCAF1 OT3ZDVOE Strong Altered Expression [480]
DDT OTF5HTYL Strong Altered Expression [549]
DDX19A OTBTDR44 Strong Biomarker [550]
DDX39A OT0Z6E1K Strong Altered Expression [416]
DDX39B OTEVCFVU Strong Altered Expression [416]
DDX46 OTB2X9TO Strong Biomarker [550]
DDX6 OTKWXVDY Strong Genetic Variation [551]
DEDD OTIL349E Strong Biomarker [552]
DEF6 OTIRBYVK Strong Genetic Variation [553]
DEFA3 OTO3N8E1 Strong Altered Expression [554]
DEFB1 OT5SV0E4 Strong Genetic Variation [555]
DGKQ OT8OEPYT Strong Genetic Variation [264]
DHX16 OTW8KZAU Strong Biomarker [550]
DHX40 OTOL02QN Strong Biomarker [556]
DHX9 OT5AAOQI Strong Biomarker [557]
DLAT OT9LBJVN Strong Altered Expression [558]
DMBT1 OTVNU9D9 Strong Biomarker [559]
DNASE2 OT6RC1BL Strong Biomarker [560]
DNTT OTFSEF12 Strong Biomarker [561]
DOCK11 OTFSTN6A Strong Genetic Variation [562]
DOCK8 OTNQLL21 Strong Biomarker [563]
DRAM1 OTIJTXEN Strong Genetic Variation [456]
DST OTHZBM4X Strong Biomarker [564]
DTX1 OTYX91DX Strong Altered Expression [565]
DUOX1 OTQ2AEW0 Strong Biomarker [338]
DUOX2 OTU14HCN Strong Biomarker [338]
DUSP22 OTEZ3U85 Strong Altered Expression [304]
DUSP23 OTE2PG54 Strong Altered Expression [566]
DUSP4 OT6WAO12 Strong Biomarker [428]
DXO OTFDTNW4 Strong Biomarker [567]
EARS2 OTNCJKY7 Strong Biomarker [568]
EBNA1BP2 OTBRVMZH Strong Biomarker [136]
EEF1A2 OT9Z23K5 Strong Genetic Variation [569]
EFNA2 OTEAUKRX Strong Biomarker [570]
EFNA5 OTOH4DRR Strong Genetic Variation [571]
EGR2 OTAVQ78J Strong Biomarker [572]
EGR3 OTGPJIRA Strong Biomarker [572]
EHF OTY6TPWD Strong Genetic Variation [73]
EIF2B5 OTV3R4RB Strong Biomarker [573]
EIF3C OTR8RF9X Strong Altered Expression [221]
EIF4G1 OT2CF1E6 Strong Altered Expression [225]
ELF1 OTV5LKIA Strong Genetic Variation [574]
ELF4 OT167PR5 Strong Biomarker [497]
ELK1 OTH9MXD6 Strong Biomarker [268]
ELOF1 OT8BXS5U Strong Biomarker [570]
EMP1 OTSZHUHQ Strong Biomarker [575]
ENHO OT91QASK Strong Altered Expression [576]
EOMES OTB9VQFA Strong Altered Expression [577]
ERAL1 OTSH78HD Strong Genetic Variation [578]
ERV3-1 OT4CW64T Strong Altered Expression [579]
ERVW-1 OTWV8DXJ Strong Biomarker [580]
EVPL OTZIAFEK Strong Biomarker [581]
FANCB OTMZTXB5 Strong Biomarker [582]
FBXO31 OTF96IC2 Strong Genetic Variation [583]
FCER1A OTIRUOHF Strong Genetic Variation [584]
FCGR2C OTNLMNYB Strong Genetic Variation [585]
FCHSD2 OTKXLIJ6 Strong Genetic Variation [326]
FCMR OTI7I47T Strong Altered Expression [221]
FCN3 OTPRENLS Strong Genetic Variation [586]
FCRL6 OTLIXQMQ Strong Genetic Variation [587]
FEN1 OT6QGG7O Strong Genetic Variation [588]
FGF22 OTVIX6J0 Strong Biomarker [534]
FLII OT7G9JG6 Strong Altered Expression [433]
FLRT2 OTGD8TID Strong Altered Expression [589]
FMR1 OTWEV0T5 Strong Biomarker [590]
FOSB OTW6C05J Strong Altered Expression [591]
FOXJ1 OT7LLBZ7 Strong Biomarker [592]
FOXO4 OT90X9LN Strong Altered Expression [593]
GADD45A OTDRV63V Strong Genetic Variation [244]
GBP2 OTVU4G07 Strong Biomarker [594]
GCHFR OTEOT8GI Strong Biomarker [197]
GDE1 OTU6FSBF Strong Altered Expression [595]
GFI1 OT9HB9H8 Strong Biomarker [596]
GIMAP5 OTMND7IR Strong Genetic Variation [597]
GORASP1 OTQS91S7 Strong Posttranslational Modification [598]
GPX4 OTRAFFX2 Strong Altered Expression [221]
GSTK1 OTDNGWAF Strong Genetic Variation [417]
GTF2IRD1 OTEG9KU1 Strong Genetic Variation [599]
H1-0 OTRLJK4Z Strong Biomarker [600]
H2BC10 OTLQH0D6 Strong Biomarker [601]
H2BC11 OTGM083T Strong Biomarker [601]
H2BC17 OT8ED05P Strong Biomarker [602]
H2BC5 OTXDTDHN Strong Biomarker [601]
H3C13 OT97FS6C Strong Biomarker [603]
H4C1 OTB71W46 Strong Biomarker [604]
HAVCR2 OTOL603T Strong Biomarker [605]
HCFC1 OT0UCK62 Strong Biomarker [606]
HCLS1 OTX7WGYN Strong Biomarker [569]
HCP5 OTV0YRI8 Strong Genetic Variation [73]
HESX1 OT5E2Z4G Strong Biomarker [543]
HFM1 OTHV3EFE Strong Biomarker [607]
HILPDA OTEID3ZM Strong Biomarker [221]
HIVEP3 OTM3QT3L Strong Altered Expression [608]
HLA-DOA OTZE5Q7R Strong Biomarker [609]
HLA-DPA1 OT7OG7Y2 Strong Genetic Variation [610]
HLA-DQA2 OT1DH0N9 Strong Genetic Variation [429]
HLA-DRA OT7KZMP2 Strong Genetic Variation [73]
HMGN1 OTSMGH99 Strong Biomarker [611]
HMGN2 OTN20MEF Strong Biomarker [612]
HNRNPC OT47AK4C Strong Biomarker [613]
HNRNPD OT5UO1FA Strong Biomarker [614]
HNRNPDL OTB3BFCV Strong Biomarker [613]
HNRNPUL1 OTJP4U7K Strong Altered Expression [221]
HSD17B6 OTSB55D2 Strong Biomarker [400]
HSPA1L OTC2V1K6 Strong Genetic Variation [615]
ICAM4 OT1BI27E Strong Genetic Variation [616]
ICAM5 OTDGGAFH Strong Genetic Variation [616]
IER2 OT5OY8BO Strong Altered Expression [221]
IER3 OTZJI5FZ Strong Biomarker [617]
IFI44 OTOKSZVA Strong Biomarker [618]
IFI6 OTWOOAM4 Strong Genetic Variation [251]
IFIT1 OTXOQDSG Strong Biomarker [618]
IFIT3 OTPGHZB9 Strong Altered Expression [530]
IFNA17 OTHXRYG3 Strong Biomarker [299]
IFNGR1 OTCTQBWW Strong Genetic Variation [260]
IFNLR1 OTWWWK45 Strong Biomarker [319]
IGFALS OTTWCZYM Strong Genetic Variation [619]
IGLL5 OT9XQFL5 Strong Altered Expression [620]
IKBKE OT5VYOSM Strong Genetic Variation [621]
IKZF1 OTCW1FKL Strong Genetic Variation [622]
IL1F10 OTJAASGC Strong Biomarker [623]
IL27 OTIS3OF8 Strong Biomarker [259]
IL34 OTZ15VVK Strong Altered Expression [624]
IMPACT OTQ923OB Strong Biomarker [625]
INSRR OT3F75WA Strong Genetic Variation [626]
IRAK2 OT6Y1QZN Strong Genetic Variation [627]
IRF2 OTAZRUW3 Strong Genetic Variation [628]
IRF6 OTKJ44EV Strong Genetic Variation [167]
IRF7 OTC1A2PQ Strong Genetic Variation [76]
IRF9 OTK4MYQJ Strong Altered Expression [629]
ITGAX OTOGIMHE Strong Altered Expression [630]
ITPA OTQ47WVR Strong Genetic Variation [631]
JCHAIN OTR8M5TX Strong Altered Expression [159]
JTB OT314JB6 Strong Biomarker [632]
JUNB OTG2JXV5 Strong Altered Expression [591]
JUND OTNKACJD Strong Altered Expression [591]
KCNH4 OTHJ8WTU Strong Biomarker [268]
KCNH8 OT3I5FLB Strong Biomarker [268]
KIAA0319L OTZ5X6IM Strong SusceptibilityMutation [633]
KIDINS220 OTLBH2MA Strong Biomarker [634]
KIR2DL4 OTXN18OA Strong Biomarker [635]
KIR2DL5A OT09FZE1 Strong Biomarker [92]
KIR2DL5B OTSV0JL9 Strong Biomarker [92]
KIR2DS3 OT3PSLDL Strong Biomarker [91]
KIR2DS5 OTXLEN11 Strong Genetic Variation [636]
KLF13 OTMIKHZ4 Strong Altered Expression [637]
KLK9 OTGJWBIF Strong Biomarker [638]
KLRB1 OTQ2959Y Strong Biomarker [639]
KLRC2 OTT4N86S Strong Genetic Variation [640]
KLRD1 OTMYLOV4 Strong Altered Expression [641]
KRIT1 OT58AP1I Strong Biomarker [508]
KRT1 OTIOJWA4 Strong Biomarker [642]
LAIR2 OTKCADXC Strong Biomarker [643]
LAMA1 OTQZMP86 Strong Genetic Variation [644]
LAMC1 OTIG527N Strong Genetic Variation [644]
LAMTOR2 OTHEDISB Strong Altered Expression [524]
LARP6 OTUQ9QS9 Strong Biomarker [645]
LAT OTZC1XZ1 Strong Altered Expression [646]
LBH OT87AT1X Strong Altered Expression [647]
LBR OT1HG3HG Strong Biomarker [648]
LCE3B OT7X6LDK Strong Genetic Variation [649]
LCE3C OT3RWMGH Strong Genetic Variation [649]
LCP2 OT57KE22 Strong Biomarker [646]
LGALS3BP OT9AGQKH Strong Biomarker [242]
LGALS8 OT71LJ8T Strong Biomarker [650]
LILRA3 OTBNQCOS Strong Biomarker [651]
LRG1 OTLD0KWA Strong Biomarker [652]
LRP1B OT4YZG2N Strong Biomarker [653]
LRRC18 OTC8M35N Strong Altered Expression [654]
LSM2 OTHL77NY Strong Biomarker [394]
LST1 OTUVG424 Strong Genetic Variation [416]
LUM OTSRC874 Strong Genetic Variation [655]
LY6E OTMG16BZ Strong Biomarker [276]
MAEA OTPA2FDE Strong Altered Expression [656]
MAGEB2 OTAGUVU5 Strong Biomarker [657]
MAP1LC3B OTUYHB84 Strong Biomarker [299]
MASP1 OTWWCNZP Strong Biomarker [658]
MBD4 OTWR9YXE Strong Biomarker [659]
MBNL1 OTOV7J85 Strong Biomarker [660]
MDGA2 OTIJ0T5J Strong Genetic Variation [661]
MED1 OTOO24C4 Strong Genetic Variation [73]
MED14 OTMD20XN Strong Biomarker [662]
MEF2A OTV2SF6E Strong Altered Expression [663]
MEF2D OT7CEIG0 Strong Genetic Variation [664]
MFHAS1 OTS922CJ Strong Genetic Variation [665]
MICB OTS2DVDW Strong Genetic Variation [666]
MILR1 OT0O30C7 Strong Biomarker [667]
MLKL OTDSLC81 Strong Biomarker [668]
MNAT1 OTXLOYCB Strong Biomarker [197]
MPIG6B OTVNKQWA Strong Genetic Variation [73]
MPP1 OTA2ENZQ Strong Biomarker [669]
MRE11 OTGU8TZM Strong Biomarker [670]
MRPS30 OTDXIAGG Strong Biomarker [349]
MRTFA OTCVXASM Strong Biomarker [671]
MSN OTZJ4J6G Strong Biomarker [672]
MT1B OTUA4FFH Strong Altered Expression [100]
MT1E OTXJKU4Y Strong Altered Expression [100]
MT1F OTZVUYG1 Strong Altered Expression [100]
MT1H OT0MVBM6 Strong Altered Expression [100]
MTA2 OTCCYIQJ Strong Biomarker [673]
MTMR3 OTBIT23O Strong Altered Expression [299]
MTPAP OT6HQ02S Strong Biomarker [349]
MTREX OTSQY30V Strong Genetic Variation [674]
MTX1 OTLSDNZO Strong Biomarker [675]
MX1 OT6X8G5T Strong Biomarker [676]
MYO9B OTQ94R5K Strong Genetic Variation [677]
MZB1 OT071TET Strong Biomarker [678]
MZF1 OTMVZCPW Strong Genetic Variation [679]
NAA25 OTS3QVF1 Strong Genetic Variation [680]
NBDY OTV8WY4S Strong Genetic Variation [681]
NBEAL2 OTMCAXWR Strong Biomarker [682]
NCKIPSD OT24UORN Strong Biomarker [683]
NCR2 OT2H13BX Strong Altered Expression [684]
NDUFS4 OTJKUYEE Strong Genetic Variation [685]
NECTIN2 OTIE0W6O Strong Altered Expression [221]
NEU1 OTH9BY8Y Strong Altered Expression [295]
NFATC2 OTK5T6HZ Strong Biomarker [686]
NFIL3 OTQH9HM3 Strong Altered Expression [687]
NFKBIL1 OTYFTPS0 Strong Genetic Variation [73]
NHS OTKE8QAT Strong Biomarker [688]
NLRC4 OTAIA3NA Strong Biomarker [689]
NLRP2 OTJA81JU Strong Genetic Variation [690]
NT5C3A OT67KZJA Strong Biomarker [691]
NUDT15 OTX8SZOT Strong Genetic Variation [692]
NUP98 OTNT12G2 Strong Biomarker [477]
NXF1 OTEFHXG6 Strong Genetic Variation [380]
OAS1 OT8ZLOCY Strong Altered Expression [693]
OAS2 OT64CCTM Strong Altered Expression [694]
OASL OTZ05YRP Strong Biomarker [695]
OAZ1 OTPT0PKZ Strong Altered Expression [696]
OCA2 OTDWIGBF Strong Biomarker [697]
OR2AG1 OTEITRP4 Strong Biomarker [690]
ORMDL3 OTAB7MZF Strong Altered Expression [698]
OXA1L OTS0BFRD Strong Biomarker [699]
P2RX2 OT0LF34A Strong Biomarker [325]
P2RX5 OTLBR20R Strong Biomarker [325]
P2RX6 OT1FNTXA Strong Biomarker [325]
PADI2 OTT40K94 Strong Biomarker [700]
PAK3 OT80M3BV Strong Genetic Variation [412]
PAPOLA OTPHD65D Strong Biomarker [349]
PAPPA OTTTG9PG Strong Altered Expression [203]
PBX1 OTORABGO Strong Altered Expression [701]
PC OT6O0V51 Strong Biomarker [702]
PDAP1 OTJSWMOD Strong Biomarker [349]
PDHX OTG7O271 Strong Genetic Variation [703]
PDLIM7 OTAZVODU Strong Biomarker [559]
PFDN5 OTTKPTUP Strong Altered Expression [221]
PGK1 OT6V1ICH Strong Biomarker [704]
PHLDB1 OTIRCB6I Strong Genetic Variation [551]
PIGF OTJKE6VW Strong Altered Expression [705]
PIK3C2A OTFBU4GD Strong Biomarker [706]
PIK3R3 OTXGJ8N1 Strong Biomarker [669]
PLAAT4 OTI66SAJ Strong Biomarker [218]
PLD4 OT5I74II Strong Biomarker [707]
PLSCR1 OTGY9B5T Strong Altered Expression [708]
POLG2 OTDBMZJB Strong Biomarker [669]
POU4F1 OTMHYGWQ Strong Altered Expression [709]
POU4F2 OT6SW5H0 Strong Altered Expression [710]
PPBP OT1FHGQS Strong Altered Expression [711]
PRC1 OTHD0XS0 Strong Biomarker [712]
PRDM1 OTQLSVBS Strong Genetic Variation [713]
PRF1 OTFVXD7H Strong Altered Expression [714]
PROCR OTRHED17 Strong Genetic Variation [715]
PRPS2 OTCY1B1O Strong Genetic Variation [716]
PRR12 OTY2ILFT Strong Genetic Variation [264]
PSMA5 OT38E6Y1 Strong Biomarker [488]
PSMD12 OTWICA51 Strong Biomarker [669]
PSMD4 OTH1VZTM Strong Altered Expression [492]
PSMD7 OT7PZZ4K Strong Biomarker [136]
PSME3 OTSTC4YY Strong Biomarker [717]
PTPRU OTHDO0QG Strong Biomarker [347]
PUF60 OTG90DYF Strong Biomarker [718]
RAB3D OTGKRR3C Strong Biomarker [719]
RABEPK OTCZSREH Strong Biomarker [136]
RABGAP1L OT7QO47I Strong Genetic Variation [720]
RAG1 OTV131E4 Strong Biomarker [721]
RAG2 OTG9UYTW Strong Biomarker [721]
RAPGEF5 OT53VS75 Strong Biomarker [722]
RASGRF1 OTNWJ7EN Strong Altered Expression [723]
RASGRP1 OTX9WN2E Strong Altered Expression [723]
RASGRP3 OTEMEV3P Strong Genetic Variation [76]
RASSF2 OT2JHDO4 Strong Genetic Variation [73]
RASSF5 OT6Q41I2 Strong Biomarker [724]
RBM23 OTDNGLHY Strong Altered Expression [492]
RBMX OTFZN66E Strong Biomarker [725]
RC3H1 OTCU6CYA Strong Biomarker [726]
RELB OTU3QYEF Strong Biomarker [727]
RETN OTW5Z1NH Strong Altered Expression [728]
RIPK3 OTL1D484 Strong Genetic Variation [668]
RLN2 OTY3OG71 Strong Biomarker [729]
RMDN1 OTE1NB6U Strong Biomarker [730]
RMDN2 OTK5WSFI Strong Biomarker [730]
RMDN3 OTKO7AUM Strong Biomarker [730]
RNASE2 OT8Z4FNE Strong Biomarker [128]
RNASEH2A OT8G3G7K Strong Biomarker [731]
RNF114 OTF06FRP Strong Genetic Variation [73]
RNF128 OTJO86CJ Strong Altered Expression [572]
RNF185 OTU1NS9O Strong Altered Expression [732]
ROBO3 OTPVG40S Strong Biomarker [218]
RPAIN OTBMXAYK Strong Altered Expression [480]
RPL17 OTTYMPS6 Strong Genetic Variation [113]
RPLP0 OT3XKD6Y Strong Biomarker [394]
RPP14 OT4OYFSK Strong Altered Expression [524]
RPS19 OTBKGP48 Strong Biomarker [733]
RPS27A OTIIGGZ2 Strong Biomarker [734]
RPS6 OTT4D1LN Strong Biomarker [735]
RSPH6A OTJ96T2F Strong Biomarker [736]
RSU1 OTO5GHT1 Strong Biomarker [736]
RTRAF OTJ6NVMW Strong Biomarker [573]
RUBCN OTF1UIZC Strong Biomarker [299]
RUNX1T1 OT30DED5 Strong Biomarker [422]
S100A10 OTI71243 Strong Altered Expression [737]
SAMD9L OTKEJUCI Strong Genetic Variation [633]
SAMHD1 OTBCIBC7 Strong Genetic Variation [738]
SCARF1 OT25OJDU Strong Biomarker [739]
SCD5 OTSSUQ3Z Strong Genetic Variation [740]
SCYL1 OTQ0IN7P Strong Biomarker [317]
SDS OT5WTJ2M Strong Biomarker [741]
SEC61G OT7MJRXY Strong Genetic Variation [73]
SEMA5A OTUOIOJV Strong Altered Expression [742]
SEMA7A OT0ZJK64 Strong Altered Expression [361]
SERPINB1 OT5RDUFO Strong Altered Expression [128]
SERPINB2 OT72QLZB Strong Genetic Variation [743]
SET OTGYYQJO Strong Genetic Variation [744]
SETD1A OTVVWRIC Strong Biomarker [744]
SF3B6 OTPRKS6S Strong Altered Expression [524]
SGMS1 OTZQE7PW Strong Biomarker [745]
SGSM3 OTIB1P8A Strong Biomarker [746]
SH2D1A OTLU49I5 Strong Biomarker [471]
SH3BGRL3 OTKMW34I Strong Altered Expression [221]
SH3BP2 OT90JNBS Strong Biomarker [747]
SHOC2 OTUNQ2CT Strong Genetic Variation [748]
SIGLEC1 OTNWSQA9 Strong Altered Expression [749]
SIGLEC12 OTC36XP9 Strong Biomarker [446]
SIGLEC14 OT2JGGXD Strong Altered Expression [750]
SIGLEC5 OTYC440J Strong Biomarker [751]
SIRPG OTE2P8G0 Strong Biomarker [387]
SLURP1 OT89YD2E Strong Biomarker [752]
SMC1A OT9ZMRK9 Strong Posttranslational Modification [753]
SMG7 OTZDB0JX Strong Genetic Variation [264]
SMS OT8JYKNH Strong Biomarker [754]
SNRPA OT02TSQT Strong Biomarker [755]
SNRPB OT3UJ4ZU Strong Altered Expression [756]
SNRPC OTI67SR2 Strong Biomarker [757]
SNRPD1 OTWKZV4E Strong Biomarker [758]
SNRPN OTQB1ID1 Strong Altered Expression [759]
SOAT1 OTB4Y5RJ Strong Biomarker [760]
SOCS2 OTBPNKJQ Strong Biomarker [761]
SPATA2 OTOA45GL Strong Genetic Variation [113]
SPI1 OTVCA1D0 Strong Genetic Variation [762]
SPTAN1 OT6VY3A3 Strong Biomarker [763]
SRCIN1 OTQZNQQ5 Strong Biomarker [287]
SRP19 OT8RP8JB Strong Altered Expression [764]
SRP54 OT9SGF3X Strong Genetic Variation [765]
SRSF1 OTF61HOV Strong Biomarker [766]
SRSF5 OTC5WP98 Strong Biomarker [303]
SS18L1 OT9ZEGV7 Strong Genetic Variation [767]
STAT2 OTO9G2RZ Strong Biomarker [768]
STAT5A OTBSJGN3 Strong Biomarker [769]
STAT5B OTZVPEBT Strong Biomarker [769]
STUB1 OTSUYI9A Strong Altered Expression [770]
SYBU OT3FQV7N Strong Biomarker [730]
SYNPO OTICDJAB Strong Biomarker [313]
SYT1 OTVTPOI6 Strong Posttranslational Modification [598]
TAP2 OTWSYFI7 Strong Genetic Variation [380]
TERF2IP OT3M5P3G Strong Altered Expression [670]
TG OT3ELHIJ Strong Biomarker [771]
TIMD4 OTGGC20G Strong Genetic Variation [772]
TMC8 OTUAD95X Strong Altered Expression [221]
TMED10 OTUXSHH7 Strong Altered Expression [221]
TMEM187 OTOE4G8T Strong Biomarker [606]
TMEM39A OTRT51D9 Strong Genetic Variation [773]
TNFAIP8L2 OTII0RM0 Strong Biomarker [774]
TNFRSF10C OTVHOL9B Strong Altered Expression [775]
TNFRSF6B OTKAN9G7 Strong Biomarker [776]
TNFSF9 OTV9L89D Strong Biomarker [125]
TNPO3 OTOT3HH0 Strong Genetic Variation [777]
TNXB OTVBWAV5 Strong Genetic Variation [778]
TRAF3IP2 OTLLZERL Strong Biomarker [779]
TRAP1 OTNG0L8J Strong Genetic Variation [57]
TREML4 OT2VLMTL Strong Biomarker [780]
TREX2 OT5QAGJ4 Strong Genetic Variation [781]
TRIB1 OTPEO17G Strong Biomarker [782]
TRIM22 OTJBLG5R Strong Altered Expression [221]
TRIM38 OT6SP1M9 Strong Biomarker [783]
TRIM63 OTUSWA74 Strong Genetic Variation [784]
TRIM68 OTHMDMOG Strong Biomarker [785]
TSC22D3 OT03UM03 Strong Altered Expression [786]
TSGA10 OTIF1O1T Strong Biomarker [787]
TSPAN33 OTH6C0WU Strong Altered Expression [788]
TTC34 OT6UGMDV Strong Genetic Variation [789]
ATP6 OTPHOGLX Definitive Genetic Variation [790]
CBLIF OTNE20WU Definitive Altered Expression [730]
CCL14 OT8QETQU Definitive Genetic Variation [791]
CRYGC OTYSTQWI Definitive Biomarker [791]
FCN2 OTTHJBKZ Definitive Genetic Variation [792]
KALRN OT8WRCBH Definitive Genetic Variation [261]
MGAT5 OTU4DD4G Definitive Genetic Variation [261]
MYDGF OT9HRPL6 Definitive Altered Expression [87]
PTX3 OTPXHRKU Definitive Biomarker [793]
RAVER2 OT0MDL7K Definitive Genetic Variation [794]
------------------------------------------------------------------------------------
⏷ Show the Full List of 663 DOT(s)

References

1 Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022 Feb 15;14:199-211.
2 Therapeutic Interventions of Tissue Specific Autoimmune Onset in Systemic Lupus Erythematosus. Mini Rev Med Chem. 2017;17(15):1418-1424.
3 FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761123.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6887).
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 Betamethasone FDA Label
7 Busulfan FDA Label
8 Chloroquine FDA Label
9 Cortisone acetate FDA Label
10 Dexamethasone FDA Label
11 Fludarabine FDA Label
12 Hydrocortisone FDA Label
13 Hydroxychloroquine FDA Label
14 Methylprednisolone FDA Label
15 Mycophenolate mofetil FDA Label
16 Prednisolone FDA Label
17 Prednisone FDA Label
18 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8257).
19 Triamcinolone FDA Label
20 ClinicalTrials.gov (NCT04895241) A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care (TOPAZ-1). U.S. National Institutes of Health.
21 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8088).
22 ClinicalTrials.gov (NCT01240694) A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus. U.S. National Institutes of Health.
23 ClinicalTrials.gov (NCT05352919) A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus. U.S.National Institutes of Health.
24 ClinicalTrials.gov (NCT04882878) A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus. U.S.National Institutes of Health.
25 ClinicalTrials.gov (NCT01609452) MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP. U.S. National Institutes of Health.
26 ClinicalTrials.gov (NCT04895696) A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus. U.S.National Institutes of Health.
27 ClinicalTrials.gov (NCT02334306) A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sj ren's Syndrome. U.S. National Institutes of Health.
28 ClinicalTrials.gov (NCT04058028) Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE). U.S. National Institutes of Health.
29 ClinicalTrials.gov (NCT05430854) An Open-Label Extension Study To Evaluate The Long- Term Safety And Tolerability Of Daxdilimab (Hzn-7734) In Subjects With Systemic Lupus Erythematosus. U.S.National Institutes of Health.
30 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039050)
31 ClinicalTrials.gov (NCT04680637) A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy. U.S.National Institutes of Health.
32 ClinicalTrials.gov (NCT05039840) Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double Blind, Placebo-controlled, Phase 2, Proof of Concept Study. U.S.National Institutes of Health.
33 ClinicalTrials.gov (NCT01777256) An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184. U.S. National Institutes of Health.
34 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
35 ClinicalTrials.gov (NCT05123586) A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus. U.S.National Institutes of Health.
36 ClinicalTrials.gov (NCT01031836) A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.. U.S. National Institutes of Health.
37 ClinicalTrials.gov (NCT04433585) A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus. U.S.National Institutes of Health.
38 ClinicalTrials.gov (NCT01405196) Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus. U.S. National Institutes of Health.
39 ClinicalTrials.gov (NCT03334851) A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN SUBJECTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS. U.S.National Institutes of Health.
40 Clinical pipeline report, company report or official report of Genentech (2011).
41 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8268).
42 ClinicalTrials.gov (NCT02437890) A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus. U.S. National Institutes of Health.
43 ClinicalTrials.gov (NCT00960362) An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE). U.S. National Institutes of Health.
44 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028077)
45 ClinicalTrials.gov (NCT03030976) A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)
46 ClinicalTrials.gov (NCT01093911) Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE). U.S. National Institutes of Health.
47 Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat Rev Rheumatol. 2014 Jan;10(1):23-34.
48 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035150)
49 ClinicalTrials.gov (NCT04643067) A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients (Lupus). U.S. National Institutes of Health.
50 ClinicalTrials.gov (NCT01127321) A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus. U.S. National Institutes of Health.
51 ClinicalTrials.gov (NCT02321709) Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients. U.S. National Institutes of Health.
52 Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. Vaccine. 2012 January 17; 30(4): 691-702.
53 Emergence of targeted immune therapies for systemic lupus. Expert Opin Emerg Drugs. 2005 Feb;10(1):53-65.
54 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008196)
55 Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. Ann Rheum Dis. 2015 Feb;74(2):452-63.
56 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
57 Dnase1-deficient mice spontaneously develop a systemic lupus erythematosus-like disease. Eur J Immunol. 2019 Apr;49(4):590-599. doi: 10.1002/eji.201847875. Epub 2019 Feb 21.
58 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
59 Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome.Lupus. 2019 Apr;28(4):465-474. doi: 10.1177/0961203319828499. Epub 2019 Feb 10.
60 Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal -actinin-4 expression and stabilizing integrin-cytoskeleton linkage.Arthritis Res Ther. 2019 Jan 29;21(1):40. doi: 10.1186/s13075-019-1820-3.
61 Combined Assay for Detecting Autoantibodies to Nucleic Acids and Apolipoprotein H in Patients with Systemic Lupus Erythematosus.Methods Mol Biol. 2020;2063:57-71. doi: 10.1007/978-1-0716-0138-9_6.
62 Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.Eur J Immunol. 2015 Sep;45(9):2683-93. doi: 10.1002/eji.201445219. Epub 2015 Jun 26.
63 Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.Sci Transl Med. 2019 Mar 6;11(482):eaav1648. doi: 10.1126/scitranslmed.aav1648.
64 Anti-CD22 epratuzumab for systemic lupus erythematosus: A systematic review and meta-analysis of randomized controlled trials.Exp Ther Med. 2019 Aug;18(2):1500-1506. doi: 10.3892/etm.2019.7630. Epub 2019 May 29.
65 CD4+CD28+KIR+CD11a(hi) T cells correlate with disease activity and are characterized by a pro-inflammatory epigenetic and transcriptional profile in lupus patients.J Autoimmun. 2018 Jan;86:19-28. doi: 10.1016/j.jaut.2017.09.011. Epub 2017 Oct 20.
66 The skewed frequency of B-cell subpopulation CD19(+) CD24 (hi) CD38 (hi) cells in peripheral blood mononuclear cells is correlated with the elevated serum sCD40L in patients with active systemic lupus erythematosus.J Cell Biochem. 2019 Jul;120(7):11490-11497. doi: 10.1002/jcb.28427. Epub 2019 Feb 16.
67 CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.J Immunol. 2017 Apr 1;198(7):2568-2577. doi: 10.4049/jimmunol.1600028. Epub 2017 Feb 20.
68 Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.Nat Genet. 2015 Dec;47(12):1457-1464. doi: 10.1038/ng.3434. Epub 2015 Oct 26.
69 Autoimmune risk loci of IL12RB2, IKZF1, XKR6, TMEM39A and CSK in Chinese patients with systemic lupus erythematosus.Tissue Antigens. 2015 Mar;85(3):200-3. doi: 10.1111/tan.12522.
70 Upregulated fractalkine levels in Chinese patients with lupus nephritis.Cytokine. 2018 Apr;104:23-28. doi: 10.1016/j.cyto.2018.01.027. Epub 2018 Feb 5.
71 Evaluation of potential biomarkers for the diagnosis and monitoring of Systemic Lupus Erythematosus using the Cytometric Beads Array (CBA).Clin Chim Acta. 2019 Dec;499:16-23. doi: 10.1016/j.cca.2019.08.033. Epub 2019 Aug 31.
72 Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.Clin Rheumatol. 2020 Jan;39(1):281-290. doi: 10.1007/s10067-019-04775-z. Epub 2019 Sep 16.
73 GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.Genes Immun. 2014 Sep;15(6):347-54. doi: 10.1038/gene.2014.23. Epub 2014 May 29.
74 Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice.Arthritis Rheumatol. 2018 Nov;70(11):1807-1819. doi: 10.1002/art.40559. Epub 2018 Sep 14.
75 Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKC/ERK Signaling Pathway.Cell Physiol Biochem. 2016;40(3-4):743-756. doi: 10.1159/000453135. Epub 2016 Dec 5.
76 Transancestral mapping and genetic load in systemic lupus erythematosus.Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.
77 Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice.PLoS One. 2019 Sep 9;14(9):e0217190. doi: 10.1371/journal.pone.0217190. eCollection 2019.
78 Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association Study.PLoS One. 2016 Jun 22;11(6):e0158065. doi: 10.1371/journal.pone.0158065. eCollection 2016.
79 Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.Front Immunol. 2019 Mar 14;10:460. doi: 10.3389/fimmu.2019.00460. eCollection 2019.
80 Oxidative stress and vitamin D receptor BsmI gene polymorphism in Egyptian children with systemic lupus erythematosus: a single center study.Lupus. 2019 May;28(6):771-777. doi: 10.1177/0961203319846380. Epub 2019 May 1.
81 Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90.Clin Immunol. 2018 Dec;197:6-18. doi: 10.1016/j.clim.2018.08.011. Epub 2018 Aug 24.
82 Insights into IL-29: Emerging role in inflammatory autoimmune diseases.J Cell Mol Med. 2019 Dec;23(12):7926-7932. doi: 10.1111/jcmm.14697. Epub 2019 Oct 2.
83 Interferon-3/4 genetic variants and interferon-3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese.Arthritis Res Ther. 2018 Aug 29;20(1):193. doi: 10.1186/s13075-018-1683-z.
84 Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus.Nat Genet. 2016 Aug;48(8):940-946. doi: 10.1038/ng.3603. Epub 2016 Jul 11.
85 IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.Arthritis Res Ther. 2018 Feb 8;20(1):27. doi: 10.1186/s13075-018-1525-z.
86 Genetic polymorphisms near IL-21 gene associated with Th17 cytokines confer risk for systemic lupus erythematosus in Chinese Han population.Lupus. 2019 Mar;28(3):406-413. doi: 10.1177/0961203319829821. Epub 2019 Feb 18.
87 Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.PLoS One. 2019 Nov 7;14(11):e0224707. doi: 10.1371/journal.pone.0224707. eCollection 2019.
88 Interleukin-32: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.Int J Rheum Dis. 2019 Jul;22(7):1305-1311. doi: 10.1111/1756-185X.13550. Epub 2019 Apr 3.
89 Interaction between IL-33 Gene Polymorphisms and Current Smoking with Susceptibility to Systemic Lupus Erythematosus.J Immunol Res. 2019 Mar 11;2019:1547578. doi: 10.1155/2019/1547578. eCollection 2019.
90 Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.J Am Soc Nephrol. 2020 Jan;31(1):54-65. doi: 10.1681/ASN.2019050545. Epub 2019 Oct 11.
91 The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.Clin Rheumatol. 2016 Apr;35(4):919-25. doi: 10.1007/s10067-016-3222-0. Epub 2016 Mar 9.
92 Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2017 Mar;96(10):e6166. doi: 10.1097/MD.0000000000006166.
93 Genome-wide association study identifies three novel susceptibility loci for systemic lupus erythematosus in Han Chinese.Br J Dermatol. 2018 Aug;179(2):506-508. doi: 10.1111/bjd.16500. Epub 2018 May 23.
94 Pim-1 as a Therapeutic Target in Lupus Nephritis.Arthritis Rheumatol. 2019 Aug;71(8):1308-1318. doi: 10.1002/art.40863. Epub 2019 Jul 2.
95 Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.PLoS One. 2017 Oct 11;12(10):e0186073. doi: 10.1371/journal.pone.0186073. eCollection 2017.
96 Basophils and the T helper 2 environment can promote the development of lupus nephritis.Nat Med. 2010 Jun;16(6):701-7. doi: 10.1038/nm.2159. Epub 2010 May 30.
97 MAP4K Family Kinases in Immunity and Inflammation. Adv Immunol. 2016;129:277-314.
98 The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.Int Immunopharmacol. 2019 Nov;76:105874. doi: 10.1016/j.intimp.2019.105874. Epub 2019 Sep 6.
99 The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.Nephrol Dial Transplant. 2007 Jan;22(1):109-17. doi: 10.1093/ndt/gfl618. Epub 2006 Nov 3.
100 The renal metallothionein expression profile is altered in human lupus nephritis.Arthritis Res Ther. 2008;10(4):R76. doi: 10.1186/ar2450. Epub 2008 Jul 6.
101 Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.J Thromb Haemost. 2004 Aug;2(8):1436-42. doi: 10.1111/j.1538-7836.2004.00854.x.
102 Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6.
103 Monogenic lupus: Dissecting heterogeneity.Autoimmun Rev. 2019 Oct;18(10):102361. doi: 10.1016/j.autrev.2019.102361. Epub 2019 Aug 8.
104 The kinase GLK controls autoimmunity and NF-B signaling by activating the kinase PKC- in T cells.Nat Immunol. 2011 Oct 9;12(11):1113-8. doi: 10.1038/ni.2121.
105 Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Genes Immun. 2015 Jan-Feb;16(1):15-23. doi: 10.1038/gene.2014.57. Epub 2014 Oct 23.
106 Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.Hum Immunol. 2003 Feb;64(2):274-84. doi: 10.1016/s0198-8859(02)00804-2.
107 Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.J Rheumatol. 2018 May;45(5):655-662. doi: 10.3899/jrheum.170561. Epub 2018 Feb 15.
108 Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.J Rheumatol. 2016 Jun;43(6):1045-9. doi: 10.3899/jrheum.150665. Epub 2016 Mar 15.
109 Human low-affinity IgG receptor FcRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.J Thromb Haemost. 2019 Mar;17(3):532-537. doi: 10.1111/jth.14385. Epub 2019 Feb 13.
110 A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.Nat Genet. 2009 Nov;41(11):1228-33. doi: 10.1038/ng.468. Epub 2009 Oct 18.
111 Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.Arthritis Rheumatol. 2016 Apr;68(4):932-43. doi: 10.1002/art.39504.
112 Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.Arthritis Res Ther. 2018 May 30;20(1):100. doi: 10.1186/s13075-018-1604-1.
113 Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.Int J Immunogenet. 2020 Feb;47(1):57-64. doi: 10.1111/iji.12456. Epub 2019 Sep 29.
114 Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus.Front Immunol. 2017 Oct 16;8:1292. doi: 10.3389/fimmu.2017.01292. eCollection 2017.
115 Epigenetic programming underpins B cell dysfunction in human SLE.Nat Immunol. 2019 Aug;20(8):1071-1082. doi: 10.1038/s41590-019-0419-9. Epub 2019 Jul 1.
116 High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry.Nat Genet. 2016 Mar;48(3):323-30. doi: 10.1038/ng.3496. Epub 2016 Jan 25.
117 BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.Cytokine. 2019 Feb;114:115-127. doi: 10.1016/j.cyto.2018.11.008. Epub 2018 Nov 19.
118 Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF.Arthritis Rheumatol. 2020 Feb;72(2):292-302. doi: 10.1002/art.41097. Epub 2019 Dec 26.
119 Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16.EMBO Rep. 2018 Oct;19(10):e45737. doi: 10.15252/embr.201845737. Epub 2018 Aug 13.
120 Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.J Immunol. 2019 Jan 1;202(1):56-68. doi: 10.4049/jimmunol.1801209. Epub 2018 Dec 3.
121 Evaluation of genetic susceptibility between systemic lupus erythematosus and GRB2 gene.Sci Rep. 2019 Jul 17;9(1):10335. doi: 10.1038/s41598-019-46827-z.
122 The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.Rheumatol Int. 2016 Jun;36(6):799-805. doi: 10.1007/s00296-016-3422-6. Epub 2016 Jan 14.
123 Low Levels of IgM and IgA Recognizing Acetylated C1-Inhibitor Peptides Are Associated with Systemic Lupus Erythematosus in Taiwanese Women.Molecules. 2019 Apr 26;24(9):1645. doi: 10.3390/molecules24091645.
124 Association between TL1A gene polymorphisms and systemic lupus erythematosus in a Chinese Han population.J Cell Physiol. 2019 Dec;234(12):22543-22553. doi: 10.1002/jcp.28818. Epub 2019 May 12.
125 The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.Cells. 2019 Sep 6;8(9):1044. doi: 10.3390/cells8091044.
126 Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.AIDS. 2020 Jan 1;34(1):25-32. doi: 10.1097/QAD.0000000000002401.
127 Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages.Biochem Pharmacol. 2017 Dec 15;146:151-164. doi: 10.1016/j.bcp.2017.10.001. Epub 2017 Oct 4.
128 Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.Front Immunol. 2019 Mar 11;10:423. doi: 10.3389/fimmu.2019.00423. eCollection 2019.
129 Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.Arthritis Res Ther. 2016 Jul 13;18:162. doi: 10.1186/s13075-016-1050-x.
130 Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.Sci Rep. 2019 Jun 20;9(1):8993. doi: 10.1038/s41598-019-45299-5.
131 Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.Nat Med. 2015 Sep;21(9):1018-27. doi: 10.1038/nm.3933. Epub 2015 Aug 24.
132 Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.Clin Rheumatol. 2018 Jan;37(1):81-85. doi: 10.1007/s10067-017-3676-8. Epub 2017 May 16.
133 High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.Arthritis Rheumatol. 2020 Jan;72(1):20-30. doi: 10.1002/art.41059. Epub 2019 Nov 26.
134 Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.Nephrol Dial Transplant. 2012 Apr;27(4):1358-67. doi: 10.1093/ndt/gfr544. Epub 2011 Oct 10.
135 Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.Clin Exp Rheumatol. 2013 Mar-Apr;31(2):172-9. Epub 2012 Nov 6.
136 High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus.Arthritis Rheumatol. 2020 Jan;72(1):89-99. doi: 10.1002/art.41054.
137 Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.Arthritis Res Ther. 2018 Oct 24;20(1):238. doi: 10.1186/s13075-018-1702-0.
138 ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico.PLoS One. 2019 Nov 27;14(11):e0224543. doi: 10.1371/journal.pone.0224543. eCollection 2019.
139 Kallikreins and lupus nephritis.J Clin Invest. 2009 Apr;119(4):768-71. doi: 10.1172/jci38786.
140 Apoptosis in patients with primary antiphospholipid antibody syndrome.Int J Rheum Dis. 2019 Apr;22(4):677-685. doi: 10.1111/1756-185X.13468. Epub 2019 Feb 6.
141 Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.J Clin Invest. 2009 Apr;119(4):911-23. doi: 10.1172/JCI36728.
142 Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production.PLoS Genet. 2011 Mar;7(3):e1001323. doi: 10.1371/journal.pgen.1001323. Epub 2011 Mar 3.
143 Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus.Ann Transl Med. 2018 Dec;6(23):452. doi: 10.21037/atm.2018.11.04.
144 Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy.Lab Invest. 2002 May;82(5):543-6. doi: 10.1038/labinvest.3780448.
145 Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.Lupus. 2017 Jul;26(8):815-824. doi: 10.1177/0961203316678674. Epub 2016 Dec 21.
146 Multifactor dimensionality reduction analysis to elucidate the cross-talk between one-carbon and xenobiotic metabolic pathways in multi-disease models.Mol Biol Rep. 2015 Jul;42(7):1211-24. doi: 10.1007/s11033-015-3856-z. Epub 2015 Feb 4.
147 Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis.Rheumatol Int. 2015 Dec;35(12):1975-83. doi: 10.1007/s00296-015-3298-x. Epub 2015 Jun 5.
148 Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway.J Cell Physiol. 2019 Jul;234(7):11555-11566. doi: 10.1002/jcp.27810. Epub 2019 Jan 15.
149 Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages.Front Immunol. 2018 Feb 2;9:135. doi: 10.3389/fimmu.2018.00135. eCollection 2018.
150 PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.Ann Rheum Dis. 2015 Mar;74(3):e14. doi: 10.1136/annrheumdis-2013-204909. Epub 2014 Feb 17.
151 Activity and expression of E-NTPDase is altered in peripheral lymphocytes of systemic lupus erythematosus patients.Clin Chim Acta. 2019 Jan;488:90-97. doi: 10.1016/j.cca.2018.10.032. Epub 2018 Oct 25.
152 B Cell ADAM10 Controls Murine Lupus Progression through Regulation of the ICOS:ICOS Ligand Axis.J Immunol. 2019 Feb 1;202(3):664-674. doi: 10.4049/jimmunol.1801207. Epub 2019 Jan 4.
153 Altered mRNA expression levels of vaspin and adiponectin in peripheral blood mononuclear cells of systemic lupus erythematosus patients.Clin Exp Rheumatol. 2019 May-Jun;37(3):458-464. Epub 2018 Aug 29.
154 Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.Rheumatol Int. 2003 May;23(3):99-103. doi: 10.1007/s00296-002-0266-z. Epub 2003 Mar 12.
155 Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.J Autoimmun. 2015 Apr;58:67-77. doi: 10.1016/j.jaut.2015.01.006. Epub 2015 Jan 26.
156 Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations.Ann Rheum Dis. 2016 May;75(5):891-8. doi: 10.1136/annrheumdis-2014-206367. Epub 2015 Apr 10.
157 Exploration of vascular adhesion protein-1 expression in patients with conjunctivitis associated systemic lupus erythematosus using 2D-DIGE.Exp Ther Med. 2019 Dec;18(6):5072-5077. doi: 10.3892/etm.2019.8009. Epub 2019 Sep 16.
158 Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.J Immunol. 2016 Jun 15;196(12):4915-24. doi: 10.4049/jimmunol.1501523. Epub 2016 May 11.
159 A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus.Lupus. 2008 Sep;17(9):799-804. doi: 10.1177/0961203308089444.
160 APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).Am J Kidney Dis. 2020 Feb;75(2):287-290. doi: 10.1053/j.ajkd.2019.07.010. Epub 2019 Oct 7.
161 Gene-gene interaction of ATG5, ATG7, BLK and BANK1 in systemic lupus erythematosus.Int J Rheum Dis. 2016 Dec;19(12):1284-1293. doi: 10.1111/1756-185X.12768. Epub 2015 Sep 30.
162 Anti--enolase antibody combined with 2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.Lupus. 2019 Mar;28(3):365-370. doi: 10.1177/0961203319828822.
163 The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity.Nat Commun. 2017 Aug 15;8(1):254. doi: 10.1038/s41467-017-00348-3.
164 Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.Clin Exp Rheumatol. 2014 Sep-Oct;32(5):705-14. Epub 2014 Aug 15.
165 The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.J Clin Invest. 2010 Dec;120(12):4251-72. doi: 10.1172/JCI42213. Epub 2010 Nov 15.
166 PPARgamma-2 and BMPR2 genes were differentially expressed in peripheral blood of SLE patients with osteonecrosis.DNA Cell Biol. 2008 Nov;27(11):623-8. doi: 10.1089/dna.2008.0772.
167 Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.J Autoimmun. 2013 Mar;41:168-74. doi: 10.1016/j.jaut.2012.12.012. Epub 2013 Feb 18.
168 BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.Int J Mol Sci. 2019 Sep 11;20(18):4505. doi: 10.3390/ijms20184505.
169 Systematic identification of trans eQTLs as putative drivers of known disease associations.Nat Genet. 2013 Oct;45(10):1238-1243. doi: 10.1038/ng.2756. Epub 2013 Sep 8.
170 Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.BMC Immunol. 2010 Aug 20;11:43. doi: 10.1186/1471-2172-11-43.
171 Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials.Arthritis Rheumatol. 2019 Sep;71(9):1413-1425. doi: 10.1002/art.40933. Epub 2019 Aug 7.
172 Cathelicidin (LL-37) and its correlation with pro-oxidant, antioxidant balance and disease activity in systemic lupus erythematosus: a cross-sectional human study.Lupus. 2017 Aug;26(9):975-982. doi: 10.1177/0961203317691368. Epub 2017 Mar 17.
173 A pathogenic role for ER stress-induced autophagy and ER chaperone GRP78/BiP in T lymphocyte systemic lupus erythematosus.J Leukoc Biol. 2015 Feb;97(2):425-33. doi: 10.1189/jlb.6A0214-097R. Epub 2014 Dec 16.
174 Overexpression of X-linked genes in T cells from women with lupus.J Autoimmun. 2013 Mar;41:60-71. doi: 10.1016/j.jaut.2012.12.006. Epub 2013 Feb 19.
175 Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population.Lupus. 2011 May;20(6):628-35. doi: 10.1177/0961203310394896.
176 CD4(+) CD52(lo) T-cell expression contributes to the development of systemic lupus erythematosus.Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13.
177 Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.Cytokine. 2019 Feb;114:67-73. doi: 10.1016/j.cyto.2018.10.013. Epub 2018 Dec 12.
178 Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.Cell Mol Immunol. 2016 Nov;13(6):764-775. doi: 10.1038/cmi.2015.48. Epub 2015 Jul 6.
179 Basophil Recruitment to Skin Lesions of Patients with Systemic Lupus Erythematosus Mediated by CCR1 and CCR2.Cell Physiol Biochem. 2017;43(2):832-839. doi: 10.1159/000481609. Epub 2017 Sep 28.
180 PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.Rheumatology (Oxford). 2019 Dec 1;58(12):2188-2192. doi: 10.1093/rheumatology/kez228.
181 Increased frequency of CCR7(+)CD4(+) T cells from patients with primary Sjgren's syndrome: An indicator of disease activity rather than of damage severity.Cytokine. 2018 Oct;110:9-17. doi: 10.1016/j.cyto.2018.04.015. Epub 2018 Apr 21.
182 Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.Immunology. 2004 Jun;112(2):274-89. doi: 10.1111/j.1365-2567.2004.01862.x.
183 Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.Scand J Rheumatol. 2020 Jan;49(1):33-37. doi: 10.1080/03009742.2019.1614213. Epub 2019 Jun 4.
184 Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus.Immunity. 2004 Dec;21(6):769-80. doi: 10.1016/j.immuni.2004.10.009.
185 Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus.Cell Death Dis. 2019 May 21;10(6):393. doi: 10.1038/s41419-019-1623-0.
186 Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.Sci Rep. 2017 Mar 21;7(1):270. doi: 10.1038/s41598-017-00290-w.
187 Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.Pharmacol Res. 2017 Jun;120:252-257. doi: 10.1016/j.phrs.2017.04.005. Epub 2017 Apr 8.
188 Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.J Rheumatol. 2008 Nov;35(11):2113-8. doi: 10.3899/jrheum.070993.
189 A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients.Cytokine. 2017 Aug;96:189-194. doi: 10.1016/j.cyto.2017.04.016. Epub 2017 Apr 21.
190 Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts.J Rheumatol. 2011 Jun;38(6):1033-8. doi: 10.3899/jrheum.101053. Epub 2011 Mar 1.
191 Hypomethylation of STAT1 and HLA-DRB1 is associated with type-I interferon-dependent HLA-DRB1 expression in lupus CD8+ T cells.Ann Rheum Dis. 2019 Apr;78(4):519-528. doi: 10.1136/annrheumdis-2018-214323. Epub 2019 Jan 23.
192 Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.Blood. 2013 Oct 24;122(17):3020-9. doi: 10.1182/blood-2012-12-473744. Epub 2013 Jul 2.
193 Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.Eur J Immunol. 2017 Aug;47(8):1368-1376. doi: 10.1002/eji.201746923. Epub 2017 Jul 10.
194 Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.Lupus. 2008 Jul;17(7):654-62. doi: 10.1177/0961203308089410.
195 Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus.Mediators Inflamm. 2019 Mar 3;2019:2473164. doi: 10.1155/2019/2473164. eCollection 2019.
196 Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus.Clin Chem Lab Med. 2002 May;40(5):493-5. doi: 10.1515/CCLM.2002.085.
197 Decreased IL-12 production by polymorphonuclear leukocytes in patients with active systemic lupus erythematosus.Immunol Invest. 2002 Aug-Nov;31(3-4):177-89. doi: 10.1081/imm-120016239.
198 Analysis on the risk factors for organ damage in patients with systemic lupus erythematosus: a cross-sectional single-center experience.Sao Paulo Med J. 2019 Jul 15;137(2):155-161. doi: 10.1590/1516-3180.2018.0258060219.
199 Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.Ann N Y Acad Sci. 2015 Dec;1362(1):215-23. doi: 10.1111/nyas.12607. Epub 2015 Feb 26.
200 Upregulation of the C/EBP LAP isoform could be due to decreased TNFAIP3/TNIP1 expression in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.Mod Rheumatol. 2017 Jul;27(4):657-663. doi: 10.1080/14397595.2016.1232331. Epub 2016 Sep 23.
201 Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Gentique de la Nephropathie Diabtique Study Group. Donnes Epidmiologiques sur le Syndrome d'Insulino-Rsistance Study Group.Nephrol Dial Transplant. 2000 Dec;15(12):1971-6. doi: 10.1093/ndt/15.12.1971.
202 Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome.Thromb Res. 2018 Apr;164:63-68. doi: 10.1016/j.thromres.2018.02.142. Epub 2018 Feb 21.
203 Influence of maternal systemic lupus erythematosus on first-trimester combined screening for chromosomal abnormalities.Prenat Diagn. 2007 Jul;27(7):600-2. doi: 10.1002/pd.1737.
204 Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.J Clin Invest. 2019 Mar 1;129(3):1359-1371. doi: 10.1172/JCI124466. Epub 2019 Feb 18.
205 The discovery and optimization of a series of 2-aminobenzoxazole derivatives as ChemR23 inhibitors.Bioorg Med Chem. 2019 Nov 1;27(21):115091. doi: 10.1016/j.bmc.2019.115091. Epub 2019 Sep 6.
206 A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.J Med Chem. 2018 Jan 25;61(2):535-542. doi: 10.1021/acs.jmedchem.6b01921. Epub 2017 Apr 20.
207 Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.J Immunol. 2011 Apr 1;186(7):4508-17. doi: 10.4049/jimmunol.1000340. Epub 2011 Feb 23.
208 Chronic pain and impaired glial glutamate transporter function in lupus-prone mice are ameliorated by blocking macrophage colony-stimulating factor-1 receptors.J Neurochem. 2017 Mar;140(6):963-976. doi: 10.1111/jnc.13952. Epub 2017 Feb 1.
209 Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.Front Immunol. 2018 May 9;9:1053. doi: 10.3389/fimmu.2018.01053. eCollection 2018.
210 Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity.Biomolecules. 2018 Oct 3;8(4):105. doi: 10.3390/biom8040105.
211 Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells.Sci Rep. 2019 Feb 28;9(1):3054. doi: 10.1038/s41598-019-38809-y.
212 Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus.Clin Immunol. 2019 Nov;208:108255. doi: 10.1016/j.clim.2019.108255. Epub 2019 Aug 30.
213 Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.Cytokine. 2019 Jul;119:95-112. doi: 10.1016/j.cyto.2019.03.010. Epub 2019 Mar 20.
214 Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.Ann Rheum Dis. 2017 Jan;76(1):153-158. doi: 10.1136/annrheumdis-2016-209157. Epub 2016 Jun 9.
215 Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.Br J Clin Pharmacol. 2016 Feb;81(2):327-40. doi: 10.1111/bcp.12800. Epub 2015 Dec 25.
216 Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.J Clin Pharm Ther. 2020 Apr;45(2):309-317. doi: 10.1111/jcpt.13072. Epub 2019 Nov 21.
217 REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A).Ann Rheum Dis. 2019 Feb;78(2):238-248. doi: 10.1136/annrheumdis-2018-213181. Epub 2018 Dec 18.
218 Antiviral Adaptor MAVS Promotes Murine Lupus With a B Cell Autonomous Role.Front Immunol. 2019 Oct 16;10:2452. doi: 10.3389/fimmu.2019.02452. eCollection 2019.
219 Physical Activity and Genome-wide DNA Methylation: The REgistre GIron del COR Study.Med Sci Sports Exerc. 2020 Mar;52(3):589-597. doi: 10.1249/MSS.0000000000002174.
220 De novo mutations implicate novel genes in systemic lupus erythematosus.Hum Mol Genet. 2018 Feb 1;27(3):421-429. doi: 10.1093/hmg/ddx407.
221 Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.Mol Immunol. 2006 Mar;43(9):1497-507. doi: 10.1016/j.molimm.2005.07.039. Epub 2005 Sep 6.
222 MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1.Arthritis Rheum. 2011 May;63(5):1376-86. doi: 10.1002/art.30196.
223 Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.Mol Immunol. 2017 Dec;92:125-131. doi: 10.1016/j.molimm.2017.10.004. Epub 2017 Oct 26.
224 Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt-mTORC1 pathway depending on activation of p70S6K and Cdc2.Cell Microbiol. 2017 Jul;19(7). doi: 10.1111/cmi.12725. Epub 2017 Feb 1.
225 Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients.J Clin Invest. 2000 Dec;106(12):1561-8. doi: 10.1172/JCI9352.
226 Higher elastase activity associated with lower IL-18 in GCF from juvenile systemic lupus patients.Oral Health Prev Dent. 2008;6(1):75-81.
227 The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex.J Biol Chem. 2008 Jul 18;283(29):20037-44. doi: 10.1074/jbc.M710434200. Epub 2008 May 27.
228 Neutrophil proteases degrade autoepitopes of NET-associated proteins.Clin Exp Immunol. 2020 Jan;199(1):1-8. doi: 10.1111/cei.13392. Epub 2019 Nov 15.
229 Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco.Hum Immunol. 2019 Jul;80(7):523-532. doi: 10.1016/j.humimm.2019.02.012. Epub 2019 Feb 23.
230 Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus.J Reprod Immunol. 2018 Jun;127:19-23. doi: 10.1016/j.jri.2018.04.002. Epub 2018 Apr 18.
231 ATP signaling and NTPDase in Systemic Lupus Erythematosus (SLE).Immunobiology. 2019 May;224(3):419-426. doi: 10.1016/j.imbio.2019.02.005. Epub 2019 Feb 8.
232 c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells.J Biol Chem. 2012 Apr 6;287(15):11833-41. doi: 10.1074/jbc.M111.333997. Epub 2012 Feb 21.
233 Prothrombotic risk factors in childhood stroke and venous thrombosis.Eur J Pediatr. 1999 Dec;158 Suppl 3:S117-21. doi: 10.1007/pl00014333.
234 Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.J Rheumatol. 2018 Aug;45(9):1263-1272. doi: 10.3899/jrheum.170751. Epub 2018 Jul 15.
235 FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.J Immunol. 2007 Mar 15;178(6):3973-82. doi: 10.4049/jimmunol.178.6.3973.
236 FcRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression.J Biol Chem. 2016 Jan 15;291(3):1368-86. doi: 10.1074/jbc.M115.684795. Epub 2015 Nov 18.
237 Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis.Clin Rheumatol. 2019 Apr;38(4):997-1005. doi: 10.1007/s10067-018-4334-5. Epub 2018 Nov 16.
238 Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus.J Clin Invest. 1995 Apr;95(4):1766-72. doi: 10.1172/JCI117854.
239 C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.Clin Exp Immunol. 1988 Sep;73(3):461-6.
240 Proprotein convertase enzyme FURIN is upregulated in primary Sjgren's syndrome.Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):47-50. Epub 2018 Feb 21.
241 Fyn and CD70 expression in CD4+ T cells from patients with systemic lupus erythematosus.J Rheumatol. 2010 Jan;37(1):53-9. doi: 10.3899/jrheum.090424. Epub 2009 Dec 1.
242 Stimulation of Mononuclear Cells Through Toll-Like Receptor 9 Induces Release of Microvesicles Expressing Double-Stranded DNA and Galectin 3-Binding Protein in an Interferon--Dependent Manner.Front Immunol. 2019 Oct 11;10:2391. doi: 10.3389/fimmu.2019.02391. eCollection 2019.
243 The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus.J Immunol Res. 2015;2015:602154. doi: 10.1155/2015/602154. Epub 2015 Nov 8.
244 GADD45a and GADD45b Genes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients.J Clin Med. 2019 Jun 5;8(6):801. doi: 10.3390/jcm8060801.
245 Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.Clin Rheumatol. 2020 Feb;39(2):509-514. doi: 10.1007/s10067-019-04799-5. Epub 2019 Oct 26.
246 Association of HLA-DQB1 allelic sequence variation with susceptibility to systemic lupus erythematosus.Iran J Allergy Asthma Immunol. 2008 Jun;7(2):91-5.
247 The Role of Estrogen Membrane Receptor (G Protein-Coupled Estrogen Receptor 1) in Skin Inflammation Induced by Systemic Lupus Erythematosus Serum IgG.Front Immunol. 2017 Dec 4;8:1723. doi: 10.3389/fimmu.2017.01723. eCollection 2017.
248 The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584.
249 Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):54-60. Epub 2017 Mar 10.
250 Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.J Interferon Cytokine Res. 2020 Jan;40(1):33-42. doi: 10.1089/jir.2019.0047. Epub 2019 Dec 4.
251 Common Marker Genes Identified from Various Sample Types for Systemic Lupus Erythematosus.PLoS One. 2016 Jun 3;11(6):e0156234. doi: 10.1371/journal.pone.0156234. eCollection 2016.
252 Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.Mediators Inflamm. 2019 Mar 31;2019:4236562. doi: 10.1155/2019/4236562. eCollection 2019.
253 Copy number variations of the human histamine H4 receptor gene are associated with systemic lupus erythematosus.Br J Dermatol. 2010 Nov;163(5):935-40. doi: 10.1111/j.1365-2133.2010.09928.x.
254 Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids.J Cell Mol Med. 2019 Aug;23(8):5340-5348. doi: 10.1111/jcmm.14410. Epub 2019 May 24.
255 Glycoprotein 96 polymorphisms are associated with the risk of systemic lupus erythematosus: A case-control study.Int J Rheum Dis. 2019 May;22(5):905-912. doi: 10.1111/1756-185X.13515. Epub 2019 Mar 12.
256 Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus.Lupus. 2011 Jun;20(7):678-89. doi: 10.1177/0961203310394892. Epub 2011 Mar 7.
257 BACH2 regulates the function of human CD4(+) CD45RA(-) Foxp3(l) cytokine-secreting T cells and promotes B-cell response in systemic lupus erythematosus.Eur J Immunol. 2020 Mar;50(3):426-438. doi: 10.1002/eji.201948320. Epub 2019 Dec 19.
258 Genetic association of interferon-alpha subtypes 1, 2 and 5 in systemic lupus erythematosus.Tissue Antigens. 2008 Dec;72(6):588-92. doi: 10.1111/j.1399-0039.2008.01146.x. Epub 2008 Oct 18.
259 The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus.J Leukoc Biol. 2019 Oct;106(4):967-975. doi: 10.1002/JLB.3AB0518-180RR. Epub 2019 Jun 19.
260 The interferon-gamma receptor gene polymorphisms (Val14Met and Gln64Arg) are not associated with systemic lupus erythematosus in Chinese patients.Arch Dermatol Res. 2007 Oct;299(8):367-71. doi: 10.1007/s00403-007-0741-1. Epub 2007 Jul 6.
261 Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.Genet Epidemiol. 2019 Oct;43(7):844-863. doi: 10.1002/gepi.22242. Epub 2019 Aug 13.
262 IL-10RB rs2834167 (A/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: evidence from a study in Chinese Han population.Inflammation. 2013 Dec;36(6):1218-24. doi: 10.1007/s10753-013-9658-3.
263 Association of GTF2I and GTF2IRD1 polymorphisms with systemic lupus erythematosus in a Chinese Han population.Clin Exp Rheumatol. 2015 Sep-Oct;33(5):632-8. Epub 2015 Aug 31.
264 Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases.Ann Rheum Dis. 2019 Mar;78(3):311-319. doi: 10.1136/annrheumdis-2018-214127. Epub 2018 Dec 20.
265 Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.Lupus. 2019 Jan;28(1):34-43. doi: 10.1177/0961203318812679. Epub 2018 Nov 19.
266 A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity.Genes Immun. 2012 Apr;13(3):214-20. doi: 10.1038/gene.2011.74. Epub 2011 Nov 3.
267 Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc.J Immunol Res. 2019 Jul 16;2019:3575803. doi: 10.1155/2019/3575803. eCollection 2019.
268 Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.PLoS Genet. 2013;9(10):e1003870. doi: 10.1371/journal.pgen.1003870. Epub 2013 Oct 10.
269 Elevated levels of IL-24 in systemic lupus erythematosus patients.Lupus. 2019 May;28(6):748-754. doi: 10.1177/0961203319845476. Epub 2019 Apr 25.
270 Correlation between some Th1 and Th2 cytokine receptor gene polymorphisms and systemic lupus erythematosus in Chinese patients.Int J Dermatol. 2007 Nov;46(11):1129-35. doi: 10.1111/j.1365-4632.2007.03258.x.
271 Innate lymphoid cells are increased in systemic lupus erythematosus.Clin Exp Rheumatol. 2019 Jul-Aug;37(4):676-679. Epub 2019 Feb 15.
272 A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.J Immunol. 2019 Jun 15;202(12):3381-3393. doi: 10.4049/jimmunol.1801394. Epub 2019 May 10.
273 Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.Evid Based Complement Alternat Med. 2019 Nov 3;2019:2357217. doi: 10.1155/2019/2357217. eCollection 2019.
274 Prolactin activates IRF1 and leads to altered balance of histone acetylation: Implications for systemic lupus erythematosus.Mod Rheumatol. 2020 May;30(3):532-543. doi: 10.1080/14397595.2019.1620999. Epub 2019 Jun 7.
275 Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.J Autoimmun. 2019 Nov;104:102317. doi: 10.1016/j.jaut.2019.102317. Epub 2019 Aug 20.
276 Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.Lupus. 2017 Jan;26(1):62-72. doi: 10.1177/0961203316651738. Epub 2016 May 26.
277 CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.Rheumatology (Oxford). 2019 Nov 1;58(11):2039-2050. doi: 10.1093/rheumatology/kez112.
278 Single nucleotide polymorphism rs2229634 in the ITPR3 gene is associated with the risk of developing coronary artery aneurysm in children with Kawasaki disease.Int J Immunogenet. 2010 Dec;37(6):439-43. doi: 10.1111/j.1744-313X.2010.00943.x.
279 The Jakinibs in systemic lupus erythematosus: progress and prospects.Expert Opin Investig Drugs. 2019 Jan;28(1):85-92. doi: 10.1080/13543784.2019.1551358. Epub 2018 Nov 26.
280 JAK2 and PTPRC mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.Clin Rheumatol. 2020 Feb;39(2):443-448. doi: 10.1007/s10067-019-04778-w. Epub 2019 Nov 23.
281 Association of c-Jun gene polymorphism with susceptibility to systemic lupus erythematosus in a Chinese population.DNA Cell Biol. 2012 Jul;31(7):1274-8. doi: 10.1089/dna.2011.1536. Epub 2012 Apr 10.
282 Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus.Clin Exp Rheumatol. 2011 Mar-Apr;29(2):351-7. Epub 2011 Apr 19.
283 Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.J Immunol. 2007 Jul 1;179(1):346-56. doi: 10.4049/jimmunol.179.1.346.
284 Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus.Oncotarget. 2017 Jul 25;8(30):48938-48947. doi: 10.18632/oncotarget.16894.
285 IRF5, PTPN22, CD28, IL2RA, KIF5A, BLK and TNFAIP3 genes polymorphisms and lupus susceptibility in a cohort from the Egypt Delta; relation to other ethnic groups.Hum Immunol. 2015 Jul;76(7):525-31. doi: 10.1016/j.humimm.2015.06.001. Epub 2015 Jun 17.
286 HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus.Hum Immunol. 2018 Mar;79(3):172-177. doi: 10.1016/j.humimm.2018.01.005. Epub 2018 Feb 2.
287 Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression.Arthritis Rheumatol. 2018 Jul;70(7):1077-1088. doi: 10.1002/art.40470. Epub 2018 May 15.
288 Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.Front Immunol. 2019 Sep 11;10:2164. doi: 10.3389/fimmu.2019.02164. eCollection 2019.
289 NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.Sci Rep. 2017 Apr 28;7(1):1288. doi: 10.1038/s41598-017-01379-y.
290 TGF-3 Inhibits Antibody Production by Human B Cells.PLoS One. 2017 Jan 4;12(1):e0169646. doi: 10.1371/journal.pone.0169646. eCollection 2017.
291 Dysregulation of p56lck kinase in patients with systemic lupus erythematosus.Autoimmunity. 2001;34(1):27-38. doi: 10.3109/08916930108994123.
292 Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.J Autoimmun. 2019 Jan;96:59-73. doi: 10.1016/j.jaut.2018.08.005. Epub 2018 Aug 30.
293 IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.Thromb Res. 2019 May;177:157-160. doi: 10.1016/j.thromres.2019.03.006. Epub 2019 Mar 8.
294 Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.Ann Rheum Dis. 2019 Jul;78(7):957-966. doi: 10.1136/annrheumdis-2018-214620. Epub 2019 Apr 30.
295 Altered Cell Surface N-Glycosylation of Resting and Activated T Cells in Systemic Lupus Erythematosus.Int J Mol Sci. 2019 Sep 10;20(18):4455. doi: 10.3390/ijms20184455.
296 Plasma galectin-3 levels do not differ in systemic lupus erythematosus patients.Int J Rheum Dis. 2019 Oct;22(10):1820-1824. doi: 10.1111/1756-185X.13677. Epub 2019 Aug 11.
297 Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.Int Immunopharmacol. 2017 Mar;44:234-241. doi: 10.1016/j.intimp.2017.01.024. Epub 2017 Jan 25.
298 Gp49B is a pathogenic marker for auto-antibody-producing plasma cells in lupus-prone BXSB/Yaa mice.Int Immunol. 2019 May 21;31(6):397-406. doi: 10.1093/intimm/dxz017.
299 Podocytes and autophagy: a potential therapeutic target in lupus nephritis.Autophagy. 2019 May;15(5):908-912. doi: 10.1080/15548627.2019.1580512. Epub 2019 Feb 17.
300 Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus.Hum Mol Genet. 2004 Jan 15;13(2):171-9. doi: 10.1093/hmg/ddh020.
301 A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report.Arch Pathol Lab Med. 2010 Apr;134(4):532-44. doi: 10.5858/134.4.532.
302 Genetic remodeling of protein glycosylation in vivo induces autoimmune disease.Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1142-7. doi: 10.1073/pnas.98.3.1142.
303 Expression of glucocorticoid receptor isoforms and associations with serine/arginine-rich protein 30c and 40 in patients with systemic lupus erythematosus.Clin Exp Rheumatol. 2015 Mar-Apr;33(2):225-33. Epub 2015 Feb 9.
304 MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.Cells. 2019 Nov 13;8(11):1433. doi: 10.3390/cells8111433.
305 Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.Sci Rep. 2017 Sep 7;7(1):10788. doi: 10.1038/s41598-017-11315-9.
306 The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.Clin Immunol. 2017 Feb;175:10-15. doi: 10.1016/j.clim.2016.11.008. Epub 2016 Nov 23.
307 Involvement of midkine in autoimmune and autoinflammatory diseases.Mod Rheumatol. 2019 Jul;29(4):567-571. doi: 10.1080/14397595.2018.1523701. Epub 2018 Oct 25.
308 Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.J Autoimmun. 2018 Mar;88:75-82. doi: 10.1016/j.jaut.2017.10.004. Epub 2017 Oct 23.
309 The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus.J Immunol Res. 2014;2014:431896. doi: 10.1155/2014/431896. Epub 2014 Mar 20.
310 Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus.Sci Rep. 2019 Dec 6;9(1):18565. doi: 10.1038/s41598-019-55061-6.
311 MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting.Mult Scler. 2020 Jul;26(8):997-1000. doi: 10.1177/1352458519872895. Epub 2019 Oct 17.
312 Eltrombopag: Efficacy and Safety in Steroid Refractory Lupus-Associated Immune Thrombocytopenia.J Clin Rheumatol. 2020 Oct;26(7):274-278. doi: 10.1097/RHU.0000000000001083.
313 Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.Nephrol Dial Transplant. 2019 Apr 1;34(4):597-605. doi: 10.1093/ndt/gfy195.
314 Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.Gene. 2017 Dec 30;637:161-172. doi: 10.1016/j.gene.2017.09.037. Epub 2017 Sep 22.
315 NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus.Ann Rheum Dis. 2020 Feb;79(2):254-261. doi: 10.1136/annrheumdis-2019-215820. Epub 2019 Nov 8.
316 Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.PLoS One. 2017 Oct 12;12(10):e0186223. doi: 10.1371/journal.pone.0186223. eCollection 2017.
317 Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.Eur J Immunol. 2004 Jun;34(6):1654-62. doi: 10.1002/eji.200324201.
318 Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus.J Inflamm (Lond). 2018 Sep 3;15:16. doi: 10.1186/s12950-018-0192-9. eCollection 2018.
319 Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population.J Med Genet. 2013 Dec;50(12):812-8. doi: 10.1136/jmedgenet-2013-101787. Epub 2013 Sep 26.
320 Meta-analysis of the association between NLRP1 polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases.Oncotarget. 2017 Sep 22;8(50):88179-88188. doi: 10.18632/oncotarget.21165. eCollection 2017 Oct 20.
321 CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.Front Immunol. 2018 Nov 15;9:2643. doi: 10.3389/fimmu.2018.02643. eCollection 2018.
322 Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans.Arthritis Res Ther. 2014 May 14;16(3):R112. doi: 10.1186/ar4563.
323 Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.Clin Respir J. 2019 Sep;13(9):545-554. doi: 10.1111/crj.13056. Epub 2019 Aug 27.
324 Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.Autoimmunity. 2014 Feb;47(1):23-6. doi: 10.3109/08916934.2013.849701. Epub 2013 Nov 12.
325 Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.Hum Immunol. 2010 Aug;71(8):818-25. doi: 10.1016/j.humimm.2010.05.008. Epub 2010 May 20.
326 Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans.Arthritis Rheumatol. 2016 May;68(5):1197-1209. doi: 10.1002/art.39548.
327 Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.Eur Respir J. 2017 Aug 17;50(2):1602493. doi: 10.1183/13993003.02493-2016. Print 2017 Aug.
328 A Role for Receptor-Interacting Protein Kinase-1 in Neutrophil Extracellular Trap Formation in Patients with Systemic Lupus Erythematosus: a Preliminary Study.Cell Physiol Biochem. 2018;45(6):2317-2328. doi: 10.1159/000488179. Epub 2018 Mar 13.
329 Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells.Arthritis Rheumatol. 2019 Sep;71(9):1539-1544. doi: 10.1002/art.40897. Epub 2019 Aug 6.
330 Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes.Immunology. 2008 Nov;125(3):408-19. doi: 10.1111/j.1365-2567.2008.02850.x. Epub 2008 May 6.
331 Phosphodiesterase 7A: a new therapeutic target for alleviating chronic inflammation?.Curr Pharm Des. 2006;12(25):3207-20. doi: 10.2174/138161206778194123.
332 Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors.Lupus. 2019 Feb;28(2):210-216. doi: 10.1177/0961203318821161. Epub 2019 Jan 4.
333 Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency.J Inherit Metab Dis. 2007 Oct;30(5):814. doi: 10.1007/s10545-007-0496-z. Epub 2007 Jun 14.
334 An epitope on Ki antigen recognized by autoantibodies from lupus patients shows homology with the SV40 large T antigen nuclear localization signal.Arthritis Rheum. 1996 May;39(5):855-62. doi: 10.1002/art.1780390519.
335 Serum uromodulin-a marker of kidney function and renal parenchymal integrity.Nephrol Dial Transplant. 2018 Feb 1;33(2):284-295. doi: 10.1093/ndt/gfw422.
336 Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.Arthritis Rheumatol. 2017 Dec;69(12):2328-2337. doi: 10.1002/art.40304. Epub 2017 Nov 9.
337 Mutation of POLB causes lupus in mice.Cell Rep. 2014 Jan 16;6(1):1-8. doi: 10.1016/j.celrep.2013.12.017. Epub 2014 Jan 2.
338 Activation of Peroxisome Proliferator Activator Receptor / Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus.Hypertension. 2017 Apr;69(4):641-650. doi: 10.1161/HYPERTENSIONAHA.116.08655. Epub 2017 Feb 27.
339 Association between PPP2CA polymorphisms and clinical features in southwest Chinese systemic lupus erythematosus patients.Medicine (Baltimore). 2018 Jul;97(27):e11451. doi: 10.1097/MD.0000000000011451.
340 Does Leukopenia Influence Performance of the New European League Against Rheumatism/American College of Rheumatology Classification Criteria in an African-Descendent Population With Childhood-Onset Systemic Lupus Erythematosus? Comment on the Article by Aringer et al.Arthritis Rheumatol. 2020 Apr;72(4):694-695. doi: 10.1002/art.41178. Epub 2020 Feb 11.
341 Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T cells.J Immunol. 2003 Oct 1;171(7):3636-44. doi: 10.4049/jimmunol.171.7.3636.
342 Increased levels of serum histone H4 and activated protein C in patients with active rheumatoid arthritis.Clin Exp Rheumatol. 2018 May-Jun;36(3):455-461. Epub 2017 Dec 27.
343 Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.J Am Soc Nephrol. 2004 Aug;15(8):2103-14. doi: 10.1097/01.ASN.0000135058.46193.72.
344 Clinical significance of anti-dense fine speckled 70 antibody in patients with fibromyalgia.Korean J Intern Med. 2019 Mar;34(2):426-433. doi: 10.3904/kjim.2016.276. Epub 2017 Nov 24.
345 Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.Clin Exp Immunol. 1994 Sep;97(3):430-8. doi: 10.1111/j.1365-2249.1994.tb06106.x.
346 Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.Autoimmun Rev. 2009 Feb;8(4):337-42. doi: 10.1016/j.autrev.2008.12.008. Epub 2009 Jan 22.
347 Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.Front Immunol. 2019 Sep 24;10:2136. doi: 10.3389/fimmu.2019.02136. eCollection 2019.
348 Expression of reversion-inducing cysteine-rich protein with Kazal motifs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus: links to disease activity, damage accrual and matrix metalloproteinase 9 secretion.J Int Med Res. 2008 Jul-Aug;36(4):704-13. doi: 10.1177/147323000803600412.
349 Evaluation of pulmonary artery pressure in patients with juvenile systemic lupus erythematosus (jSLE).Bosn J Basic Med Sci. 2018 Feb 20;18(1):66-71. doi: 10.17305/bjbms.2017.2178.
350 Genetic interaction between genes involved in NF-B signaling pathway in systemic lupus erythematosus.Mol Immunol. 2013 Dec;56(4):643-8. doi: 10.1016/j.molimm.2013.07.006. Epub 2013 Aug 2.
351 Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population.Mutagenesis. 2012 May;27(3):319-22. doi: 10.1093/mutage/ger081. Epub 2011 Nov 9.
352 PKK deficiency in B cells prevents lupus development in Sle lupus mice.Immunol Lett. 2017 May;185:1-11. doi: 10.1016/j.imlet.2017.03.002. Epub 2017 Mar 6.
353 Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.Ann Rheum Dis. 2017 Apr;76(4):740-747. doi: 10.1136/annrheumdis-2016-209850. Epub 2016 Nov 9.
354 XX Disorder of Sex Development is associated with an insertion on chromosome 9 and downregulation of RSPO1 in dogs (Canis lupus familiaris).PLoS One. 2017 Oct 20;12(10):e0186331. doi: 10.1371/journal.pone.0186331. eCollection 2017.
355 Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.Front Immunol. 2019 May 17;10:1029. doi: 10.3389/fimmu.2019.01029. eCollection 2019.
356 Association of S100B polymorphisms and serum S100B with risk of systemic lupus erythematous in a Chinese population.Genet Mol Biol. 2019 Apr-Jun;42(2):321-328. doi: 10.1590/1678-4685-GMB-2017-0354. Epub 2019 Jul 1.
357 miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice.J Immunol. 2015 Jun 1;194(11):5437-45. doi: 10.4049/jimmunol.1403028. Epub 2015 Apr 24.
358 Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.Immunol Lett. 2017 Jan;181:16-19. doi: 10.1016/j.imlet.2016.11.005. Epub 2016 Nov 9.
359 Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus.Front Immunol. 2017 Mar 27;8:348. doi: 10.3389/fimmu.2017.00348. eCollection 2017.
360 Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.Clin Exp Rheumatol. 2017 Sep-Oct;35(5):823-830. Epub 2017 Apr 18.
361 Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.Immunol Invest. 2020 Feb;49(1-2):69-80. doi: 10.1080/08820139.2019.1649280. Epub 2019 Aug 15.
362 Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.J Microbiol Immunol Infect. 2019 Oct;52(5):816-826. doi: 10.1016/j.jmii.2018.02.004. Epub 2018 Mar 29.
363 SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.Front Immunol. 2018 Sep 11;9:2081. doi: 10.3389/fimmu.2018.02081. eCollection 2018.
364 A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.Hum Reprod. 1999 Jun;14(6):1624-7. doi: 10.1093/humrep/14.6.1624.
365 Circulating surfactant protein D is decreased in systemic lupus erythematosus.J Rheumatol. 2009 Nov;36(11):2449-53. doi: 10.3899/jrheum.090069. Epub 2009 Oct 15.
366 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer.Clin Immunol. 2019 Jul;204:50-56. doi: 10.1016/j.clim.2018.10.009. Epub 2018 Oct 19.
367 Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus.Inflammation. 2015 Dec;38(6):2185-90. doi: 10.1007/s10753-015-0201-6.
368 Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance.Arthritis Care Res (Hoboken). 2018 Jan;70(1):114-124. doi: 10.1002/acr.23237. Epub 2017 Dec 6.
369 Impaired TGF- signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22.Cytokine. 2018 Aug;108:182-189. doi: 10.1016/j.cyto.2018.04.011. Epub 2018 Apr 21.
370 Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.Clin Rheumatol. 2019 May;38(5):1361-1366. doi: 10.1007/s10067-019-04467-8. Epub 2019 Feb 15.
371 Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.J Biol Chem. 2011 Jan 21;286(3):1795-801. doi: 10.1074/jbc.M110.166785. Epub 2010 Nov 19.
372 Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.FASEB J. 2019 Jun;33(6):7061-7071. doi: 10.1096/fj.201802535R. Epub 2019 Mar 6.
373 Abnormal expression of CD43 in patients with systemic lupus erythematosus and its clinical significance.Chin Med J (Engl). 2012 Apr;125(7):1266-71.
374 Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.J Rheumatol. 2010 Apr;37(4):766-75. doi: 10.3899/jrheum.090663. Epub 2010 Jan 28.
375 Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations.Gene. 2013 Sep 25;527(2):435-9. doi: 10.1016/j.gene.2013.06.074. Epub 2013 Jul 13.
376 RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.Arthritis Res Ther. 2010;12(6):R227. doi: 10.1186/ar3214. Epub 2010 Dec 30.
377 Role of Hepatic Deposited Immunoglobulin G in the Pathogenesis of Liver Damage in Systemic Lupus Erythematosus.Front Immunol. 2018 Jun 25;9:1457. doi: 10.3389/fimmu.2018.01457. eCollection 2018.
378 Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.BMC Genomics. 2016 Jul 11;17:488. doi: 10.1186/s12864-016-2809-9.
379 Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.PLoS One. 2017 Sep 14;12(9):e0184738. doi: 10.1371/journal.pone.0184738. eCollection 2017.
380 Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC. Genes Immun. 2009 Jun;10(4):350-5.
381 Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.Arthritis Rheum. 2012 May;64(5):1601-9. doi: 10.1002/art.33494.
382 Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells.Curr Top Microbiol Immunol. 2017;410:29-45. doi: 10.1007/82_2017_59.
383 Treatment of murine lupus with TIGIT-Ig.Clin Immunol. 2019 Jun;203:72-80. doi: 10.1016/j.clim.2019.04.007. Epub 2019 Apr 18.
384 Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF- promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians.Lupus. 2015 Jan;24(1):50-7. doi: 10.1177/0961203314549792. Epub 2014 Sep 2.
385 Cutting Edge: Intracellular IFN- and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.J Immunol. 2018 Oct 15;201(8):2203-2208. doi: 10.4049/jimmunol.1800791. Epub 2018 Sep 10.
386 Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.Lupus. 2019 Sep;28(10):1233-1242. doi: 10.1177/0961203319867129. Epub 2019 Aug 12.
387 Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus.Clin Exp Rheumatol. 2009 Mar-Apr;27(2):260-6.
388 Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.Lupus. 2016 May;25(6):582-92. doi: 10.1177/0961203315608254. Epub 2015 Sep 29.
389 Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.Immunology. 2006 Feb;117(2):280-6. doi: 10.1111/j.1365-2567.2005.02306.x.
390 A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland.Ann Rheum Dis. 1998 Aug;57(8):503-5. doi: 10.1136/ard.57.8.503.
391 NF-B inducing kinase is a therapeutic target for systemic lupus erythematosus.Nat Commun. 2018 Jan 12;9(1):179. doi: 10.1038/s41467-017-02672-0.
392 Characteristic Distribution Pattern of CD30-positive Cytotoxic T Cells Aids Diagnosis of Kikuchi-Fujimoto Disease.Appl Immunohistochem Mol Morphol. 2018 Apr;26(4):274-282. doi: 10.1097/PAI.0000000000000411.
393 Genome-wide differential expression reveals candidate genes involved in the pathogenesis of lupus and lupus nephritis.Int J Rheum Dis. 2016 Jan;19(1):55-64. doi: 10.1111/1756-185X.12745. Epub 2015 Sep 25.
394 Screening epitopes on systemic lupus erythematosus autoantigens with a peptide array.Oncotarget. 2017 Sep 18;8(49):85559-85567. doi: 10.18632/oncotarget.20994. eCollection 2017 Oct 17.
395 Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.EBioMedicine. 2019 Apr;42:76-85. doi: 10.1016/j.ebiom.2019.03.063. Epub 2019 Apr 3.
396 Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.Int J Rheum Dis. 2016 May;19(5):512-20. doi: 10.1111/1756-185X.12393. Epub 2014 Dec 15.
397 The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function.J Neuroimmunol. 2018 Dec 15;325:43-53. doi: 10.1016/j.jneuroim.2018.10.010. Epub 2018 Oct 23.
398 CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism.Sci Rep. 2018 Feb 20;8(1):3357. doi: 10.1038/s41598-018-21337-6.
399 Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [(11)C]DPA-713 positron emission tomography.Lupus. 2017 Feb;26(2):170-178. doi: 10.1177/0961203316657432. Epub 2016 Jul 11.
400 Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis.J Mol Recognit. 2019 Dec;32(12):e2807. doi: 10.1002/jmr.2807. Epub 2019 Aug 6.
401 USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFN receptor.Mol Med Rep. 2017 Aug;16(2):2274-2280. doi: 10.3892/mmr.2017.6819. Epub 2017 Jun 20.
402 Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians.Arthritis Rheum. 2013 Jan;65(1):211-5. doi: 10.1002/art.37751.
403 PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.Sci Transl Med. 2019 Dec 11;11(522):eaax1159. doi: 10.1126/scitranslmed.aax1159.
404 Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model.Front Immunol. 2017 Dec 11;8:1765. doi: 10.3389/fimmu.2017.01765. eCollection 2017.
405 Characteristics of Acquired Inhibitors to Factor VIII and Von Willebrand Factor Secondary to Systemic Lupus Erythematosus: Experiences From a Chinese Tertiary Medical Center.J Clin Rheumatol. 2021 Aug 1;27(5):201-205. doi: 10.1097/RHU.0000000000001284.
406 Association Between Functional Polymorphisms of DNA Double-Strand Breaks in Repair Genes XRCC5, XRCC6 and XRCC7 with the Risk of Systemic Lupus Erythematosus in South East Iran.DNA Cell Biol. 2015 May;34(5):360-6. doi: 10.1089/dna.2014.2465. Epub 2015 Mar 10.
407 Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.Cell Signal. 2019 Jun;58:9-19. doi: 10.1016/j.cellsig.2019.03.003. Epub 2019 Mar 3.
408 Factor VIII related antigen in connective tissue disease patients and relatives.Br J Rheumatol. 1990 Feb;29(1):6-9. doi: 10.1093/rheumatology/29.1.6.
409 Peptidylarginine deiminase-4 gene polymorphisms are associated with systemic lupus erythematosus and lupus nephritis.Scand J Rheumatol. 2019 Mar;48(2):133-140. doi: 10.1080/03009742.2018.1488273. Epub 2018 Sep 30.
410 Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.Lupus. 2019 May;28(6):713-721. doi: 10.1177/0961203319845487. Epub 2019 May 2.
411 The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases.Autoimmun Rev. 2019 Jan;18(1):25-35. doi: 10.1016/j.autrev.2018.07.008. Epub 2018 Nov 5.
412 A family survey of lupus erythematosus. 1. Heritability.J Rheumatol. 1987 Oct;14(5):913-21.
413 SLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside.Hum Genomics. 2019 Sep 14;13(Suppl 1):51. doi: 10.1186/s40246-019-0233-3.
414 Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.J Am Soc Nephrol. 2014 Dec;25(12):2859-70. doi: 10.1681/ASN.2013050446. Epub 2014 Jun 12.
415 Immunological abnormalities in a patient with lysinuric protein intolerance.Eur J Pediatr. 1987 Jul;146(4):427-8. doi: 10.1007/BF00444955.
416 Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases.Genes Immun. 2006 Dec;7(8):625-31. doi: 10.1038/sj.gene.6364339. Epub 2006 Sep 14.
417 Application of Various Statistical Models to Explore Gene-Gene Interactions in Folate, Xenobiotic, Toll-Like Receptor and STAT4 Pathways that Modulate Susceptibility to Systemic Lupus Erythematosus.Mol Diagn Ther. 2016 Feb;20(1):83-95. doi: 10.1007/s40291-015-0181-0.
418 Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.BMC Med Genet. 2011 Jan 11;12:7. doi: 10.1186/1471-2350-12-7.
419 Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study.Schizophr Res. 2012 May;137(1-3):151-8. doi: 10.1016/j.schres.2012.02.012. Epub 2012 Mar 7.
420 Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.Lupus. 2018 Sep;27(10):1600-1615. doi: 10.1177/0961203318778774. Epub 2018 Jun 29.
421 Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.Lupus. 2018 Sep;27(10):1636-1643. doi: 10.1177/0961203318784649. Epub 2018 Jun 28.
422 Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 D-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3.Autoimmunity. 2017 Feb;50(1):42-51. doi: 10.1080/08916934.2016.1272597.
423 Red cell enzyme types in rheumatic diseases.Hum Hered. 1985;35(2):107-10. doi: 10.1159/000153525.
424 High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.Clin Rheumatol. 2018 Apr;37(4):963-970. doi: 10.1007/s10067-017-3955-4. Epub 2017 Dec 20.
425 Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.Nat Genet. 2012 Mar 25;44(5):511-6. doi: 10.1038/ng.2231.
426 Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study.Arthritis Care Res (Hoboken). 2020 Apr;72(4):534-543. doi: 10.1002/acr.23880.
427 Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.Arthritis Rheumatol. 2019 May;71(5):766-772. doi: 10.1002/art.40785. Epub 2019 Mar 20.
428 cAMP Response Element Modulator Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus.J Immunol. 2019 Dec 1;203(11):2807-2816. doi: 10.4049/jimmunol.1900760. Epub 2019 Oct 25.
429 Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European Ancestry.Arthritis Rheumatol. 2016 Jan;68(1):174-83. doi: 10.1002/art.39403.
430 Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.J Rheumatol. 2020 Mar;47(3):377-386. doi: 10.3899/jrheum.181232. Epub 2019 May 15.
431 Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus.Arthritis Rheumatol. 2020 Feb;72(2):282-291. doi: 10.1002/art.41083. Epub 2019 Dec 26.
432 Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.Am J Hum Genet. 2014 Apr 3;94(4):586-98. doi: 10.1016/j.ajhg.2014.03.008.
433 Fli-1, a Functional Factor Performed in Autoimmune Lupus.Inflammation. 2016 Feb;39(1):493-498. doi: 10.1007/s10753-015-0257-3.
434 Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.PLoS Genet. 2019 Apr 25;15(4):e1008092. doi: 10.1371/journal.pgen.1008092. eCollection 2019 Apr.
435 A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.Ann Rheum Dis. 2017 Jan;76(1):286-294. doi: 10.1136/annrheumdis-2016-209436. Epub 2016 May 18.
436 The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.Front Immunol. 2018 May 28;9:1180. doi: 10.3389/fimmu.2018.01180. eCollection 2018.
437 Interferon-induced protein 44-like gene promoter is differentially methylated in peripheral blood mononuclear cells of systemic lupus erythematosus patients.J Res Med Sci. 2019 Nov 27;24:99. doi: 10.4103/jrms.JRMS_83_19. eCollection 2019.
438 Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.Ann Rheum Dis. 2018 Nov;77(11):1653-1664. doi: 10.1136/annrheumdis-2018-213197. Epub 2018 Jul 18.
439 Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.Arthritis Rheumatol. 2018 Jul;70(7):1089-1101. doi: 10.1002/art.40467. Epub 2018 May 24.
440 Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis.Genes Immun. 2008 Apr;9(3):214-23. doi: 10.1038/gene.2008.5. Epub 2008 Feb 14.
441 Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjgren's Syndrome and Systemic Lupus Erythematosus.Front Immunol. 2018 Jun 5;9:1200. doi: 10.3389/fimmu.2018.01200. eCollection 2018.
442 Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9288-9293. doi: 10.1073/pnas.1805717115. Epub 2018 Aug 27.
443 Phosphatase PP2A is essential for T(H)17 differentiation.Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):982-987. doi: 10.1073/pnas.1807484116. Epub 2018 Dec 28.
444 Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.JCI Insight. 2020 Jan 16;5(1):e134010. doi: 10.1172/jci.insight.134010.
445 Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.Arthritis Res Ther. 2005;7(4):R896-903. doi: 10.1186/ar1759. Epub 2005 May 20.
446 Siglec genes confer resistance to systemic lupus erythematosus in humans and mice.Cell Mol Immunol. 2019 Feb;16(2):154-164. doi: 10.1038/cmi.2017.160. Epub 2018 Mar 5.
447 A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis.Genes Immun. 2009 Jul;10(5):482-6. doi: 10.1038/gene.2009.5. Epub 2009 Mar 5.
448 Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? A novel gene variant in SNRNP70 gene.Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):32-40. Epub 2019 Sep 17.
449 Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19.
450 Multiple variants in 5q31.1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese population.Br J Dermatol. 2017 Sep;177(3):801-808. doi: 10.1111/bjd.15362. Epub 2017 Jun 12.
451 Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.Inflamm Res. 2012 Dec;61(12):1347-54. doi: 10.1007/s00011-012-0535-6. Epub 2012 Jul 31.
452 A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese.PLoS Genet. 2012 Jan;8(1):e1002455. doi: 10.1371/journal.pgen.1002455. Epub 2012 Jan 26.
453 Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.Arthritis Res Ther. 2019 May 2;21(1):110. doi: 10.1186/s13075-019-1890-2.
454 Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis.J Proteome Res. 2008 May;7(5):1963-70. doi: 10.1021/pr700861s. Epub 2008 Mar 21.
455 Publisher Correction: Genetic variants in systemic lupus erythematosus susceptibility loci, XKR6 and GLT1D1 are associated with childhood-onset SLE in a Korean cohort.Sci Rep. 2018 Jul 31;8(1):11713. doi: 10.1038/s41598-018-30082-9.
456 Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians.Am J Hum Genet. 2013 Jan 10;92(1):41-51. doi: 10.1016/j.ajhg.2012.11.018. Epub 2012 Dec 27.
457 Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis.Clin Exp Immunol. 2013 Jan;171(1):91-9. doi: 10.1111/j.1365-2249.2012.04676.x.
458 Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients.Nat Commun. 2019 Jun 7;10(1):2498. doi: 10.1038/s41467-019-10491-8.
459 MicroRNA?98 contributes to lupus nephritis progression by inhibition of phosphatase and tensin homology deleted on chromosome ten expression.Mol Med Rep. 2017 Nov;16(5):7813-7820. doi: 10.3892/mmr.2017.7527. Epub 2017 Sep 19.
460 The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.J Neuroimmunol. 2019 Dec 15;337:577045. doi: 10.1016/j.jneuroim.2019.577045. Epub 2019 Aug 28.
461 Gene-function studies in systemic lupus erythematosus.Curr Opin Rheumatol. 2019 Mar;31(2):185-192. doi: 10.1097/BOR.0000000000000572.
462 Immunoglobulin Binding Protein 1 as a Potential Urine Biomarker in Patients with Lupus Nephritis.Int J Mol Sci. 2019 May 27;20(10):2606. doi: 10.3390/ijms20102606.
463 Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis.Clin Immunol. 2008 Nov;129(2):277-85. doi: 10.1016/j.clim.2008.07.006. Epub 2008 Sep 3.
464 Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.Clin Rheumatol. 2018 Feb;37(2):451-458. doi: 10.1007/s10067-017-3812-5. Epub 2017 Sep 9.
465 Expression and Polymorphisms of Lysosome-Associated Protein Transmembrane 5 (LAPTM5) in Patients with Systemic Lupus Erythematosus in a Chinese Population.Biochem Genet. 2015 Aug;53(7-8):200-10. doi: 10.1007/s10528-015-9682-0. Epub 2015 May 22.
466 The Sgp3 locus derived from the 129 strain is responsible for enhanced endogenous retroviral expression in macroH2A1-deficient mice.J Autoimmun. 2010 Dec;35(4):398-403. doi: 10.1016/j.jaut.2010.08.003. Epub 2010 Sep 15.
467 Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.J Autoimmun. 2019 Sep;103:102286. doi: 10.1016/j.jaut.2019.05.014. Epub 2019 May 24.
468 IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.Nat Commun. 2018 Feb 8;9(1):583. doi: 10.1038/s41467-018-02890-0.
469 Autoimmunogenic HLA-DRB1*0301 allele (DR3) may be distinguished at the DRB1 non-coding regions of HLA-B8,DR3,Dw24 and B18,DR3,Dw25 haplotypes.Mol Immunol. 1991 Jan-Feb;28(1-2):189-92. doi: 10.1016/0161-5890(91)90105-s.
470 Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.Nat Genet. 2008 Feb;40(2):204-10. doi: 10.1038/ng.81. Epub 2008 Jan 20.
471 Signaling lymphocyte activation molecule family in systemic lupus erythematosus.Clin Immunol. 2019 Jul;204:57-63. doi: 10.1016/j.clim.2018.11.001. Epub 2018 Nov 8.
472 Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?.Clin Exp Rheumatol. 2020 Jul-Aug;38(4):602-608. Epub 2019 Oct 28.
473 Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus.Hum Immunol. 2012 Jan;73(1):107-10. doi: 10.1016/j.humimm.2011.10.012. Epub 2011 Oct 21.
474 High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells.PLoS One. 2011;6(12):e28591. doi: 10.1371/journal.pone.0028591. Epub 2011 Dec 6.
475 Enhancer RNA and NFB-dependent P300 regulation of ADAMDEC1.Mol Immunol. 2018 Nov;103:312-321. doi: 10.1016/j.molimm.2018.09.019. Epub 2018 Oct 20.
476 Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus.Cell Rep. 2018 Apr 3;23(1):50-57. doi: 10.1016/j.celrep.2018.03.036.
477 Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.Immunology. 2007 Jul;121(3):359-69. doi: 10.1111/j.1365-2567.2007.02582.x. Epub 2007 Mar 22.
478 Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population.Immunogenetics. 2012 Dec;64(12):935-8. doi: 10.1007/s00251-012-0650-0. Epub 2012 Sep 16.
479 A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist's office.Immunol Res. 2017 Feb;65(1):363-368. doi: 10.1007/s12026-016-8846-2.
480 Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus.J Rheumatol. 2010 Aug 1;37(8):1658-66. doi: 10.3899/jrheum.091123. Epub 2010 Jun 1.
481 Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus.Biochem Biophys Res Commun. 2002 Mar 8;291(4):951-8. doi: 10.1006/bbrc.2002.6534.
482 Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.Clin Exp Rheumatol. 2018 Jul-Aug;36(4):533-539. Epub 2018 Jan 15.
483 Blockade of interferon- normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.Arthritis Rheumatol. 2015 Oct;67(10):2713-22. doi: 10.1002/art.39248.
484 Anti-Mllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.Endocrine. 2019 Feb;63(2):369-375. doi: 10.1007/s12020-018-1783-1. Epub 2018 Oct 15.
485 NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.J Transl Med. 2018 Dec 22;16(1):370. doi: 10.1186/s12967-018-1739-5.
486 Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus.Pharmacogenet Genomics. 2019 Aug;29(6):132-135. doi: 10.1097/FPC.0000000000000378.
487 Gene-based meta-analysis of genome-wide association study data identifies independent single-nucleotide polymorphisms in ANXA6 as being associated with systemic lupus erythematosus in Asian populations.Arthritis Rheumatol. 2015 Nov;67(11):2966-77. doi: 10.1002/art.39275.
488 Stability and translation of TCR zeta mRNA are regulated by the adenosine-uridine-rich elements in splice-deleted 3' untranslated region of zeta-chain.J Immunol. 2006 Dec 1;177(11):8248-57. doi: 10.4049/jimmunol.177.11.8248.
489 Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.Arthritis Res Ther. 2019 Jul 1;21(1):161. doi: 10.1186/s13075-019-1947-2.
490 ARID3a gene profiles are strongly associated with human interferon alpha production.J Autoimmun. 2019 Jan;96:158-167. doi: 10.1016/j.jaut.2018.09.013. Epub 2018 Oct 5.
491 ADP-ribosylation factor-like 8b is required for the development of mouse models of systemic lupus erythematosus.Int Immunol. 2019 Mar 28;31(4):225-237. doi: 10.1093/intimm/dxy084.
492 Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1845-50. doi: 10.1073/pnas.1214207110. Epub 2013 Jan 14.
493 Elevated gene expression of argininosuccinate synthetase in peripheral lymphocytes from systemic lupus erythematosus (SLE) patients.Autoimmunity. 1992;13(2):127-32. doi: 10.3109/08916939209001913.
494 High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.PLoS Genet. 2009 Oct;5(10):e1000696. doi: 10.1371/journal.pgen.1000696. Epub 2009 Oct 23.
495 HTLV-1, Immune Response and Autoimmunity.Viruses. 2015 Dec 24;8(1):5. doi: 10.3390/v8010005.
496 Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1.J Immunol. 2019 Oct 1;203(7):1820-1829. doi: 10.4049/jimmunol.1800419. Epub 2019 Aug 26.
497 The ATG5-binding and coiled coil domains of ATG16L1 maintain autophagy and tissue homeostasis in mice independently of the WD domain required for LC3-associated phagocytosis.Autophagy. 2019 Apr;15(4):599-612. doi: 10.1080/15548627.2018.1534507. Epub 2018 Nov 7.
498 Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families.Genes Immun. 2002 Oct;3 Suppl 1:S42-6. doi: 10.1038/sj.gene.6363907.
499 IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.J Immunol. 2009 May 1;182(9):5623-32. doi: 10.4049/jimmunol.0802412.
500 Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4(+) T cells of systemic lupus erythematosus.Clin Immunol. 2018 Feb;187:113-121. doi: 10.1016/j.clim.2017.11.002. Epub 2017 Nov 4.
501 The correlations of psychological status, quality of life, self-esteem, social support and body image disturbance in Chinese patients with Systemic Lupus Erythematosus.Psychol Health Med. 2018 Aug;23(7):779-787. doi: 10.1080/13548506.2018.1434214. Epub 2018 Jan 31.
502 Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy.Lupus. 2005;14(5):356-62. doi: 10.1191/0961203305lu2093oa.
503 Brief Report: Deficiency of Complement 1r Subcomponent in Early-Onset Systemic Lupus Erythematosus: The Role of Disease-Modifying Alleles in a Monogenic Disease. Arthritis Rheumatol. 2017 Sep;69(9):1832-1839. doi: 10.1002/art.40158. Epub 2017 Jul 10.
504 Investigation of C1-complex regions reveals new C1Q variants associated with protection from systemic lupus erythematosus, and affect its transcript abundance.Sci Rep. 2018 May 23;8(1):8048. doi: 10.1038/s41598-018-26380-x.
505 Genetic association of complement component 2 polymorphism with systemic lupus erythematosus.Tissue Antigens. 2015 Aug;86(2):122-33. doi: 10.1111/tan.12602. Epub 2015 Jul 14.
506 Hereditary complement (C6) deficiency associated with systemic lupus erythematosus, Sjgren's syndrome and hyperthyroidism.J Rheumatol. 1987 Oct;14(5):1030-3.
507 Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.Int J Rheum Dis. 2019 Mar;22(3):468-472. doi: 10.1111/1756-185X.13418. Epub 2018 Nov 8.
508 Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.Inflammopharmacology. 2020 Apr;28(2):363-384. doi: 10.1007/s10787-019-00674-6. Epub 2019 Dec 9.
509 The anti-inflammatory CASPASE-12 gene does not influence SLE phenotype in African-Americans.Immunol Lett. 2016 May;173:21-5. doi: 10.1016/j.imlet.2016.03.004. Epub 2016 Mar 10.
510 Autoantibodies directed against the amino-terminal domain I of human calpastatin (ACAST-DI Ab) in connective tissue diseases. High levels of ACAST-DI Ab are associated with vasculitis in lupus.J Autoimmun. 2002 Aug-Sep;19(1-2):55-61. doi: 10.1006/jaut.2002.0598.
511 Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.Immunol Lett. 2017 Jan;181:58-62. doi: 10.1016/j.imlet.2016.11.011. Epub 2016 Nov 22.
512 Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus.Sci Rep. 2018 Feb 19;8(1):3268. doi: 10.1038/s41598-018-20203-9.
513 Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus.Arthritis Rheumatol. 2017 Oct;69(10):2018-2028. doi: 10.1002/art.40181.
514 Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases.Genes Immun. 2010 Mar;11(2):155-60. doi: 10.1038/gene.2009.71. Epub 2009 Sep 10.
515 Chaperonin-containing T-complex Protein 1 Subunit Serves as an Autoantigen Recognized by Human V2 T Cells in Autoimmune Diseases.J Biol Chem. 2016 Sep 16;291(38):19985-93. doi: 10.1074/jbc.M115.700070. Epub 2016 Aug 3.
516 Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.Acta Biochim Biophys Sin (Shanghai). 2017 Apr 1;49(4):328-337. doi: 10.1093/abbs/gmx011.
517 Downregulation of CD3 in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.J Immunol. 2018 May 1;200(9):3077-3086. doi: 10.4049/jimmunol.1700588. Epub 2018 Mar 30.
518 Elevation of serum CD5L concentration is correlated with disease activity in patients with systemic lupus erythematosus.Int Immunopharmacol. 2018 Oct;63:311-316. doi: 10.1016/j.intimp.2018.07.022. Epub 2018 Aug 30.
519 Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.Cell Mol Immunol. 2017 Oct;14(10):842-849. doi: 10.1038/cmi.2016.47. Epub 2016 Sep 26.
520 CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus Erythematosus.Immune Netw. 2019 Feb 13;19(1):e1. doi: 10.4110/in.2019.19.e1. eCollection 2019 Feb.
521 CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.Clin Immunol. 2019 Jul;204:43-49. doi: 10.1016/j.clim.2018.10.017. Epub 2018 Oct 26.
522 CD8+CD28-, suppressive T cells in systemic lupus erythematosus.Lupus. 2008 Jul;17(7):630-7. doi: 10.1177/0961203308089400.
523 cAMP responsive element modulator (CREM) mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.J Biol Chem. 2014 Jan 24;289(4):2361-70. doi: 10.1074/jbc.M113.523605. Epub 2013 Dec 2.
524 Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases.J Biochem. 1990 Oct;108(4):650-3. doi: 10.1093/oxfordjournals.jbchem.a123257.
525 Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.AJNR Am J Neuroradiol. 2019 Mar;40(3):470-477. doi: 10.3174/ajnr.A5990. Epub 2019 Feb 21.
526 Type-C RNA virus gene expression in human tissue.J Virol. 1974 Dec;14(6):1584-96. doi: 10.1128/JVI.14.6.1584-1596.1974.
527 Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.Clin Rheumatol. 2017 Dec;36(12):2859-2867. doi: 10.1007/s10067-017-3823-2. Epub 2017 Sep 13.
528 Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.PLoS Genet. 2011 May;7(5):e1002079. doi: 10.1371/journal.pgen.1002079. Epub 2011 May 26.
529 The clinical significance of plasma CFHR 1-5 in lupus nephropathy.Immunobiology. 2019 May;224(3):339-346. doi: 10.1016/j.imbio.2019.03.005. Epub 2019 Apr 3.
530 Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.Arthritis Rheumatol. 2018 Dec;70(12):2036-2045. doi: 10.1002/art.40576. Epub 2018 Oct 14.
531 Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.Autoimmunity. 2017 Jun;50(4):241-246. doi: 10.1080/08916934.2017.1329422. Epub 2017 May 27.
532 Renal involvement in lupus is characterized by unique DNA methylation changes in nave CD4+ T cells.J Autoimmun. 2015 Jul;61:29-35. doi: 10.1016/j.jaut.2015.05.003. Epub 2015 May 23.
533 Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.Lupus. 2005;14(4):273-9. doi: 10.1191/0961203305lu2074oa.
534 An OMICS-based study of the role of C3dg in keratinocytes: RNA sequencing, antibody-chip array, and bioinformatics approaches.Int J Biol Macromol. 2019 Jul 15;133:391-411. doi: 10.1016/j.ijbiomac.2019.04.039. Epub 2019 Apr 8.
535 Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.Hum Immunol. 2015 Nov;76(11):808-11. doi: 10.1016/j.humimm.2015.09.040. Epub 2015 Sep 30.
536 Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.J Clin Immunol. 2013 Feb;33(2):368-77. doi: 10.1007/s10875-012-9821-x. Epub 2012 Oct 25.
537 Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.J Postgrad Med. 2017 Oct-Dec;63(4):257-261. doi: 10.4103/jpgm.JPGM_499_16.
538 Brief Report: Anti-Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjgren's Syndrome.Arthritis Rheumatol. 2018 Oct;70(10):1610-1616. doi: 10.1002/art.40550. Epub 2018 Sep 3.
539 Encephalopathy with upper body hypertonia and myoclonus in patient with systemic lupus erythematosus and anti-CASPR2.Lupus. 2017 Jan;26(1):84-87. doi: 10.1177/0961203316657431. Epub 2016 Jul 17.
540 Genetics of SLE: evidence from mouse models.Nat Rev Rheumatol. 2010 Jun;6(6):348-57. doi: 10.1038/nrrheum.2010.63. Epub 2010 May 4.
541 Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders.Exp Mol Med. 2009 May 31;41(5):354-61. doi: 10.3858/emm.2009.41.5.040.
542 Novel linkage disequilibrium clustering algorithm identifies new lupus genes on meta-analysis of GWAS datasets.Immunogenetics. 2017 May;69(5):295-302. doi: 10.1007/s00251-017-0976-8. Epub 2017 Feb 28.
543 HIGH PREVALENCE OF HYPOTHYROIDISM IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT AN INCREASE IN CIRCULATING ANTI-THYROID ANTIBODIES.Endocr Pract. 2017 Nov;23(11):1304-1310. doi: 10.4158/EP161664.OR. Epub 2017 Aug 17.
544 Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.J Immunol. 2017 Jun 1;198(11):4268-4276. doi: 10.4049/jimmunol.1601705. Epub 2017 Apr 24.
545 Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.Lupus. 2018 Nov;27(13):2076-2085. doi: 10.1177/0961203318804877. Epub 2018 Oct 18.
546 Coordinated Induction of Antimicrobial Response Factors in Systemic Lupus Erythematosus.Front Immunol. 2019 Apr 4;10:658. doi: 10.3389/fimmu.2019.00658. eCollection 2019.
547 Endothelial nitric oxide synthase and nicotinamide adenosine dinucleotide phosphate oxidase p22phox gene (C242T) polymorphisms and systemic lupus erythematosus in a Chinese Population.Lupus. 2010 Feb;19(2):192-6. doi: 10.1177/0961203309348980. Epub 2009 Dec 4.
548 Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Mllerian Hormone.Arthritis Rheumatol. 2017 Jun;69(6):1267-1271. doi: 10.1002/art.40079. Epub 2017 May 3.
549 Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis.Clin Transl Immunology. 2018 Dec 6;7(12):e1042. doi: 10.1002/cti2.1042. eCollection 2018.
550 Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue diseases.Arthritis Rheum. 1997 Aug;40(8):1487-92. doi: 10.1002/1529-0131(199708)40:8<1487::AID-ART18>3.0.CO;2-P.
551 Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians.Hum Mol Genet. 2014 Jan 15;23(2):524-33. doi: 10.1093/hmg/ddt424. Epub 2013 Sep 2.
552 Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.J Clin Immunol. 2010 Sep;30(5):649-58. doi: 10.1007/s10875-010-9429-y. Epub 2010 Jun 9.
553 Regulation of age-associated B cells by IRF5 in systemic autoimmunity.Nat Immunol. 2018 Apr;19(4):407-419. doi: 10.1038/s41590-018-0056-8. Epub 2018 Feb 26.
554 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.J Exp Med. 2003 Mar 17;197(6):711-23. doi: 10.1084/jem.20021553.
555 Functional single-nucleotide polymorphisms in the DEFB1 gene are associated with systemic lupus erythematosus in Southern Brazilians.Lupus. 2012 May;21(6):625-31. doi: 10.1177/0961203312436858. Epub 2012 Feb 9.
556 Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.Rheumatol Int. 2017 Feb;37(2):293-298. doi: 10.1007/s00296-016-3610-4. Epub 2016 Nov 21.
557 Autoantibodies to RNA helicase A: a new serologic marker of early lupus.Arthritis Rheum. 2007 Feb;56(2):596-604. doi: 10.1002/art.22329.
558 Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.Rheumatology (Oxford). 2006 Jun;45(6):694-702. doi: 10.1093/rheumatology/kei244. Epub 2006 Jan 17.
559 The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.Front Immunol. 2018 Feb 12;9:187. doi: 10.3389/fimmu.2018.00187. eCollection 2018.
560 Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature.Pulm Circ. 2019 Aug 9;9(3):2045894019869837. doi: 10.1177/2045894019869837. eCollection 2019 Jul-Sep.
561 An entropy-based genome-wide transmission/disequilibrium test.Hum Genet. 2007 May;121(3-4):357-67. doi: 10.1007/s00439-007-0322-6. Epub 2007 Feb 13.
562 Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk?.Lupus. 2005;14(5):391-8. doi: 10.1191/0961203305lu2104oa.
563 Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus.Pediatrics. 2014 Nov;134(5):e1458-63. doi: 10.1542/peds.2013-1383.
564 Bisphenol A modified DNA: A possible immunogenic stimulus for anti-DNA autoantibodies in systemic lupus erythematosus.Autoimmunity. 2019 Nov-Dec;52(7-8):272-280. doi: 10.1080/08916934.2019.1683545. Epub 2019 Oct 26.
565 Deltex1 suppresses T cell function and is a biomarker for diagnosis and disease activity of systemic lupus erythematosus.Rheumatology (Oxford). 2019 Apr 1;58(4):719-728. doi: 10.1093/rheumatology/key418.
566 DUSP23 is over-expressed and linked to the expression of DNMTs in CD4(+) T cells from systemic lupus erythematosus patients.Clin Exp Immunol. 2017 Feb;187(2):242-250. doi: 10.1111/cei.12883. Epub 2016 Nov 16.
567 Features of the two gene pairs RD-SKI2W and DOM3Z-RP1 located between complement component genes factor B and C4 at the MHC class III region.Front Biosci. 2001 Aug 1;6:D927-35. doi: 10.2741/yang.
568 No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.Clin Endocrinol (Oxf). 1998 Sep;49(3):331-4. doi: 10.1046/j.1365-2265.1998.00542.x.
569 Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: molecular and functional analysis.Arthritis Rheum. 2004 Mar;50(3):871-81. doi: 10.1002/art.20192.
570 PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells.J Immunol. 2008 Sep 1;181(5):3658-64. doi: 10.4049/jimmunol.181.5.3658.
571 Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen.Cytokine. 2020 Aug;132:154631. doi: 10.1016/j.cyto.2018.12.014. Epub 2019 Jan 24.
572 Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.Int J Rheum Dis. 2016 Dec;19(12):1294-1303. doi: 10.1111/1756-185X.12509. Epub 2014 Oct 28.
573 Hypersensitive IFN Responses in Lupus Keratinocytes Reveal Key Mechanistic Determinants in Cutaneous Lupus.J Immunol. 2019 Apr 1;202(7):2121-2130. doi: 10.4049/jimmunol.1800650. Epub 2019 Feb 11.
574 ELF1 is associated with systemic lupus erythematosus in Asian populations.Hum Mol Genet. 2011 Feb 1;20(3):601-7. doi: 10.1093/hmg/ddq474. Epub 2010 Nov 2.
575 Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.BMC Pharmacol Toxicol. 2018 Nov 20;19(1):76. doi: 10.1186/s40360-018-0269-3.
576 ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.Adv Clin Exp Med. 2018 Dec;27(12):1637-1641. doi: 10.17219/acem/75944.
577 Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.Clin Rheumatol. 2018 Oct;37(10):2675-2684. doi: 10.1007/s10067-018-4138-7. Epub 2018 May 17.
578 Molecular analysis of estrogen receptor alpha and beta in lupus patients.Eur J Clin Invest. 2001 Jan;31(1):86-93. doi: 10.1046/j.1365-2362.2001.00762.x.
579 The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block.Clin Exp Immunol. 1996 Jun;104(3):388-93.
580 The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV.Immunity. 2019 Feb 19;50(2):334-347.e9. doi: 10.1016/j.immuni.2018.12.022. Epub 2019 Jan 29.
581 RETRACTED: Bach2 regulates aberrant activation of B cell in systemic lupus erythematosus and can be negatively regulated by BCR-ABL/PI3K.Exp Cell Res. 2018 Apr 1;365(1):138-144. doi: 10.1016/j.yexcr.2018.02.034. Epub 2018 Mar 6.
582 Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus.Med Oncol. 1997 Mar;14(1):31-4. doi: 10.1007/BF02990942.
583 A Rare Variant (rs933717) at FBXO31-MAP1LC3B in Chinese Is Associated With Systemic Lupus Erythematosus.Arthritis Rheumatol. 2018 Feb;70(2):287-297. doi: 10.1002/art.40353. Epub 2018 Jan 9.
584 Sex-specific differences in the relationship between the single-nucleotide polymorphism rs2298804 of FCER1A and the susceptibility to systemic lupus erythematosus in a Chinese Han population.Clin Exp Dermatol. 2013 Jun;38(4):410-6. doi: 10.1111/ced.12035. Epub 2013 Mar 21.
585 Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.Am J Hum Genet. 2013 Jan 10;92(1):28-40. doi: 10.1016/j.ajhg.2012.11.013. Epub 2012 Dec 20.
586 Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus.J Clin Immunol. 2019 May;39(4):421-429. doi: 10.1007/s10875-019-00627-2. Epub 2019 May 1.
587 Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.Hum Mol Genet. 2005 Aug 15;14(16):2469-80. doi: 10.1093/hmg/ddi247. Epub 2005 Jul 13.
588 Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus.Rheumatology (Oxford). 2008 Jul;47(7):996-9. doi: 10.1093/rheumatology/ken125. Epub 2008 Apr 16.
589 A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.Arthritis Res Ther. 2012 Jul 2;14(4):R157. doi: 10.1186/ar3897.
590 A first molecular approach towards CGG repeat expansion in FMR1 gene in systemic lupus erythematosus and in Sjgren's syndrome: a preliminary report.Clin Rheumatol. 2000;19(4):262-4. doi: 10.1007/s100670070042.
591 A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.J Biol Chem. 2011 Sep 16;286(37):32366-72. doi: 10.1074/jbc.M111.245811. Epub 2011 Jul 13.
592 Association of FOXJ1 polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in Korean population.Exp Mol Med. 2007 Dec 31;39(6):805-11. doi: 10.1038/emm.2007.87.
593 Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.Mol Med. 2007 Nov-Dec;13(11-12):561-6. doi: 10.2119/2007-00021.Kuo.
594 Preclinical validation of salivary biomarkers for primary Sjgren's syndrome.Arthritis Care Res (Hoboken). 2010 Nov;62(11):1633-8. doi: 10.1002/acr.20289. Epub 2010 Jul 8.
595 B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus.Front Immunol. 2018 Jun 29;9:1473. doi: 10.3389/fimmu.2018.01473. eCollection 2018.
596 The transcriptional repressor Gfi1 prevents lupus autoimmunity by restraining TLR7 signaling.Eur J Immunol. 2016 Dec;46(12):2801-2811. doi: 10.1002/eji.201646573. Epub 2016 Oct 4.
597 IAN5 polymorphisms are associated with systemic lupus erythematosus.Lupus. 2009 Oct;18(12):1045-52. doi: 10.1177/0961203309106830.
598 Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.Eur J Immunol. 2017 May;47(5):880-891. doi: 10.1002/eji.201646641. Epub 2017 Mar 31.
599 Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.Sci Rep. 2019 Nov 8;9(1):16366. doi: 10.1038/s41598-019-52920-0.
600 16 -Hydroxyestrone induced adduct generate high affinity autoantibodies in SLE.Adv Med Sci. 2019 Mar;64(1):72-78. doi: 10.1016/j.advms.2018.11.002. Epub 2018 Dec 5.
601 Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.Sci Rep. 2017 Nov 28;7(1):16495. doi: 10.1038/s41598-017-16472-5.
602 The molecular mechanism study of insulin in promoting wound healing under high-glucose conditions.J Cell Biochem. 2019 Sep;120(9):16244-16253. doi: 10.1002/jcb.28905. Epub 2019 May 12.
603 Comprehensive Longitudinal Surveillance of the IgG Autoantibody Repertoire in Established Systemic Lupus Erythematosus.Arthritis Rheumatol. 2019 May;71(5):736-743. doi: 10.1002/art.40788. Epub 2019 Mar 24.
604 High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus.Rheumatology (Oxford). 2018 Mar 1;57(3):533-537. doi: 10.1093/rheumatology/kex462.
605 Frontline Science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE.J Leukoc Biol. 2017 Dec;102(6):1313-1322. doi: 10.1189/jlb.3HI0117-005RR. Epub 2017 Jul 28.
606 Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.Ann Rheum Dis. 2013 Mar;72(3):437-44. doi: 10.1136/annrheumdis-2012-201851. Epub 2012 Aug 17.
607 Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients.Sci Rep. 2018 Jun 21;8(1):9442. doi: 10.1038/s41598-018-27782-7.
608 Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.Mol Immunol. 2013 May;54(1):23-31. doi: 10.1016/j.molimm.2012.10.026. Epub 2012 Nov 22.
609 Identifying dynamic pathway interactions based on clinical information.Comput Biol Chem. 2017 Jun;68:260-265. doi: 10.1016/j.compbiolchem.2017.04.009. Epub 2017 Apr 24.
610 HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus.Ann Rheum Dis. 1994 Mar;53(3):188-90. doi: 10.1136/ard.53.3.188.
611 Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone.Clin Exp Immunol. 1996 Nov;106(2):389-95. doi: 10.1046/j.1365-2249.1996.d01-848.x.
612 Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.J Pept Sci. 2002 Dec;8(12):683-94. doi: 10.1002/psc.429.
613 Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.J Neurosci. 2019 Sep 25;39(39):7759-7777. doi: 10.1523/JNEUROSCI.1657-18.2019. Epub 2019 Aug 12.
614 AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.Arthritis Rheum. 2008 Feb;58(2):511-20. doi: 10.1002/art.23306.
615 Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus.Ann Rheum Dis. 2010 Nov;69(11):1983-9. doi: 10.1136/ard.2009.122630. Epub 2010 May 24.
616 Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries.Ann Rheum Dis. 2012 Nov;71(11):1809-14. doi: 10.1136/annrheumdis-2011-201110. Epub 2012 Apr 20.
617 Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA).Kidney Int. 2002 Nov;62(5):1638-49. doi: 10.1046/j.1523-1755.2002.00619.x.
618 Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations.Front Immunol. 2019 Mar 15;10:487. doi: 10.3389/fimmu.2019.00487. eCollection 2019.
619 Clinical trials from the patient perspective: survey in an online patient community.BMC Health Serv Res. 2017 Feb 27;17(1):166. doi: 10.1186/s12913-017-2090-x.
620 Immunoglobulin V-lambda transcription profiling of systemic lupus erythematosus patients reveals biased usage of genes located near the Jlambda-Clambda segments.Scand J Immunol. 2004 Apr;59(4):395-9. doi: 10.1111/j.0300-9475.2004.01407.x.
621 Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility.Genes Immun. 2013 Jun;14(4):217-22. doi: 10.1038/gene.2013.9. Epub 2013 Mar 28.
622 Association of the IKZF1 5' UTR variant rs1456896 with lupus nephritis in a northern Han Chinese population.Scand J Rheumatol. 2017 May;46(3):210-214. doi: 10.1080/03009742.2016.1194458. Epub 2016 Aug 16.
623 In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.Immunobiology. 2017 Mar;222(3):483-493. doi: 10.1016/j.imbio.2016.10.012. Epub 2016 Oct 17.
624 Targeting IL-34 in inflammatory autoimmune diseases.J Cell Physiol. 2019 Dec;234(12):21810-21816. doi: 10.1002/jcp.28946. Epub 2019 Jun 7.
625 Secular trends in the impact factors of SLE publications over a 45-year period-a systematic review.Lupus. 2018 May;27(6):1018-1022. doi: 10.1177/0961203317751855. Epub 2018 Jan 10.
626 High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth.Arthritis Care Res (Hoboken). 2018 Sep;70(9):1303-1311. doi: 10.1002/acr.23485. Epub 2018 Aug 16.
627 IRAK2 is associated with systemic lupus erythematosus risk.Clin Rheumatol. 2020 Feb;39(2):419-424. doi: 10.1007/s10067-019-04781-1. Epub 2019 Oct 25.
628 Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.PLoS One. 2014 Oct 6;9(10):e109764. doi: 10.1371/journal.pone.0109764. eCollection 2014.
629 MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.J Autoimmun. 2017 May;79:105-111. doi: 10.1016/j.jaut.2017.03.003. Epub 2017 Mar 17.
630 PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.JCI Insight. 2019 Oct 17;4(20):e130062. doi: 10.1172/jci.insight.130062.
631 Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus.Am J Health Syst Pharm. 2012 Dec 1;69(23):2072-8. doi: 10.2146/ajhp120179.
632 Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus.Arthritis Rheum. 2006 Apr;54(4):1270-8. doi: 10.1002/art.21733.
633 A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.Hum Mol Genet. 2013 Oct 1;22(19):4021-9. doi: 10.1093/hmg/ddt248. Epub 2013 Jun 4.
634 Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus.Ann Rheum Dis. 1994 Jan;53(1):61-3. doi: 10.1136/ard.53.1.61.
635 Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells.J Immunol. 2009 Sep 1;183(5):3481-7. doi: 10.4049/jimmunol.0900034. Epub 2009 Aug 12.
636 Systemic lupus erythematosus: association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population.Lupus. 2011 Mar;20(3):265-73. doi: 10.1177/0961203310385266. Epub 2011 Jan 13.
637 Circular RNAS: novel biomarkers of disease activity in systemic lupus erythematosus?.Clin Sci (Lond). 2019 May 7;133(9):1049-1052. doi: 10.1042/CS20180826. Print 2019 May 15.
638 MiRNA and mRNA Profiling in Systemic Lupus Reveals a Novel Set of Cytokine - Related miRNAs and their Target Genes in Cases With and Without Renal Involvement.Kidney Blood Press Res. 2017;42(6):1322-1337. doi: 10.1159/000485987. Epub 2017 Dec 15.
639 Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.Clin Exp Med. 2017 Feb;17(1):101-109. doi: 10.1007/s10238-015-0402-1. Epub 2015 Nov 21.
640 Molecular genetic analyses of human NKG2C (KLRC2) gene deletion.Int Immunol. 2004 Jan;16(1):163-8. doi: 10.1093/intimm/dxh013.
641 Downregulation of CD94/NKG2A inhibitory receptor on decreased T cells in patients with systemic lupus erythematosus.Scand J Immunol. 2012 Jul;76(1):62-9. doi: 10.1111/j.1365-3083.2012.02705.x.
642 Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population.PLoS One. 2017 Oct 13;12(10):e0186409. doi: 10.1371/journal.pone.0186409. eCollection 2017.
643 C1q limits dendritic cell differentiation and activation by engaging LAIR-1.Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3160-7. doi: 10.1073/pnas.1212753109. Epub 2012 Oct 23.
644 Laminin-1 (LM-111) in preeclampsia and systemic lupus erythematosus.Autoimmunity. 2013 Feb;46(1):14-20. doi: 10.3109/08916934.2012.730586. Epub 2012 Dec 3.
645 The novel lupus antigen related protein acheron enhances the development of human breast cancer.Int J Cancer. 2012 Feb 1;130(3):544-54. doi: 10.1002/ijc.26015. Epub 2011 May 9.
646 Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus.Clin Rheumatol. 2008 Jan;27(1):21-7. doi: 10.1007/s10067-007-0644-8. Epub 2007 May 11.
647 Downregulated expression of LBH mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.J Dermatol. 2016 Jan;43(1):99-102. doi: 10.1111/1346-8138.13006. Epub 2015 Jun 30.
648 Alterations in nuclear structure promote lupus autoimmunity in a mouse model.Dis Model Mech. 2016 Aug 1;9(8):885-97. doi: 10.1242/dmm.024851. Epub 2016 Jun 9.
649 Deletion of LCE3C_LCE3B is associated with rheumatoid arthritis and systemic lupus erythematosus in the Chinese Han population.Ann Rheum Dis. 2011 Sep;70(9):1648-51. doi: 10.1136/ard.2010.148072. Epub 2011 May 30.
650 Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.Lupus. 2009 May;18(6):539-46. doi: 10.1177/0961203308099973.
651 The expression and clinical significance of different forms of LILRA3 in systemic lupus erythematosus.Clin Rheumatol. 2019 Nov;38(11):3099-3107. doi: 10.1007/s10067-019-04624-z. Epub 2019 Jun 17.
652 Serum leucine-rich 2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.Clin Chim Acta. 2018 Nov;486:253-258. doi: 10.1016/j.cca.2018.08.020. Epub 2018 Aug 14.
653 Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients.Clin Exp Rheumatol. 2010 Mar-Apr;28(2):158-68. Epub 2010 May 13.
654 An intronic variant associated with systemic lupus erythematosus changes the binding affinity of Yinyang1 to downregulate WDFY4.Genes Immun. 2012 Oct;13(7):536-42. doi: 10.1038/gene.2012.33. Epub 2012 Sep 13.
655 Association analysis of polymorphisms in lumican gene and systemic lupus erythematosus in a Taiwan Chinese Han population.J Rheumatol. 2011 Nov;38(11):2376-81. doi: 10.3899/jrheum.101310. Epub 2011 Sep 1.
656 Differential tissue expression of erythroblast macrophage protein in a MRL/lpr mouse model of lupus.Lupus. 2019 Jun;28(7):843-853. doi: 10.1177/0961203319851572. Epub 2019 May 27.
657 MAGE Xp-2: a member of the MAGE gene family isolated from an expression library using systemic lupus erythematosus sera.Mol Genet Metab. 1998 Jan;63(1):3-13. doi: 10.1006/mgme.1997.2639.
658 Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.Front Immunol. 2018 May 28;9:1191. doi: 10.3389/fimmu.2018.01191. eCollection 2018.
659 Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4(+) T cells in systemic lupus erythematosus.Clin Epigenetics. 2017 Sep 22;9:104. doi: 10.1186/s13148-017-0405-8. eCollection 2017.
660 Predictive value of the neutrophil-to-lymphocyte ratio and hemoglobin insystemic lupus erythematosus.Exp Ther Med. 2018 Aug;16(2):1547-1553. doi: 10.3892/etm.2018.6309. Epub 2018 Jun 13.
661 Single-nucleotide polymorphisms of MAMDC1 are associated with rash and photosensitivity, but not disease risk, of systemic lupus erythematosus in Chinese mainland population.Clin Rheumatol. 2011 Oct;30(10):1373-8. doi: 10.1007/s10067-011-1794-2. Epub 2011 Jun 10.
662 Estradiol targets T cell signaling pathways in human systemic lupus.Clin Immunol. 2009 Dec;133(3):428-36. doi: 10.1016/j.clim.2009.09.002. Epub 2009 Sep 30.
663 Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci.Hum Mol Genet. 2017 Mar 15;26(6):1205-1216. doi: 10.1093/hmg/ddx026.
664 A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts.Eur J Hum Genet. 2019 Mar;27(3):432-441. doi: 10.1038/s41431-018-0297-x. Epub 2018 Nov 20.
665 Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning.Ann Rheum Dis. 2018 Jul;77(7):1078-1084. doi: 10.1136/annrheumdis-2018-213093. Epub 2018 Apr 6.
666 Association Between Major Histocompatibility Complex Class I Chain-Related Gene Polymorphisms and Susceptibility of Systemic Lupus Erythematosus.Am J Med Sci. 2017 Oct;354(4):430-435. doi: 10.1016/j.amjms.2017.06.003. Epub 2017 Jun 12.
667 Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.Int J Rheum Dis. 2018 Dec;21(12):2071-2078. doi: 10.1111/1756-185X.13381. Epub 2018 Dec 16.
668 Necroptotic cell binding of (2) -glycoprotein I provides a potential autoantigenic stimulus in systemic lupus erythematosus.Immunol Cell Biol. 2019 Oct;97(9):799-814. doi: 10.1111/imcb.12279. Epub 2019 Jun 12.
669 Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies.Arthritis Rheum. 1992 Dec;35(12):1483-91. doi: 10.1002/art.1780351212.
670 Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.Lupus. 2011 Jul;20(8):820-8. doi: 10.1177/0961203310397964.
671 Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.J Clin Invest. 2015 Jul 1;125(7):2877-90. doi: 10.1172/JCI81059. Epub 2015 Jun 22.
672 The ERM Protein Moesin Regulates CD8(+) Regulatory T Cell Homeostasis and Self-Tolerance.J Immunol. 2017 Nov 15;199(10):3418-3426. doi: 10.4049/jimmunol.1700074. Epub 2017 Oct 4.
673 Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice.J Biol Chem. 2008 May 16;283(20):13825-33. doi: 10.1074/jbc.M801275200. Epub 2008 Mar 19.
674 Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.Immunogenetics. 1993;38(6):421-9. doi: 10.1007/BF00184522.
675 Cervical neoplasia in systemic lupus erythematosus: a nationwide study.Rheumatology (Oxford). 2017 Apr 1;56(4):613-619. doi: 10.1093/rheumatology/kew459.
676 Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-nave lupus nephritis, but not in those under immunosuppressive treatment.Mod Rheumatol. 2018 Jul;28(4):661-669. doi: 10.1080/14397595.2017.1404711. Epub 2017 Nov 30.
677 MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population.Hum Immunol. 2007 Jul;68(7):610-5. doi: 10.1016/j.humimm.2007.03.006. Epub 2007 Apr 10.
678 Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.Arthritis Res Ther. 2018 Jan 30;20(1):13. doi: 10.1186/s13075-018-1511-5.
679 Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese.Arch Dermatol Res. 2008 Feb;300(2):91-3. doi: 10.1007/s00403-007-0814-1. Epub 2007 Nov 13.
680 Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis.Arthritis Rheum. 2009 Jul;60(7):2124-30. doi: 10.1002/art.24618.
681 Discovery of a novel genetic susceptibility locus on X chromosome for systemic lupus erythematosus.Arthritis Res Ther. 2015 Dec 3;17:349. doi: 10.1186/s13075-015-0857-1.
682 Energetics and evasion dynamics of large predators and prey: pumas vs. hounds.PeerJ. 2017 Aug 17;5:e3701. doi: 10.7717/peerj.3701. eCollection 2017.
683 Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.Arthritis Rheum. 2006 Jun;54(6):1906-16. doi: 10.1002/art.21890.
684 The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFN production.PLoS One. 2010 Nov 30;5(11):e15080. doi: 10.1371/journal.pone.0015080.
685 Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry.J Rheumatol. 2013 Jun;40(6):842-9. doi: 10.3899/jrheum.120989. Epub 2013 May 1.
686 Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks.J Autoimmun. 2019 Feb;97:48-58. doi: 10.1016/j.jaut.2018.10.002. Epub 2018 Nov 1.
687 E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.J Autoimmun. 2013 Mar;41:152-60. doi: 10.1016/j.jaut.2013.01.004. Epub 2013 Jan 20.
688 Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016.Rheumatol Int. 2019 Dec;39(12):2069-2075. doi: 10.1007/s00296-019-04450-1. Epub 2019 Sep 30.
689 Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus.Autoimmunity. 2012 Jun;45(4):271-8. doi: 10.3109/08916934.2011.637532. Epub 2012 Feb 7.
690 The NBS1 genetic polymorphisms and the risk of the systemic lupus erythematosus in Taiwanese patients.J Clin Immunol. 2010 Sep;30(5):643-8. doi: 10.1007/s10875-010-9427-0. Epub 2010 Jun 23.
691 Purification, microsequencing, and immunolocalization of p36, a new interferon-alpha-induced protein that is associated with human lupus inclusions.J Biol Chem. 1996 Jan 12;271(2):1118-26. doi: 10.1074/jbc.271.2.1118.
692 NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients.Front Pharmacol. 2018 May 7;9:460. doi: 10.3389/fphar.2018.00460. eCollection 2018.
693 Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.Clin Rheumatol. 2007 Feb;26(2):186-90. doi: 10.1007/s10067-006-0260-z. Epub 2006 Mar 25.
694 Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients.Lupus. 2008 Sep;17(9):805-13. doi: 10.1177/0961203308089694.
695 Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus.Clin Rheumatol. 2015 Jan;34(1):71-9. doi: 10.1007/s10067-014-2799-4. Epub 2014 Oct 26.
696 Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.Arthritis Rheumatol. 2014 Dec;66(12):3413-23. doi: 10.1002/art.38879.
697 Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease.Mod Rheumatol. 2019 Jul;29(4):612-618. doi: 10.1080/14397595.2018.1508801. Epub 2018 Sep 5.
698 ORMDL3 Facilitates the Survival of Splenic B Cells via an ATF6-Endoplasmic Reticulum Stress-Beclin1 Autophagy Regulatory Pathway.J Immunol. 2017 Sep 1;199(5):1647-1659. doi: 10.4049/jimmunol.1602124. Epub 2017 Jul 26.
699 Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.Front Immunol. 2018 Oct 2;9:2090. doi: 10.3389/fimmu.2018.02090. eCollection 2018.
700 Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.JCI Insight. 2018 Dec 6;3(23):e124729. doi: 10.1172/jci.insight.124729.
701 The PBX1 lupus susceptibility gene regulates CD44 expression.Mol Immunol. 2017 May;85:148-154. doi: 10.1016/j.molimm.2017.02.016. Epub 2017 Mar 1.
702 Antiphospholipid antibodies impact the protein C (PC) pathway behavior.Am J Hematol. 2002 Oct;71(2):128-30. doi: 10.1002/ajh.10180.
703 Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.Am J Hum Genet. 2011 Jan 7;88(1):83-91. doi: 10.1016/j.ajhg.2010.11.014. Epub 2010 Dec 30.
704 Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line.Clin Immunol. 2006 Sep;120(3):326-34. doi: 10.1016/j.clim.2006.06.002. Epub 2006 Jul 20.
705 Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus.Eur Cytokine Netw. 2007 Dec;18(4):181-7. doi: 10.1684/ecn.2007.0103. Epub 2007 Oct 26.
706 Can SLE classification rules be effectively applied to diagnose unclear SLE cases?.Lupus. 2017 Feb;26(2):150-162. doi: 10.1177/0961203316655212. Epub 2016 Jul 11.
707 PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes.Ann Rheum Dis. 2019 Apr;78(4):509-518. doi: 10.1136/annrheumdis-2018-214116. Epub 2019 Jan 24.
708 Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus.J Rheumatol. 2010 Aug 1;37(8):1639-45. doi: 10.3899/jrheum.091420. Epub 2010 Jun 1.
709 Heat shock protein 27 and its regulatory molecules express differentially in SLE patients with distinct autoantibody profiles.Immunol Lett. 2015 Mar;164(1):25-32. doi: 10.1016/j.imlet.2015.01.007. Epub 2015 Feb 2.
710 Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.Arthritis Rheum. 2005 Apr;52(4):1171-9. doi: 10.1002/art.21000.
711 Elevated beta-thromboglobulin and mean platelet volume levels may show persistent platelet activation in systemic lupus erythematosus patients.Adv Clin Exp Med. 2018 Sep;27(9):1279-1283. doi: 10.17219/acem/74389.
712 ASE-1: an autoantigen in systemic lupus erythematosus.Lupus. 2000;9(9):681-7. doi: 10.1191/096120300670803230.
713 Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.JCI Insight. 2017 Jan 12;2(1):e89569. doi: 10.1172/jci.insight.89569.
714 Clinical and serological findings associated with the expression of ITGAL, PRF1, and CD70 in systemic lupus erythematosus.Clin Exp Rheumatol. 2014 Jan-Feb;32(1):113-6. Epub 2013 Nov 15.
715 Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence.Kidney Int. 2005 Jul;68(1):110-20. doi: 10.1111/j.1523-1755.2005.00385.x.
716 Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus.Hum Mol Genet. 2015 Jan 1;24(1):274-84. doi: 10.1093/hmg/ddu429. Epub 2014 Aug 22.
717 Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus.J Rheumatol. 2003 Jun;30(6):1208-14.
718 The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.Clin Rheumatol. 2018 Jun;37(6):1573-1580. doi: 10.1007/s10067-018-4031-4. Epub 2018 Mar 15.
719 Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus.Clin Pharmacokinet. 2020 Mar;59(3):335-347. doi: 10.1007/s40262-019-00818-5.
720 Deletion variants of RABGAP1L, 10q21.3, and C4 are associated with the risk of systemic lupus erythematosus in Korean women.Arthritis Rheum. 2013 Apr;65(4):1055-63. doi: 10.1002/art.37854.
721 Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.Immunology. 2007 Nov;122(3):371-80. doi: 10.1111/j.1365-2567.2007.02649.x. Epub 2007 Jul 3.
722 Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.Arthritis Rheum. 2006 Jul;54(7):2220-7. doi: 10.1002/art.21967.
723 Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.Arthritis Rheumatol. 2018 Dec;70(12):2046-2056. doi: 10.1002/art.40585. Epub 2018 Oct 1.
724 Deficiency of Rap1-binding protein RAPL causes lymphoproliferative disorders through mislocalization of p27kip1.Immunity. 2011 Jan 28;34(1):24-38. doi: 10.1016/j.immuni.2010.12.010. Epub 2010 Dec 30.
725 Autoimmune antibodies to hnRNPG protein in dogs with systemic lupus erythematosus: epitope mapping of the antigen.J Autoimmun. 2002 May;18(3):221-9. doi: 10.1006/jaut.2002.0584.
726 Roquin--a multifunctional regulator of immune homeostasis.Genes Immun. 2016 Mar;17(2):79-84. doi: 10.1038/gene.2015.58. Epub 2015 Dec 17.
727 Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes invitro.Immunology. 2016 Sep;149(1):48-61. doi: 10.1111/imm.12628.
728 Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.Cytokine. 2018 Nov;111:20-27. doi: 10.1016/j.cyto.2018.08.002. Epub 2018 Aug 8.
729 Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H234-H242. doi: 10.1152/ajpheart.00174.2019. Epub 2019 May 24.
730 Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells.Autophagy. 2020 Jan;16(1):28-37. doi: 10.1080/15548627.2019.1630223. Epub 2019 Jun 18.
731 Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.Hum Genet. 2019 Feb;138(2):141-150. doi: 10.1007/s00439-018-01966-7. Epub 2019 Feb 1.
732 The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response.PLoS Pathog. 2017 Mar 8;13(3):e1006264. doi: 10.1371/journal.ppat.1006264. eCollection 2017 Mar.
733 Assessment of the translational value of mouse lupus models using clinically relevant biomarkers.Transl Res. 2014 Jun;163(6):515-32. doi: 10.1016/j.trsl.2014.01.003. Epub 2014 Jan 6.
734 Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.Immunol Res. 2017 Dec;65(6):1110-1123. doi: 10.1007/s12026-017-8952-9.
735 Mesangial Cell Mammalian Target of Rapamycin Complex 1 Activation Results in Mesangial Expansion.J Am Soc Nephrol. 2017 Oct;28(10):2879-2885. doi: 10.1681/ASN.2016111196. Epub 2017 Jul 12.
736 Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient.Immunology. 1995 Nov;86(3):487-94.
737 Prevalence of anti-S100A10 antibodies in antiphospholipid syndrome patients.Thromb Res. 2019 Jul;179:15-19. doi: 10.1016/j.thromres.2019.04.027. Epub 2019 Apr 24.
738 SAMHD1 prevents autoimmunity by maintaining genome stability.Ann Rheum Dis. 2015 Mar;74(3):e17. doi: 10.1136/annrheumdis-2013-204845. Epub 2014 Jan 20.
739 SCARF1: a multifaceted, yet largely understudied, scavenger receptor.Inflamm Res. 2018 Aug;67(8):627-632. doi: 10.1007/s00011-018-1154-7. Epub 2018 May 3.
740 Increased soluble CD4 in serum of rheumatoid arthritis patients is generated by matrix metalloproteinase (MMP)-like proteinases.PLoS One. 2013 May 21;8(5):e63963. doi: 10.1371/journal.pone.0063963. Print 2013.
741 Decellularized liver transplant could be recellularized in rat partial hepatectomy model.J Biomed Mater Res A. 2019 Nov;107(11):2576-2588. doi: 10.1002/jbm.a.36763. Epub 2019 Aug 9.
742 Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.Clin Exp Immunol. 2017 May;188(2):234-242. doi: 10.1111/cei.12924. Epub 2017 Feb 17.
743 The -675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population.Autoimmunity. 2020 Mar;53(2):71-77. doi: 10.1080/08916934.2019.1700957. Epub 2019 Dec 12.
744 Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.Clin Epigenetics. 2016 Nov 24;8:126. doi: 10.1186/s13148-016-0294-2. eCollection 2016.
745 Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response.EBioMedicine. 2019 Jul;45:578-587. doi: 10.1016/j.ebiom.2019.06.038. Epub 2019 Jun 28.
746 AhR-ROR-t complex is a therapeutic target for MAP4K3/GLK(high)IL-17A(high) subpopulation of systemic lupus erythematosus.FASEB J. 2019 Oct;33(10):11469-11480. doi: 10.1096/fj.201900105RR. Epub 2019 Aug 1.
747 Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Fas(lpr) Mice.Cells. 2019 Apr 30;8(5):402. doi: 10.3390/cells8050402.
748 Systemic lupus erythematosus in a patient with Noonan syndrome-like disorder with loose anagen hair 1: More than a chance association.Am J Med Genet A. 2018 Jul;176(7):1662-1666. doi: 10.1002/ajmg.a.38834. Epub 2018 May 7.
749 Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry.J Immunol. 2019 May 15;202(10):3103-3112. doi: 10.4049/jimmunol.1801640. Epub 2019 Apr 15.
750 Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.Rheumatology (Oxford). 2017 Jun 1;56(6):1025-1030. doi: 10.1093/rheumatology/kew498.
751 Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.J Autoimmun. 2019 Jun;100:114-119. doi: 10.1016/j.jaut.2019.03.008. Epub 2019 Mar 25.
752 Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.Front Immunol. 2019 Aug 28;10:2058. doi: 10.3389/fimmu.2019.02058. eCollection 2019.
753 Defective DNA double-strand break repair in pediatric systemic lupus erythematosus.Arthritis Rheum. 2012 Feb;64(2):568-78. doi: 10.1002/art.33334.
754 Pathways of impending disease flare in African-American systemic lupus erythematosus patients.J Autoimmun. 2017 Mar;78:70-78. doi: 10.1016/j.jaut.2016.12.005. Epub 2017 Feb 2.
755 Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3551-6. doi: 10.1073/pnas.0306267101. Epub 2004 Feb 26.
756 Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'.Biochem Biophys Res Commun. 2001 Aug 3;285(5):1206-12. doi: 10.1006/bbrc.2001.5302.
757 Immunoscreening of phage-displayed cDNA-encoded polypeptides identifies B cell targets in autoimmune disease.Biochem Biophys Res Commun. 2002 Oct 18;298(1):169-77. doi: 10.1016/s0006-291x(02)02421-x.
758 Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus.Clin Rheumatol. 2018 Mar;37(3):703-707. doi: 10.1007/s10067-017-3886-0. Epub 2017 Nov 18.
759 Enhanced transcription of the gene encoding the SmN autoantigen in patients with systemic lupus erythematosus does not result in enhanced levels of the SmN protein.Autoimmunity. 1994;19(2):81-7. doi: 10.3109/08916939409009535.
760 STAT signaling as a marker of SLE disease severity and implications for clinical therapy.Autoimmun Rev. 2019 Feb;18(2):144-154. doi: 10.1016/j.autrev.2018.08.010. Epub 2018 Dec 18.
761 The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.Clin Exp Med. 2008 Dec;8(4):179-85. doi: 10.1007/s10238-008-0006-0. Epub 2008 Sep 27.
762 Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus.Arthritis Rheum. 2011 Mar;63(3):755-63. doi: 10.1002/art.30188.
763 Autoantibodies to alpha-fodrin in primary Sjgren's syndrome and SLE detected by an in vitro transcription and translation assay.Clin Exp Rheumatol. 2003 Jan-Feb;21(1):49-56.
764 Novel Autoantibodies Related to Cell Death and DNA Repair Pathways in Systemic Lupus Erythematosus.Genomics Proteomics Bioinformatics. 2019 Jun;17(3):248-259. doi: 10.1016/j.gpb.2018.11.004. Epub 2019 Sep 5.
765 Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.
766 Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.J Clin Invest. 2019 Dec 2;129(12):5411-5423. doi: 10.1172/JCI127949.
767 The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.Br J Dermatol. 2006 Mar;154(3):445-9. doi: 10.1111/j.1365-2133.2005.07044.x.
768 A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.PLoS One. 2019 Dec 2;14(12):e0225651. doi: 10.1371/journal.pone.0225651. eCollection 2019.
769 Altered Homeostasis of Regulatory T Lymphocytes and Differential Regulation of STAT1/STAT5 in CD4+ T Lymphocytes in Childhood-onset Systemic Lupus Erythematosus.J Rheumatol. 2020 Apr;47(4):557-566. doi: 10.3899/jrheum.181418. Epub 2019 Jul 1.
770 Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus.Clin Immunol. 2016 Aug;169:1-7. doi: 10.1016/j.clim.2016.06.003. Epub 2016 Jun 6.
771 Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus.Int J Rheum Dis. 2018 Jan;21(1):186-193. doi: 10.1111/1756-185X.13089. Epub 2017 May 25.
772 Promoter polymorphisms of the TIM-4 gene are correlated with disease activity in patients with systemic lupus erythematosus.Int J Immunogenet. 2017 Jun;44(3):122-128. doi: 10.1111/iji.12316. Epub 2017 Mar 31.
773 Association of novel polymorphisms in TMEM39A gene with systemic lupus erythematosus in a Chinese Han population.BMC Med Genet. 2017 Apr 20;18(1):43. doi: 10.1186/s12881-017-0405-8.
774 Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.Clin Immunol. 2009 Dec;133(3):422-7. doi: 10.1016/j.clim.2009.08.014. Epub 2009 Sep 12.
775 TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus.Blood. 2004 Jul 1;104(1):184-91. doi: 10.1182/blood-2003-12-4274. Epub 2004 Mar 4.
776 DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.J Rheumatol. 2013 Aug;40(8):1316-26. doi: 10.3899/jrheum.121285. Epub 2013 Jun 1.
777 An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation.J Invest Dermatol. 2020 Feb;140(2):348-360.e11. doi: 10.1016/j.jid.2019.06.147. Epub 2019 Aug 15.
778 Genetic Alleles Associated with SLE Susceptibility and Clinical Manifestations in Hispanic Patients from the Dominican Republic.Curr Mol Med. 2019;19(3):164-171. doi: 10.2174/1566524019666190424130809.
779 TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.Immunogenetics. 2013 Oct;65(10):703-9. doi: 10.1007/s00251-013-0717-6. Epub 2013 Jul 9.
780 The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity.Nat Immunol. 2015 May;16(5):495-504. doi: 10.1038/ni.3143. Epub 2015 Apr 6.
781 TREX1 polymorphisms associated with autoantibodies in patients with systemic lupus erythematosus.Rheumatol Int. 2008 Jun;28(8):783-9. doi: 10.1007/s00296-007-0509-0. Epub 2007 Dec 19.
782 Trib1 Is Overexpressed in Systemic Lupus Erythematosus, While It Regulates Immunoglobulin Production in Murine B Cells.Front Immunol. 2018 Mar 15;9:373. doi: 10.3389/fimmu.2018.00373. eCollection 2018.
783 The 52 000 MW Ro/SS-A autoantigen in Sjgren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.Immunology. 2002 Jun;106(2):246-56. doi: 10.1046/j.1365-2567.2002.01417.x.
784 Association of an IRF5 gene functional polymorphism with Sjgren's syndrome.Arthritis Rheum. 2007 Dec;56(12):3989-94. doi: 10.1002/art.23142.
785 SS-56, a novel cellular target of autoantibody responses in Sjgren syndrome and systemic lupus erythematosus.J Clin Invest. 2001 Sep;108(6):861-9. doi: 10.1172/JCI13469.
786 Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?.Front Immunol. 2019 Jul 17;10:1684. doi: 10.3389/fimmu.2019.01684. eCollection 2019.
787 TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.Scand J Immunol. 2011 Feb;73(2):147-53. doi: 10.1111/j.1365-3083.2010.02486.x.
788 TSPAN33 is a novel marker of activated and malignant B cells.Clin Immunol. 2013 Dec;149(3):388-99. doi: 10.1016/j.clim.2013.08.005. Epub 2013 Aug 15.
789 Coherent somatic mutation in autoimmune disease.PLoS One. 2014 Jul 2;9(7):e101093. doi: 10.1371/journal.pone.0101093. eCollection 2014.
790 Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.Clin Immunol. 2008 Oct;129(1):31-5. doi: 10.1016/j.clim.2008.07.011. Epub 2008 Aug 16.
791 CCL genes in multiple sclerosis and systemic lupus erythematosus.J Neuroimmunol. 2008 Aug 30;200(1-2):145-52. doi: 10.1016/j.jneuroim.2008.05.016. Epub 2008 Jul 3.
792 Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study.Lupus. 2019 Jul;28(8):995-1002. doi: 10.1177/0961203319856089. Epub 2019 Jun 10.
793 Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.Front Immunol. 2019 Jan 25;10:29. doi: 10.3389/fimmu.2019.00029. eCollection 2019.
794 Association of the RAVER2 gene with increased susceptibility for ulcerative colitis.Hum Immunol. 2012 Jul;73(7):732-5. doi: 10.1016/j.humimm.2012.04.018. Epub 2012 May 2.